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Isoflavones are phytoestrogens, belonging to a group of phenolic compounds found in 
soybeans and soy foods. The parent isoflavones in soybeans are genistein, daidzein and 
glycitein, while their respective glucosides are genistin, daidzin and glycitin. Others 
include their corresponding acetyl and malonyl glucosides. These compounds have been 
associated with the decreased incidence of different types of cancers, cardiovascular 
diseases and osteoporosis. With the several health benefits associated with these 
compounds, this research work was set out to examine the effect of processing on the 
content and composition of isoflavones in different soy products during their manufacture 
as well as to study the content and composition of various soy based health products, 
supplements and infant formulas. 
 
Initial investigations were aimed at choosing an ideal method for efficient extraction of 
isoflavones, followed by its quantification. An RP-HPLC method was developed and it 
was applied for the quantification of isoflavones in different soy based products, which 
proved successful. LC-MS using ESI interface, was further used for the peak 
identification studies. 
 
Evaluation of the effect of different extraction methods and UHT heat treatments on 
isoflavones in the prepared soymilks was carried out. Samples were drawn at different 
points during the processing and were analyzed for their isoflavone concentrations. 
Results showed that hot grinding caused a higher extraction of isoflavones into the 
 ix
soymilk than cold-grinding process. However, direct or indirect heating in the UHT 
process did not cause a difference in the concentration of isoflavones in the final soymilk 
obtained. Tofu was made by the coagulation of soymilk with salt or acid to produce a soy 
protein gel which traps water, soy lipids and other constituents in the matrix. Firm tofu 
was prepared using different coagulants and the quantification of isoflavones in the tofu 
and separated whey were carried out. This study further evaluated the yield and physical 
properties such as the moisture, texture and color of tofu prepared from different 
coagulants. Among the different coagulants studied, calcium sulfate was identified as the 
most suitable coagulant for tofu making in terms of its high yield, retention of maximum 
amount of isoflavones and in obtaining a firm, but smooth tofu. Selecting an appropriate 
processing condition can therefore result in retaining higher amounts of isoflavones in the 
soy products; soymilk or tofu, thus reducing their loss into the by-products of the process. 
 
 Analysis of isoflavones in different soy based health products and supplements were also 
carried out, and the possible isoflavone intake, calculated according to the recommended 
dosage levels showed a higher degree of variability from product to product. Similarly, 
soy based infant formulas had wide variations in their isoflavone levels. This research 
also highlights the need for expressing the concentration of isoflavones in a standardized 
manner, namely, in aglycone equivalent concentrations to minimize the differences in the 
molecular weights of the different isoflavones in different products. 
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INTRODUCTION AND LITERATUR REVIEW 
 
1.1 SOYBEAN 
1.1.1 Origin of soybeans 
Soybeans are believed to have originated in China 4000-5000 years ago. The first written 
record of the plant was contained in the book Materia Medica by the Chinese emperor 
Shen Nong in about 2838 B.C. (Anonymous, 1993). The soybean was considered one of 
the five sacred grains, along with rice, wheat, barley and millet essential to Chinese 
civilization. However large-scale production of soybean varieties did not occur until the 
1920’s.  Since that time, world production of soybeans has increased by 400% 
(Anonymous, 1993). Much of the demand for soybeans in the United States, other 
developed countries and in many Asian countries derives from its popularity as a cooking 
oil source and as a base for margarine and other consumer products. 
 
1.1.2 Agronomic characteristics  
Botanically, soybean belongs to the family Leguminosae, subfamily Papilionoideae and 
the genus Glycine, L (Liu, 1997). The cultivated form, called Glycine max (L.) Merrill, 
grows annually. The seeds are nearly spherical in shape with an average seed weight of 
120-180mg. Soybean is well known for its variation in physical properties as well as in 




1.1.3 Composition of soybean 
An excellent source of good quality protein, the soybean consists of about 38 percent 
protein, which is about double the protein content of even the other protein-rich legumes; 
18% oil, 15% soluble carbohydrates, 15% insoluble carbohydrates and 14% other 
components (moisture and ash). The average chemical composition of soybean seed on a 
dry weight basis is shown in Table 1.1 (Liu, 1997). 
 
Table 1.1: Average chemical composition of soybean seed (dry weight basis) 
     Whole soybeans U .S. soybeans (%) Japanese soybeans (%) 
     Crude protein 40.70 39.20 
     Crude fat 22.50 18.40 
     Carbohydrate 31.90 37.40 
     Ash (mineral) 4.90 5.00 
 
Most plant sources are deficient in one or more of the essential amino acids. Soybean is 
no exception and is limiting in methionine, followed by cyst(e)ine and threonine (Eggum 
and Beames, 1983). However, soy protein contains sufficient lysine, which is deficient in 
most cereal proteins. It is also unique because of the presence of isoflavones. Isoflavones 
have an extremely limited distribution in nature, while soybeans and soy foods can be 
considered as the major natural dietary sources of these compounds (Coward et al., 
1993). Increasing evidence has indicated that soybeans might have cancer-preventive 
properties by epidemiological (Adlercreutz et al., 1986; Lee et al., 1991), animal 
(Baggot et al., 1990) and in vitro (Adlercreutz et al., 1992; Wei et al., 1993) studies. 
Results from these studies have suggested that the isoflavones might be the contributing 
factors in prevention of cancer. These compounds also possess estrogenic (Miksicek, 
1993), antioxidative (Naim et al., 1976; Wei et al., 1993) and antifungal 
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(Weidenborner et al., 1990) properties. Recently there has been much interest among 
clinicians and researchers, in the potential role of soybeans and soy foods in preventing 
and treating chronic diseases. 
 
1.2 SOY FOODS 
Soybeans have been incorporated into the popular human diet throughout Asian countries 
(Wang and Murphy, 1996). These soy containing foods are traditionally divided into 
two groups: fermented and non-fermented. The non-fermented soy foods include fresh 
soybeans, soymilk, tofu, soybean sprouts and toasted soy protein flours. Miso, natto, soy 
sauce and tempeh are representatives of the fermented soy food group. A group of soy 
foods often referred to as ‘soy-added second-generation soy foods’ recently started 
appearing in the market, include the soy hot dog, soy bacon, tempeh burger, soy yogurt, 
soy Parmesan cheese, soy-Cheddar, soy-noodles etc (Wang and Murphy, 1994). 
However, they contain considerable amounts of non-soy ingredients in them. 
 
1.2.1 Soymilk 
Soymilk is a colloidal solution that is obtained as a water extract from swelled and 
ground soybeans. It is a very popular beverage consumed in the Orient. It is especially 
important for people who are allergic to lactose in cow’s milk and is an attractive 
alternative to cow’s milk. It is sugar and cholesterol free (Chinyere et al., 1997) and is 




1.2.1.1 Composition of soymilk 
Soymilk and cow’s milk have approximately the same protein content (3.5 – 4.0%). The 
main deficiency of soybean protein as compared with the protein content of cow’s milk 
and human milk is that of the sulfur containing amino acids. The chemical composition 
of typical soymilk is presented in Table 1.2, along with those of cow’s milk and human 
milk (Chen, 1989). 
 
Table 1.2: Composition of soymilk, cow’s milk and human breast milk 
Item/100g Soymilk Cow’s milk Human milk 
Calorie 44.00 59.00 62.00 
Water (g) 90.80 88.60 88.20 
Protein 3.60 2.90 1.40 
Fat 2.00 3.30 3.10 
Carbohydrates 2.90 4.50 7.10 
Ash 0.50 0.70 0.20 
Saturated fatty acids (%) 40 - 48 60 - 70 55.30 
Unsaturated fatty acids (%) 52 - 60 30 - 40 44.70 
Cholesterol (mg) 0 9.24 - 9.90 9.30 - 18.60 
 
Soymilk is traditionally and still commonly made by soaking the soybeans in excess 
water, draining, grinding with additional water, extracting the raw soymilk from the soy 
pulp residue (okara) and cooking the soymilk (Liu, 1997). Figure 1.1 shows the 






                             Water                           Soaking 
 
                Water                   Grinding 
 






                      Coagulant                        Coagulation 
 




Figure 1.1: Schematic diagram for production of soymilk and tofu 
 
1.2.1.2 Status of soymilk in Asian countries 
Singapore imports more than 50,000 tons of soybeans annually, which are used mainly 
for the production of soymilk, tofu, soy sauce, and soybean oil (Ang et al., 1985). There 
are many small backyard industries producing soymilk daily by the traditional method. 
The milk is usually sold freshly prepared in glasses or in take-away plastic bags and is 
consumed daily by persons in all age groups and in all economic strata. Large industrial 
productions of soymilk using modernized methods and sophisticated equipment resulted 
in soymilks packed in bottles, tetrapak, cartons and tear tab cans which are sterilized 
either by the conventional sterilization methods or by the ultra high temperature (UHT) 
treatment methods. However, in order to help the consumers enjoy quality soymilk and to 
prevent the production of a much diluted soymilk, many countries have established 
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soymilk quality standards. Table 1.3 shows the standards established for soymilk in some 
Asian countries (Chen, 1989). 
 
Table 1.3:  Soymilk standards followed in Asian countries 
 
 
Country  Product        Protein (%)    Fat                      Total solids (%) 
 
 
Singapore soymilk  2.0   
  soy drink           <2.0 
Thailand soymilk  2.0               1.0 (from soybean) 
Japan  soymilk  3.8                       8.0 
  soy drink             1.8            4.0 
Taiwan soymilk  3.4     2.0 
  soy drink             1.4     1.0 
 
 
In Singapore, the standard of identity for ‘soymilk’ specifies a minimum protein content 
of 2% (Soy foods association of America, 1996). Though higher protein soymilk has a 
slightly darker color, Singapore consumers prefer this slightly off-white color, associating 
it with a richer and creamier product. 
 
1.2.1.3 Soymilk preparation methods 
Preparation of soymilk in the Orient (traditional soymilk preparation method) basically 
involves the overnight soaking of whole soybeans in water which are then washed and 
ground with fresh water at a bean: water ratio of 1: 8 to 1:10. The slurry is filtered, 
whereby the okara is separated and the filtrate is boiled for a few minutes.  This method 
of soymilk preparation is commonly used by both Chinese and Japanese people. The 
soymilk so obtained not only has a residual soybean flavor and aroma, but also a 
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characteristic aftertaste frequently described as “beany”, “painty”, “rancid” or even 
“bitter”. Lipoxygenase (LOX) catalyzes the hydroperoxidation of polyunsaturated lipids 
in the presence of molecular oxygen and the primary products are hydroperoxides. The 
initial products of LOX activity may be degraded into a variety of C-6 and C-9 products 
through the action of hydroperoxide lyases or isomerases. These volatile carbonyl 
compounds including the aldehydes, ketones and alcohols are partly responsible for the 
objectionable odor and off-flavors in soymilk. During the preparation of soymilk, 
soybean is ground with water and the LOX activity is greatly enhanced when the soybean 
is damaged or crushed. Therefore the inactivation of LOX is essential and it is usually 
carried out at a higher temperature (80-100°C) during the preparation of soymilk. 
 
A number of new methods have been developed for soymilk production and a few of 
them have been commercialized. Wilkens et al (1967) developed the Cornell process, 
where unsoaked, dehulled soybeans were ground with hot water. The slurry was 
maintained at a temperature of 80-100°C to inactivate the LOX enzyme, further boiled in 
a steam jacketed kettle for 10min under stirring. After passing through a filter press, the 
resulting soymilk was formulated, bottled, sealed and sterilized at 121°C for 12min. 
Further to this, Nelson et al (1976) developed the Illinois process, where soaking of 
soybeans in water (optionally added with 0.5% NaHCO3) was first carried out followed 
by blanching it in boiled water to inactivate the enzyme. This hydrated bean is further 
ground with cold water, slurry heated and homogenized. A very bland soymilk was 
obtained and the milk felt chalky in the mouth, which prevented its commercial success. 
A rapid hydration hydrothermal cooking process was developed by Johnson et al (1981), 
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where soybeans were ground into flour, made into a slurry in hot water and subjected to 
high pressure steam infusion (154°C for 30 sec). The slurry was adjusted for its solid 
content and centrifuged. A bland flavored soymilk with high yields of solids and protein 
is obtained by this method. 
 
Soymilk is an ideal medium for bacterial growth and hence a thermal treatment is 
necessary to extend its shelf life. Heat processes are involved at several stages during 
soymilk preparation, including the pretreatment of beans and extraction to produce the 
soymilk, followed by either pasteurization or sterilization to increase its shelf life. Most 
commercial methods therefore employ single or multiple heat techniques to improve both 
milk quality and yield.  By controlling the microbiology of the product and packaging it 
in appropriate containers, the shelf life of soymilk can be greatly extended and the 
product can be distributed over a wider area. Three basic types of heat treatments are 
usually carried out to extend the shelf life of soymilk (1) pasteurization (2) in-container 
sterilization (3) ultra-high temperature treatment. The details of heat treatment along with 









Table 1.4: Processes used for the extension of shelf life of soymilk 
 
 
Treatment      Temperature        Time           Package                    Shelf life 
 
 
Pasteurization  75°C           15 sec         plastic bag         1 week 
                             (Refrig.) 
 
Sterilization           121°C           20min             can           2 years 
             glass bottle                 (Non refrig.) 
 
UHT            140°C            2 sec        aseptic pouch              6 – 8months 
                            (Non refrig.) 
Refrig. = refrigeration required; Non refrig.= refrigeration not required 
 
UHT processing involves the use of high temperatures (135 - 150°C) for short time (a 
few seconds) to obtain a product, which is commercially sterile. The advantage of such 
higher temperature treatment for a few seconds is in obtaining sterilization with greatly 
reduced product sensory and nutritional damage. The benefits of UHT sterilization cannot 
be realized in conventional canning due to the long process times needed to achieve high 
temperature. Further an aseptic packaging technology marked the milestone for 
commercialization of soymilks. An aseptic packaging consists of sterilization of the 
packaging material, filling with a sterile product in a sterile environment and thereby 
preventing any re-contamination of the product (Gosta, 1995). Additional advantages 
include low cost, light-weight, easy handling and stocking of products with longer shelf 
life. As a result, it is now used worldwide for the packaging of soymilks (Shurtleff and 
Aoyagi, 1984; Sizer, 1989). There are two main types of UHT processing systems: a 
direct UHT system or an indirect UHT system. In the direct UHT system, the product 
comes in direct contact with the heating medium, followed by flash cooling in a vacuum 
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vessel and further indirect cooling to packaging temperature. The direct systems are 
divided into (1) steam injection systems or (2) steam infusion systems. In an indirect 
UHT system, heat is transferred from the heating media to the product through a 
partition. These are based on plate heat exchangers, tubular heat exchangers or scraped 
surface heat exchangers (Gosta, 1995). After UHT processing, the sterile soymilk is 
aseptically packaged. 
 
Innovative technology developments by companies such as the Prosoya (Prosoya Inc., 
Canada) and TetraPak (TetraPak Co’, USA) have resulted in the evolution of modern 
soymilk processing units with many additional advantages. Lately, Prosoya introduced 
the VS 30/40/200 system while TetraPak introduced the Tetra Ipps Soy4000B system for 
integrated soymilk processing and packaging needs. Every stage of soymilk production 
from soybean handling to UHT treatment and aseptic packaging was achieved by these 
systems. Soymilk with a reduced beany flavor and with high protein content was 
achieved by many of these continuous extraction and processing units. However, reports 
are not available on the evaluation of the isoflavone contents in soymilk prepared from 
these processing systems. The only studies being carried out were on the available lysine, 
thiamin and riboflavin content in soymilk during its thermal processing (Kwok et al., 
1998). More interestingly, the fate of isoflavones on different types of extraction methods 
during such type of soymilk manufacturing is almost unknown. A similar understanding 




1.2.1.4 Soy pulp or okara – the byproduct during soymilk making 
The residue left from ground soybeans after extraction of water extractable fraction used 
to produce soymilk and tofu, is called soy pulp or okara (Liu, 1997). Hackler et al 
(1963) reported as obtaining 1.1 pounds of okara from every pound of soybeans 
processed into soymilk. Okara is a rich source of dietary fiber. It also contains a high 
quality of protein and appreciable amounts of oil. Wang and Cavins (1989) observed 
30% of bean solids, 20% of bean protein and 11% of oil as being retained in okara. The 
summary of proximate composition of okara obtained from two different studies and as 
reported by O’Toole (1997) is shown in Table 1.5. 
 
Table 1.5: Protein, fat, crude fiber and carbohydrates in okara expressed on a dry weight 
basis. 
 
Protein % Crude fat % Crude fiber % Carbohydrate % Reference 
18.20 - 32.20 6.90 - 22.20 9.10 - 18.60 - Bourne et al., 1976 
25.40 - 28.40 9.30 - 10.90 52.80 - 58.10 3.80 - 5.30 Riet et al., 1989 
 
Bourne et al (1976) reported the proximate composition of soymilk residue (hulls 
included) from 30 cultivars with a mean moisture content of 76.8%. Crude fiber values 
reported by Riet et al (1989) was higher than those reported by Bourne et al (1976), but 
the reported soluble fiber levels of 12.6 -14.6% by Riet et al (1989) were similar to the 
levels for crude fiber that the latter reported (Table 1.5), and the. insoluble fiber amounts 
for 40.2 - 43.6% on a dry matter basis. Large quantities of okara produced annually by 
the soymilk and tofu industry pose a significant disposal problem. Okara contains crude 
fiber; namely cellulose, hemi-cellulose and lignin and have little starch or simple 
carbohydrates. Greater consumption of okara can thus cause diarrhea due to its high fiber 
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content. Its use as a human food is constrained by its high fiber content. However, it is a 
suitable dietary additive in biscuits and snacks because it reduces calorie intake and 
increases dietary fiber intake (Khare et al., 1995). A portion of the isoflavones is also 
fractionated into the okara during the preparation of soymilk. 
 
1.2.2 Tofu 
Tofu, also referred to as soybean curd, is a protein rich, bland tasting, non-fermented 
cheese-like product (Shurtleff and Aoyagi, 1979a; Wang and Hesseltine, 1982). It is 
also consumed in significant amounts in Asian countries because of its inexpensive, high 
quality protein (Koury and Hodges, 1968). By definition, it is water-extracted and salt- 
or acid- coagulated soy protein gel with water, soy lipids and other constituents trapped 
in its network (Solomon et al., 2000). Tofu was even judged to be nutritionally 
equivalent to the protein derived from a mixture of eggs, fish and liver (Muto et al., 
1963). 
 
Tofu making process generally involves the preparation of soymilk (i.e, slurried 
soybeans), which is boiled, filtered and then treated at high temperature, with a coagulant 
that precipitates the soy proteins with the concomitant release of curds and whey; the 
curds are filtered off and moulded into shape under pressure. A large amount of original 
soybean mass is unavoidably lost into the okara during the first filtration step. While, tofu 
whey is a byproduct of relatively low nutritive value obtained during the preparation of 
pressed tofu. It also has a disadvantage of containing appreciable amounts of flatulence 
causing carbohydrates (Liener, 1981; Rackis et al., 1981). 
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1.2.2.1 Types of tofu 
Many different types of tofu have appeared in the market. Based on water content and 
textural properties, tofu is generally classified into soft, firm and extra firm tofu. 
Basically, these tofus are made in a similar fashion except for variations in the bean: 
water ratio, the type and concentration of coagulants and the amount of whey being 
pressed out. 
 
Soft or silken tofu contains 88 – 90% moisture and approximately 6% protein. It has a 
soft cheese like texture, but is firm enough to retain its shape after slicing. Silken tofu is 
normally made from soymilk containing 10% solids. Relatively low concentrations of 
calcium sulfate or glucono-δ-lactone (GDL) are used as coagulants for commercial 
production of silken tofu. The coagulant and cold soymilk are mixed, run into a container 
and sealed. The container is then immersed in hot water (85-95°C) for about 45min to 
coagulate the soy protein. The resulting curd is cooled in the container by immersing in 
cold water, after which it is refrigerated. 
 
Firm or extra firm tofus are mostly pressed tofus. There are two basic features in making 
pressed tofus. First, the coagulant is stirred into the hot soymilk rather quickly and 
vigorously. Second, the curds are broken and pressed. The heavier the weight or higher 
the pressure applied, the firmer the tofu. Therefore pressed tofu is ideal for use in pan 
frying, deep frying, freeze-drying and dicing into other foods or soups. Based on the 
methods of subsequent processing, tofu is also classified into plain tofu, frozen tofu, 
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dried-frozen tofu, deep-fried tofu, grilled tofu and fermented tofu. Their preparations 
involve either exposure to severe cold temperatures, further expulsion of water or even 
addition of seasoning ingredients and non soy components like spice powder or sweet 
and sour sauce. These are the many different types of tofu that have appeared in the 
market. 
 
1.2.2.2 Tofu coagulants 
Salts, acids and enzymes are the substances that have the ability to coagulate soy 
proteins. Coagulants commonly used for tofu making are (1) sulfate-type coagulants, 
including calcium sulfate and magnesium sulfate (2) nigari-type or chloride type 
coagulants, including natural nigari and calcium chloride (3) acidic coagulants including 
GDL, citrus juices, acetic acid and lactic acid. Coagulants are sometimes used in 
combinations in order to obtain a tofu of better quality. The most widely used tofu 
coagulant in the world is calcium sulfate, namely the di-hydrate form (CaSO4.2H2O). 
Calcium sulfate is relatively insoluble in water (3.0g/L); and thus it forms a colloidal 
suspension which, though difficult to mix uniformly in soymilk, works well in 
coagulation. It is well suited for modern mass production methods of tofu. In all 
coagulants consisting of calcium or magnesium salts, the positive double-bonded ions of 
calcium or magnesium are responsible for coagulating the soy proteins and hence they 
become part of the tofu and enhance its nutritional value. In terms of their isoflavone 
contents, different coagulants may have different ability to retain isoflavones in the tofu 
prepared, while few reports have discussed such an effect too. 
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1.2.2.3 Tofu gelation mechanism 
Kohyama et al (1995) proposed a gelation mechanism of tofu. They suggested the 
gelation of tofu as a two-step process. The first step, being the protein denaturation by 
heat and the second being the hydrophobic coagulation accelerated by calcium ions. The 
heat denatured soy protein is negatively charged, and the calcium ions from calcium salt 
coagulants neutralize the net charge of the protein in the next step. Aggregation is 
induced due to the hydrophobic interaction of the neutralized protein molecules. Random 
aggregation further resulted in the formation of a gel. In addition to hydrophobic 
interactions, hydrogen bonds and charge-to-charge interactions might also be involved in 
forming the network. 
 
1.2.2.4 Factors affecting the quality attributes of tofu 
The textural properties of tofu play an important part in influencing its quality and 
consumer acceptability, especially because of its bland taste. These include the hardness, 
chewiness, brittleness, elasticity etc, according to definitions by Bourne (1978), which 
can also be experimentally measured by using a textural measuring instrument. Good 
texture of tofu means it should be coherent, smooth and firm but not hard and rubbery. 
However, the yields of tofu are an important attribute of economic importance. High 
protein varieties of soybean yielded tofu with a higher protein content, which had a 
firmer and springy texture than the lower protein varieties (Schaefer and Love, 1992). 
 
Tofu making is a complex interaction of many factors and it is not uncommon to find 
conflicting results among reports. The quality and yield of tofu are influenced by the 
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quality of soymilk and its subsequent coagulation process, while the quality of soymilk 
depends on the variety of soybean used and the preparation conditions of soymilk. 
Coagulation being the most important step in tofu making, it depends on the 
concentration and temperature of soymilk, type and relative amounts of coagulant,  
method of mixing etc. The most difficult part of tofu making is in determining the exact 
concentration of coagulant to be added to the soymilk, since it greatly affects the quality 
and yield of tofu. Whey appearance can also be used as an indication of coagulant 
amounts. Whey becomes transparent with amber or pale yellow color, if proper amount 
of coagulant is used. But, if too much coagulant is added, whey becomes yellowish in 
color with bitter taste and the curds will have a coarse texture.  At a low concentration of 
coagulant, interaction of protein molecules induced by the coagulant is not enough to 
form a firm gel, while at higher concentration, increased interaction lead to compaction 
of protein matrix, resulting in increased syneresis and loss of water, whey protein and 
other soluble solids. Studies by Kao et al (2003) found that tofus with homogenous and 
uniform network with the highest protein recovery are obtained if prepared with optimum 
coagulant concentrations. The temperature of soymilk affects the tofu quality and reports 
suggested (Beddows and Wong, 1987; Wang and Hesseltine, 1982; Ohara et al., 
1992) an optimum temperature range of 70-85°C, because tofu produced below 70°C was 
soft and watery whereas above 85°C the tofu was hard and uneven, with considerable 
loss of bulk yield. Additionally, a smooth and firm tofu is obtained by pouring coagulants 
into soymilk without further mixing, because stronger mixing result in not only hard 
curds, but also low yields (Wang and Hesseltine, 1982). A time period of 20-25min is 
required for the complete coagulation process to occur, after the addition of coagulant to 
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the soymilk. Other factors critical during the pressing and molding of curds are the curd 
temperature, pressure applied to curds and pressing time.  Pressing should be such as to 
allow the association of protein coagula and thereby to increase tofu firmness. 
 
1.2.2.5 Tofu wheys 
Whey is the expelled liquid obtained during the preparation of a firm tofu. The soy 
protein literature considers ‘tofu whey’ as a waste stream that cannot be economically 
processed or may even be toxic (Uzzan and Labuza, 2004). Tofu whey contains a high 
% of oligosaccharide sugars. These flatulence causing factors being removed into the 
whey, the tofu does not cause intestinal gas. Tofu whey contains a smaller % of protein, 
which is mainly of low molecular weight (LMW) proteins with a molecular mass below 
16kDa (Kao et al., 2003). The LMW proteins get well dispersed in the pores of the 
homogeneous network structure with few being dispersed into the whey, if optimum 
coagulant concentrations are used. However, insufficient coagulant concentrations can 
result in the loss of LMW proteins into the tofu whey. A certain amount of isoflavones 
might also be lost into the whey. But there are few reports which have evaluated the 
amount of isoflavones being lost into the tofu wheys (Wang and Murphy, 1996). 
 
1.2.3 Other soy based products 
1.2.3.1 Soy supplements and health products 
Extracted isoflavones are commercially available in the market as dietary supplements. 
Dietary supplements containing soy extracts are more acceptable in many countries and 
they are growing in numbers over the years. Available in the form of capsules and tablets, 
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they are widely commercialized as an alternative therapy for alleviating menopausal 
discomforts, and are also advertised for the prevention of menopause related diseases 
such as osteoporosis (Penalvo et al., 2004). Moreover, the manufacturers of soy 
supplements are often competing to produce a concentrated pill of isoflavones. These 
manufacturers also label these products with high isoflavone contents and thus promoting 
their own individual products as the best. However consumers are often unaware of the 
consequences that may result from a self-induced mega dosing of these compounds 
(Setchell et al., 1997). At high dosages, isoflavones may act as antagonists of estrogen 
(Ren et al., 2001). Very disturbing is the fact that, many soy isoflavone supplements are 
flooded into the market with wide ranging claims and little regulation exits regarding 
their manufacture or efficacy (Setchell et al., 2001). Moreover, the units of labeling the 
concentration of isoflavones done by these manufacturers are many times misleading. 
One of the major issues regarding isoflavones is the question regarding the safety of 
phytoestrogens. There is abundant evidence in animals that phytoestrogens may delay 
reproductive status, as for example infertility observed in captive cheetahs that were fed a 
high phytoestrogen diet. California quail is another example, which has reduced breeding 
owing to a diet rich in phytoestrogens (Fitzpatrick, 2003). There is a paucity of data to 
confirm that isoflavone supplements are as nutritionally effective as isoflavone-rich 
foods. 
 
Additionally, there are the soy based health products, available as ‘health supplements’, 
intended to improve the health of women either for weight management or as 
instantaneous nutritional beverages. These products are commonly prepared from either 
 20
soy protein isolate or soy protein itself. Reports on the analysis of isoflavones in soy 
supplements sold in the United States (Nurmi et al., 2002) and isoflavone levels in oral / 
enteral diets from Brazil (Genovese and Lajolo, 2002) are available, while reports on the  
profile and content of isoflavones in soy supplements and health products from South 
East Asia are fewer. Soy isoflavone supplements and health products are plentiful in 
nutrition/ health shops in Singapore, Malaysia, Thailand and Indonesia. An analysis of 
isoflavone contents in various soy supplements and health products if carried out can be 
useful in evaluating the total amount of isoflavones being ingested after their 
consumption. A standard unit of expressing the concentration of isoflavones in the 
products might be even more appropriate, enabling a direct comparison of the total 
amount of isoflavones in different products available over-the-counter. 
 
1.2.3.2 Soy based infant formulas 
The development of soy based infant formulas (SBIFs) grew out of need for a non-milk 
based formula alternative for infants who had intolerance to lactose.  These are another 
group of foods consumed to a greater extent by infants with allergies to cow’s milk 
protein (Badger et al., 2002). Earlier, SBIFs were made of soy flour which compared 
with soy protein isolate (SPI) had a lower protein content and digestibility. SBIFs have 
several non protein components in it such as soy carbohydrates, fibers, protease inhibitors 
etc. By 1960s soy flour replaced SPI for SBIF making, where the used SPI had a high 
protein digestibility and or corrected amino acid score. Other recommended compounds 
and nutrients were added to SBIF to meet the requirements for the growth of infants. 
However, the recent concerns with SBIFs are with the phytochemicals found in them. 
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Isoflavones being bioactive phytoestrogens with hormonal and non-hormonal activities, 
may cause adverse effects in infants fed soy-based formulas. Studies by Setchell et al 
(1997) showed the isoflavone exposure in infants to be much higher than that of other age 
groups. However, no growth or developmental defects are related to this effect (Merritt 
and Jenks, 2004). Data on the composition of isoflavones in SBIFs are scant, while 
concerns are being expressed about the possibility of hormonal effects from exposure of 
infants to phytoestrogens from SBIFs. Thyroid abnormalities were documented in some 
case studies, where it was associated with ingestion of soy infant formula (Pinchera et 
al., 1965). For infants whose iodine intake is low or borderline or the thyroid function is 
compromised, there is potential for clinical concern. Hypothyroidism is also associated 
with infants fed soybean diets (Fort et al., 1990). 
 
Reports are available on the isoflavone contents in SBIFs from the United States and 
Brazil (Setchell et al., 1998, Genovese and Lajolo, 2002). However, there are few 
reports, in which the SBIFs available in South East Asia have been analyzed 
quantitatively for their isoflavone content. The results of analysis on the isoflavone 
contents in these products if available could be further utilized in calculating the daily 
intake of isoflavones for infants of each age group. Though there are no deleterious 
effects reported with consumption of SBIFs, long term studies to assess the possible 
chronic effects of high isoflavone ingestion levels are necessary. Moreover, the 
isoflavones may adversely affect developmental processes influenced by sex steroids 








al., 2002). Hence it is most essential to evaluate the concentrations of isoflavones in 
SBIFs available in the market and the choice of recommending the formula with lesser 
amounts of these estrogenic compounds can be made possible.  
 
1.3 ISOFLAVONES 
Isoflavones belong to a group of compounds that share a basic structure consisting of two 
benzyl rings joined by a three-carbon bridge, which may or may not be closed in a pyran 
ring.  The structure is generally simplified as C6-C3-C6. This group of compounds is 
known as flavonoids, which include by far the largest and the most diverse range of plant 
phenolics. Besides isoflavones, other subclasses of flavonoids include the red and blue 
anthocyanin pigments, flavones, flavonols, aurones and chalcones (Deshpande et al., 
1984). Isoflavones differ from flavones (Figure 1.2) in that the benzyl ring B is joined at 

















1.3.1 Isomers, Structure and Occurrences 
Soybeans contain three types of isoflavones (Figure 1.3), which are found to exist in four 
chemical forms (Kudou et al., 1991; Barnes et al., 1994; Wang and Murphy, 1994). 
They are the aglycones daidzein, genistein and glycitein; the glucosides daidzin, genistin, 
glycitin; the acetyl glucosides 6''-O-acetyldaidzin, 6''-O-acetylgenistin and 6''-O-
acetylglycitin; the malonyl glucosides  6''-O-malonyldaidzin, 6''-O-malonylgenistin  and  
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R3  R4  R5   Compounds 
H  H  H   Daidzin 
OH  H  H   Genistin 
H  OCH3  H   Glycitin 
H  H  COCH3  6''-O-acetyldaidzin 
OH  H  COCH3  6''-O-acetylgenistin   
H  OCH3  COCH3  6''-O-acetylglycitin 
H  H  COCH2COOH 6''-O-malonyldaidzin 
OH  H  COCH2COOH 6''-O-malonyl genistin 
H  OCH3  COCH2COOH 6''-O-malonylglycitin  





In soybean, isoflavones exist in the entire plant, including the seeds, leaves, stems, 
seedlings and roots. Though isoflavones are present in several species of legumes, most 
of the research has been done on soybean and soy foods, due to the widespread use of 
soybean in traditional and modern foods. In soybeans and foods derived from soy, 
isoflavones are found in different concentrations ranging from < 0.05mg to > 5.00mg/gm 
(Coward et al., 1993; Barnes et al., 1994). 
 
1.3.2 Soy and role of isoflavones in disease prevention 
Apart from the potential cancer prevention effect, isoflavones have also been found to 
have other health benefits, including heart disease prevention, bone mass density increase 
to prevent osteoporosis and the reduction of postmenopausal syndromes in women 
(Dixon and Ferreira, 2002). Isoflavones may have benefit in decreasing the risk of 
cardiovascular diseases by reducing the level of total cholesterol as well as low-density 
lipoprotein cholesterol (Carroll and Kurowska, 1995; Anderson et al., 1999). 
Structural similarities also exist between genistein and tamoxifen, a synthetic anti-
estrogen that has been clinically tested as a chemo-preventive agent in women with high 
risk of breast cancer (Gajdos and Jordan, 2002).  An early epidemiological study of 
Singapore Chinese women that included 420 healthy controls and 200 with histologically 
confirmed breast cancer indicated a direct correlation ship between soy consumption and 
reduced risk of cancer, and the effects appeared to be dietary rather than genetic (Lee et 
al., 1992). An inverse relationship between soy consumption and breast cancer risk was 
also obtained from the case-control studies carried among Japanese (Hirose et al., 1995), 
Asian American (Wu et al., 1996) and Chinese populations (Dai et al., 2001). If it is true 
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that a regular consumption of isoflavones can help reduce the risk of certain diseases, 
then it is a good reason to educate people to consume isoflavone-rich foods. But, a 
confirmation of safety and efficacy is essential for the legal or public acceptance of 
isoflavone related health claims. It is also possible that soy substances other than 
isoflavones, such as the saponins, phytic acid, amino-acid composition or a protein-
isoflavone interaction might be involved for their health benefits (Ren et al., 2001). 
 
1.3.2.1 Soy intake and heart disease 
The cholesterol lowering effects of soy protein has been studied since 1967 (Hodges et 
al., 1967) and was followed by many others. A positive relationship between the starting 
cholesterol level of the subjects and a decrease in serum cholesterol following soy protein 
consumption was also established by Potter et al (1993). Studies by Anderson et al 
(1995) using SPI and texturized soy protein were found to reduce cholesterol and the 
average amount of protein consumed was 47gm/day and a dose-response relationship 
between soy protein and serum cholesterol levels was also explained by these 
researchers. However, it is not well understood whether soy protein or isoflavones or a 
combination of these are responsible for the lowering of cholesterol (Coward et al., 
1998; Nurmi et al., 2002). Studies showed that an isoflavone containing soy product fed 
to rats resulted in a reduction in their cholesterol levels than those fed without isoflavones 
(Anthony et al., 1996). Apparently, the mechanisms associated with soy’s beneficial 
effects on cardiovascular health are not fully understood. Suggested mechanisms of 
action include a reduction in low-density lipoprotein (LDL) cholesterol, an improvement 
in vascular reactivity and an inhibition of platelet aggregation (Asahi et al., 1992; 
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Williams and Clarkson, 1998). The preferential binding of isoflavones to estrogen 
receptor beta (ERβ) and the increasing recognition of the role of this receptor in the 
endothelial walls provide additional justification for increasing awareness of the heart-
health effects of diets rich in these phytoestrogens (Zhu et al., 2002). 
 
The amount of  isoflavones required for lowering the cholesterol can be achieved more 
easily by consumption of soy protein products, while the use of isolated soy protein 
products in the market represent an intermediate approach between diet and drugs. 
However, if isoflavones lower the cholesterol, then these concentrated forms of soy 
protein may not be needed, while incorporating reasonable amounts of soy foods (i.e., 
about two servings) into the diet should be sufficient to lower the cholesterol, because on 
a per protein basis, soy foods are 2 to 3 fold higher in isoflavones than many soy protein 
isolates (Liu, 1997).  
 
1.3.2.2 Soy intake and menopause 
The consumption of soy foods has been proposed for the lower incidence of menopausal 
symptoms in Japanese women (Lock, 1994).  Less than 20% of the Japanese women 
have hot flushes compared with 80% of the European women. This is partly attributed to 
the differences observed in their diet consisting of soy (Murkies et al., 1998). The 
estrogenic effect of isoflavones was an explanation for the above results (Adlercreutz et 
al., 1992), though some conflicting reports also exist (Woods et al., 1996). The targeted 
intake of isoflavones from soy foods has been derived empirically because there are no 
guidelines for optimal levels of intake (Setchell, 2000). Most of the studies suggested the 
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consumption of soy isoflavones, intact with soy protein so as to reduce hot flushes 
(Germain et al., 2001; Knight et al., 2001). This might be considered as a healthy 
alternative to hormone replacement therapy (HRT). More research is still required to 
understand the magnitude and significance of hormonal effects of soy consumption and 
to determine the extent to which soy foods can be a substitute for HRT. Many 
menopausal women are opting to take soy isoflavone supplements as an alternative to 
postmenopausal hormone therapy and for improving bone health. Though soy 
consumption appears to exert modest hormonal effects in both pre- and post menopausal 
women (Kurzer, 2000), the effects are generally in the direction of providing positive 
health benefits. However, an exact definition on the dose and composition of isoflavone 
conjugates required for such type of disease alleviations has not been determined. 
 
1.3.2.3 Soy intake and bone health 
Osteoporosis is often associated with women in menopause. Studies by Tham et al 
(1998) suggest a diet rich in isoflavones as having a protective effect on bone mineral 
density. Similarity in structure also exists between soy isoflavones and ipriflavone, a drug 
used to inhibit bone resorption (Valente et al., 1994). Ipriflavone is metabolized to 
daidzein, which itself is a soy isoflavone. Erdman et al (1996) found that the 
consumption of isolated soy protein containing isoflavones as significantly improving the 
bone mineral density in the lumbar spine relative to controls who were given 
casein/nonfat dry milk per day. The possible mechanisms of action to explain the 
beneficial effects of isoflavones on bone loss include preventing urinary calcium loss, 
beneficial effects on osteoblasts and influences on the secretion of calcitonin which 
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suppresses bone resorption (Kurzer and Xu, 1997).  However, data supporting claims 
that isoflavone consumption improves bone health are not as strong as the data on lipid 
lowering and reduction of menopausal symptoms. More long term studies are required on 
bone density and fracture rates to determine safety, efficacy and appropriate dosages for 
these compounds. 
 
Soybeans are also a rich source of calcium. Calcium from soy is well absorbed by human 
body, to the same extent as it is absorbed from dairy milk (Heaney et al., 1991). 
Reducing calcium excretion is important for optimizing bone calcium retention. The 
somewhat lower sulfur amino acid content of soy protein may help reduce calcium 
excretion in comparison to animal protein (Pennington, 1998). 
 
1.3.2.4 Soy intake and breast health 
Epidemiological data supporting an inverse relationship between soy isoflavones and 
breast health are probably weak at best.  Some studies reported inverse associations 
between soy intake and breast cancer risk in Asian populations (Lee et al., 1991) while 
this was not observed for some other case control studies (Horn-Ross et al., 2001).  Soy 
isoflavones may be cancer preventive, if taken early in life. Effects in adulthood are less 
clear, and it is possible that they actually stimulate the growth of established breast 
cancer cells. According to Peterson and Barnes (1991), soy isoflavones can function as 
antiestrogens when administered in a high estrogen environment found pre-
menopausally. While in vitro studies by Zava and Duwe (1995) in an estrogen-free 
environment showed that genistein stimulates the growth of estrogen-sensitive breast 
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cancer cells. Thus the time of life of exposure to phytoestrogens may actually determine 
whether the effects on carcinogenesis are beneficial. There is a particular concern about 
soy consumption in breast cancer patients taking tamoxifen because of the potential for 
isoflavones to interfere with the efficacy of this drug. 
 
1.3.2.5 Major concerns about soy supplements and health products 
Soy isoflavone supplements contain relatively high concentrations of isoflavones, mainly 
in the form of β-glycoside conjugates. When ingested, the conjugated isoflavones 
undergo hydrolysis by β–glucosidases in the jejunum and the aglycones, daidzein and 
genistein are released. Further metabolism occurs in the intestine resulting in the 
formation of specific metabolites. However, till today there is no evidence to support the 
absorption of conjugated forms of isoflavones. Moreover, it is the aglycones that are 
explained as having an affinity for estrogen receptors and other non-hormonal effects on 
the cell machinery. A study by Izumi et al (2000) conducted on Japanese women also 
reported isoflavone aglycones (fermented soybean extract) as more efficiently absorbed 
than the isoflavone glucosides (unfermented soybean extract). In Asian countries soy 
intake is a marker of traditional diet and lifestyle. Positive health effects between soy 
intake and health evolved mainly from the Asian population, which occurred after 
consumption of soy foods like soymilk and tofu rather than from soy supplements.  Many 







1.3.3 Isoflavones as phytoestrogens 
Phytoestrogens are phenolic compounds that are natural components of certain plant 
foods and are structurally similar to mammalian estrogens.  Estrogens are hormones that 
our bodies make and are required for normal growth and development and to maintain 
good health.  Estrogens are not only essential for the female reproductive system, but are 
also important for the bones, the heart and possibly the brain. Though phytoestrogens 
have estrogenic activity in humans, their activity is much lower than that of human 
estrogens.  As a result phytoestrogens inhibit the activity of human estrogens and may 
provide desirable effects, for example in reducing the risk of breast cancer. 
 
Isoflavones represent one of the classes of the so called phytoestrogens (Setchell, 1998), 
are the bioactive non-nutrients that are strikingly similar in chemical structure to estradiol 
(Figure 1.4), the main female hormone. Superimposing the structure of isoflavones and 
estradiol, they become indistinguishable, and therefore fit beautifully into the pocket 
representing the binding domain of the estrogen receptor.  Isoflavones therefore share 
many of the properties of endogenous estrogens and have the ability to behave as 






Figure 1.4: Structure of estradiol  
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Estrogens form complex with proteins called estrogen receptors (ERs). These complexes 
“dock” at sites within selected genes in the cell nucleus, switching those genes on or off. 
Cells have two types of estrogen receptors, α and β. Recent research has shown that 
human estrogen has a high binding affinity for the α-receptor while isoflavones have a 
high affinity for the β-receptor (Kuiper et al., 1998). The predominance of ERβ in the 
cardiovascular system suggests that soy isoflavones may be partly responsible for the 
lower incidence of heart disease (Kuiper et al., 1997; Cassidy and Faughnan, 2000) 
 
1.3.4 Absorption and metabolism 
The definition for “bioavailability” is the “rate and extent to which the active ingredient 
or moiety is absorbed from a drug product and become available at the site of action” 
(Uzzan and Labuza, 2004). Thus the bioavailability of isoflavones is usually evaluated 
in terms of its plasma concentration and or urinary excretion. 
 
Following oral ingestion, β–glucosidases, which are produced by intestinal bacteria, 
metabolize the glucosidic isoflavones to their corresponding aglycones. Before 
absorption occurs, however, intestinal bacteria may further metabolize the isoflavone 
aglycones to isoflavone metabolites, specifically genistein to p-ethyl phenol and daidzein 
to equol and or O-desmethylangolensin (ODMA), all of which may also be absorbed 
(Heinonen et al., 1999). Following absorption, isoflavones undergo hepatic conjugation 
to glucuronic acid or sulphate (Setchell 1998; Setchell and Cassidy, 1999) to produce 
forms that are measured in biological fluids. Thus intestinal bacteria are central for the 
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absorption and metabolism of isoflavones. A clear pattern of relative bioavailability 
among the different aglycones or the corresponding conjugates is unknown. The main 
difficulty in finding a clear pattern seems to be the large variability among individuals 
concerning bioavailability and metabolites produced. Possible reasons might be the gut 
microflora, intestinal transit time, pH and redox potential (Munro et al., 2003).  
 
Furthermore, Setchell et al (2002) reported that isoflavone glucosides were not absorbed 
intact across the enterocyte of healthy adults, and the glucoside forms must be hydrolyzed 
for it to be absorbed. This suggests that consuming isoflavone aglycone-rich soy foods 
may be more effective in preventing chronic diseases. Improving the bioavailability of 
isoflavones from soy foods therefore requires both the enrichment of isoflavone aglycone 
prior to consumption and the modulation of intestinal microflora via the ingestion of 
viable bacteria. This knowledge also led to the development of aglycone-enriched 
products (Park et al., 2001; Tsangalis et al., 2003). Human bioavailability of 
isoflavones from soy products was also evaluated by Xu et al (1994), who found 
daidzein as more bioavailable than genistein and according to them, approximately 85% 
of isoflavones degraded in the intestine when 12 adult women received single doses of 
isoflavones in soymilk as part of a liquid diet. 
 
The level of isoflavonoids were found to be high in the urine and plasma of the Japanese 
and the Chinese (Adlercreutz et al., 1991), whose traditional foodstuffs contained large 
amount of soy in the form of bean curd (tofu), soymilk, miso and tempeh. These groups 
are considered to have a low risk for development of breast and other hormone dependent 
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cancers. Among the isoflavones, genistein has been reported to be the most potent 
inhibitor of cancer cell growth (Pandjaitan et al., 2000). However, ‘isolated isoflavones’ 
were found not to have the ability to lower the cholesterol in humans (Dewell et al., 
2002; Fitzpatrick, 2003). Long term effects of consuming high doses of extracted 
isoflavones or their safety and the efficacy are still unknown. Thus the natural soy protein 
matrix might be crucial in this respect. 
 
1.3.5 Adverse effects of phytoestrogens 
Contrary to health benefits, dietary soy intake has also been associated with increased 
bladder cancer incidence (Divi et al., 1997), thyroid disorders (Phillips et al., 1998; 
Ibarreta et al., 2001), breast cell hyperplasia (Petrakis et al., 1996) and dementia 
(White et al., 1996). Some studies have raised concerns about potential adverse effects 
from soy-based formula intake in infants as a result of high circulating phytoestrogen 
concentrations (Setchell et al., 1997) and the potential for early and premature estrogenic 
effects in infants (Irvine et al., 1995, Sheehan, 1998) and its ability to modify sex 
steroid metabolism (Fitzpatrick, 2003). Research is still needed to evaluate the safety of 
phytoestrogens on human systems, to find out their beneficial and harmful doses, gender 
differences in response to phytoestrogens, differences in the chemical classes of 
phytoestrogens and the effects phytoestrogens may have with other drugs or dietary 
products.  
 
Although it may be difficult for adults to consume sufficiently large quantities of 
isoflavones from normal dietary sources to cause the type of deleterious effects 
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previously experienced by several animal species (Bennetts et al., 1946), there is a 
distinct possibility of risk associated with the use of these compounds as uncontrolled 
over-the-counter pharmacologic agents, because estrogens exhibit biphasic responses that 
are highly dose dependent. Thus certain regulations on soy isoflavone supplements sold 
in health or nutrition shops are urgently required. Or at least there is a need for necessary 
information to be made available to the physicians, so that the consumption of 
isoflavones can be regulated on the advice of a physician. 
 
1.4 SOY ISOFLAVONES - ANALYSIS AND PROCESSING EFFECTS   
1.4.1 Methods for extraction and analysis of soy isoflavones 
Efficient extraction of the relatively polar isoflavones from foodstuffs requires the use of 
polar solvents (Coward et al., 1993). Solvent extraction methods are commonly used for 
isoflavones. These methods can extract all the different isoflavone forms as such, and a 
detailed data about the conjugated forms and aglycones are obtained. But the main 
disadvantage of this method is the poor stability of the ‘ester glucoside’ standards in 
solution and that compromises the precision of analyses and limits its application as a 
reliable routine method. Moreover, it is very difficult to procure these standards. 
Efficiencies of different extraction solvents were tested by many researchers (Wang et 
al., 1990; Barnes et al., 1994) and it was found that 80% aqueous methanol (MeOH) was 
as equally superior to 80% acetonitrile-0.1% HCl, another commonly used extraction 
solvent. Extractions of isoflavones using 80% MeOH at various temperatures are also 
being studied by some researchers (Coward et al., 1998). Extraction carried out at room 
temperature caused a slight conversion of the 6-O-malonyl glucoside (6OMalGlc) 
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conjugates to the β–glucoside conjugates, while if carried out at 80°C caused an 
extensive conversion of 6OMalGlc conjugates to β–glucoside conjugates (Coward et al., 
1998). But if the extraction is carried out at 4°C, highest concentrations of 6OMalGlc 
conjugates are obtained. Though the composition of the individual β–glucoside 
conjugates extracted can be drastically altered by temperature, the total amount of 
isoflavones extracted remains constant. An enzyme hydrolysis (Liggins et al., 1998) or 
acid hydrolysis (Mazur et al., 1996) of the soybean extract is sometimes applied for the 
quantification of isoflavones. 
 
Different analytical techniques including GC-MS (Mazur et al., 1996; Liggins et al., 
1998), electrochemical and fluorometric analysis (Adlercreutz and Mazur, 1997) have 
been applied for the determination of isoflavones in soybeans and soy foods. Naim et al 
(1974) prepared the trimethyl derivatives of genistein, daidzein etc and quantified them 
by gas-liquid chromatography, while Shihabi et al (1994) developed capillary 
electrophoresis techniques for the separation of isoflavones. Mazur et al (1996) modified 
the method by isotope dilution gas chromatography-mass spectrometry in a selected ion 
monitoring mode for quantitative measurement of isoflavones. Though several analytical 
methods for isoflavone analysis are utilized, high performance liquid chromatography 
(HPLC) technique is the most often applied method for separation and quantitative 
analysis of isoflavone from soybeans and soy products (Wang and Murphy, 1994; 




1.4.2 Concentration of isoflavones in soybeans and soy foods 
High concentrations of isoflavones are found in raw soybeans. Franke et al (1999) found 
an average of 2mg/gm of total isoflavones in soybean seeds relative to dry weight, but the 
concentrations varied depending on a variety of factors such as genetic, environmental, 
harvesting and processing conditions (Tsukamoto et al., 1995). The majority of 
isoflavones in soybeans are in the form of malonyl glucosides, while aglycones and 
acetyl glucosides are the minor components (Kudou et al., 1991). Japanese soybeans 
have a higher ratio of 6''-O-malonyl isoflavones to glucosides than do American soybeans 
(Wang and Murphy, 1994). Moreover, the effect of crop year on isoflavone 
concentrations seems to be more influential than that of its growth location (Wang and 
Murphy, 1994). 
 
Murphy et al (1999) carried out analysis of several institutional soy foods and found the 
level of isoflavones in soymilk, tempeh, tofu etc from the American market. They found 
a higher concentration of malonyl glucosides in the soybean seeds. While aglycones were 
the predominant forms in fermented soy products such as the tempeh and miso. 
Aglycones are formed by the action of β–glucosidases of the fermentation organisms. 
Soy sauce was found to be a poor source of isoflavones as the fermentation organisms 
probably degraded them. Further to this, Franke et al (1999) did a comparative study of 
isoflavone contents in a small group of soy foods from Hawaii and Singapore. They 
observed a mean total isoflavone levels in soy food groups within a range of 0.035 -7.50 
mg/gm, with the lowest values observed in soymilk and highest values in soybean seeds. 
However, they found no consistent pattern when the isoflavone amounts were compared 
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between the same food groups from Hawaii and Singapore. No conclusion was therefore 
derived from this study. An understanding of the protein content of the products was not 
carried out by these researchers. Neither did they evaluate the relationship between the 
protein content nor isoflavone amounts in these products.  
 
Traditionally, soy foods are consumed in high quantities in South East Asian countries 
(Murphy et al., 1999) and the most frequently consumed items being the soymilk and 
tofu. They are commonly served in food courts as well as in supermarkets and the 
consumption of these products continue to increase, since people are becoming more 
health conscious. However, there are few published reports that give quantitative data on 
the concentration of isoflavones in soy foods from Singapore, Malaysia, Thailand, 
Indonesia etc, while data available are mainly drawn after analysis of foods from USA, 
Brazil and Finland. Because of the ever increasing use of these soybean products, 
especially in the region, it was necessary to know the concentration of these biologically 
active compounds, isoflavones, in various commercial products consumed by the people 
of South East Asia. There are several ongoing clinical studies as well to explore the 
relationship between soy consumption and reduction in risk of many diseases (Seow et 
al., 1998; Jakes et al., 2002). Moreover, to evaluate the potential of isoflavones as 
health-enhancing dietary compounds, their exact concentrations in typical soy foods need 
to be quantified. It is therefore crucial to determine the qualitative and quantitative 
composition of isoflavones in selected soy foods commonly consumed by the multiethnic 
population in the region. 
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1.4.3 Effects of processing on isoflavone levels 
The chemistry of isoflavone conjugates altered during the commercial processing of soy 
into food products and further depended on the extent to which consumers cooked these 
soy foods (Setchell, 1998). The original conjugation pattern of soy foods with 
predominating malonates changed as a function of treatment by heat and bacterial 
fermentation (Kudou et al., 1991). Processing results in intra-conversions of isoflavones 
between the different forms, while cooking of soy products in water resulted in leaching 
of isoflavones into the cooking water (Setchell et al., 1998; Grun et al., 2001).  
 
In non-fermented soy foods, isoflavones are present almost exclusively as their glycosidic 
conjugates, whereas in fermented soy products, such as miso, soybean paste and tempeh, 
a large proportion of the isoflavones are in the unconjugated forms (Coward et al., 1993; 
Wang and Murphy, 1994). Conjugation patterns of the isoflavonoids are significantly 
affected by the style and duration of cooking, as well as their interaction with other 
ingredients (Setchell et al., 1997). Baking or frying of textured vegetable protein at 
190°C and baking of soy flour in cookies does not alter the total isoflavone content, but 
there was a steady increase in β–glucoside conjugates at the expense of 6OMalGlc 
conjugates. Dry heat, as in toasting of soy flour causes the decarboxylation of malonyl 
glucosides and leads to the formation of substantial amounts of the acetyl glucosides. In 
general, moist heating causes conversion to β–glucoside conjugates and dry heat results 
in the formation of 6-O-acetyl glucoside conjugates. Thus the normal cooking conditions 
do not reduce the concentration of isoflavone in soy foods, since the thermal treatments 
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only alter the isoflavone conjugate profiles, while the total isoflavone concentrations do 
not change. But as the food is burned, a decrease in total isoflavones will result. 
 
Process engineering of the common soy foods and ingredients are traditionally optimized 
for higher yield along with functionality and organoleptic properties, while isoflavone 
content has not been a major concern. Ultimately the processing of soybeans affects the 
nutritional content of the soy food products significantly. For example, textured soy 
protein is a unique product prepared by extrusion of soy isolates or soy concentrates. 
Alternatively, soy protein concentrates can be produced with an ethanol-washing step, 
resulting in an ingredient with almost no isoflavones (Song et al., 1998).  Wang and 
Murphy (1996) studied the mass balance of isoflavones during the manufacture of 
tempeh, tofu, soymilk and soy protein isolate. The main losses of isoflavones were 
related to the manufacturing steps such as: soaking (12%) and heat processing (49%) in 
tempeh production, coagulation (44%) in tofu processing, and alkaline extraction (53%) 
in soy protein isolate production. Grun et al (2001) studied the kinetics of tofu heating 
and found a decrease in the total isoflavone content because of leaching into cooking 
water, but the cooking water was not analyzed in their study. Therefore, the distribution 
of isoflavones in commercial soy food products is determined by the variety of soybeans, 
the storage conditions of raw materials and products, the processing conditions and 
dilution with non-soy ingredients. 
 
Different types of extraction procedures are being followed by different manufacturers 
for the preparation of soymilk. The extraction procedure used for the preparation of 
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soymilk might have a significant influence towards the retention of isoflavones in the 
final product. Moreover, in large-scale production of soymilk, the continuous high-
temperature, short time processes often substitute the normal low-temperature, long-time 
thermal processes. The advent of ultra high temperature (UHT) treatment processing and 
aseptic packaging has further contributed to the production of long-life soymilk packaged 
aseptically in paper-plastic cartons, which are more convenient for transportation, 
distribution and storage (Gosta, 1995). However, an understanding on the concentration 
of these beneficial phytochemicals in the soymilk prepared by different extraction 
methods or processing conditions are nearly unknown. Therefore, an evaluation on the 
isoflavone contents in the soymilk obtained after a particular extraction method and UHT 
treatment process was considered essential during this study. 
 
In a similar way, coagulation of soymilk is the most important step in the tofu-making 
process and different types of coagulants are used for its preparation. The thermal 
denaturation, aggregation and gelation properties of soy proteins during tofu making have 
been intensively investigated by many researchers (Lakemond et al., 2002; Mujoo et 
al., 2003). However, the loss of isoflavones might be significant when the soy beverage is 
coagulated to form tofu and the type of coagulant may have a different influence towards 
the retention of isoflavones in tofu and whey. But, little information is available on the 
effect of various coagulants on the level of isoflavones in tofu. An evaluation of the 
quality parameters, together with an understanding of isoflavone levels in tofu prepared 
from different coagulants, might be essential in knowing the nutritive quality of the 
obtained tofu. Moreover, the released whey has proteins associated with it and a certain 
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amount of isoflavones might be lost into it. But, there was no literature available which 
evaluated the retention of isoflavones in tofu or whey with regard to the coagulant used 
for the tofu preparation. A detailed study in this respect can provide information about 
the functional benefits and physical properties of tofu obtained after using different 
coagulants. The data on the loss of isoflavones into the whey while using different 
coagulants might also be useful in process optimization for the maximum retention of 
isoflavones into the tofu. Such an evaluation study was considered crucial during this 
research. 
 
1.4.4 Methods for reporting the concentration of isoflavones 
Some confusion exists on how the isoflavone content of a product shall be expressed. 
Setchell and Cole (2003) reported that the isoflavone content of products are 
occasionally expressed without indicating whether the stated amount refers to aglycone 
or glycoside value. This distinction is critical because the sugar moiety does not 
contribute to the biological activity and the aglycone present only 60% of the glycoside 
weight. Therefore, the total isoflavone content of a food sample is not the simple sum of 
the mass of the 12 isomers present in the food. The normalized concentrations of each 
isoflavone (daidzein, glycitein and genistein) need to be reported. Therefore the need for 
standardization of expressing the concentration of isoflavones in soy products in terms of 
aglycone equivalent amounts was considered important during this study.  More 
confusion can be avoided if these are expressed in molar values, but this has not been the 
convention within the scientific community for food labeling (Erdman et al., 2004).  
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1.5 OBJECTIVES OF THE STUDY 
The objectives of the study are as follows: 
♦ The initial objective of this study was to identify an extraction procedure for the 
efficient extraction of isoflavones from soy based products with minimum co-
extractives. Further aim of the study was to develop a method for the quantification of 
isoflavones in different soy based samples using HPLC method. The second objective 
of this study was to understand if there is any relationship between the protein content 
and isoflavone amounts in soymilk and tofu samples. It was hypothesized that a higher 
amount of isoflavones are present in soymilk and tofu samples with higher protein 
content. 
 
♦ The amount of isoflavones in commercially available soy based supplements, health 
products and infant formulas varied. An understanding of the actual amounts and 
composition of isoflavones in these commercially available products was also part of 
this study.  
 
♦ The types of processing have had a significant influence on the level of isoflavones in 
soymilk and tofu. With the novel and cost-effective methods of making soymilk in 
industry, it is important to know the effect of processing conditions on the extractability 
of isoflavones into the soymilk. Therefore the third objective of this study was to 
evaluate the loss or improvement in the extraction of isoflavones into the soymilk by 
hot grinding of soybeans compared to cold grinding. Soymilks are subjected to UHT 
treatment processes for extending its shelf life. Understanding the fate of isoflavones in 
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soymilk obtained from a direct UHT process compared to an indirect UHT process was 
also part of this study. 
 
♦ Different types of coagulants are used for the preparation of a firm tofu. The retention 
of isoflavones in the prepared tofu and wheys varied with the type of coagulant used for 
its preparation. Understanding the effect of different coagulants on the level of 
isoflavones in the tofu and whey was another objective of this study. Evaluating the 
quality parameters of the prepared tofu was also part of this study. This study was thus 
aimed at identifying the best coagulant that might result in a better quality tofu with a 




MATERIALS AND METHODS  
 
2.1 MATERIALS  
2.1.1 Chemicals  
1) Acetonitrile, HPLC grade 
2) Acetic acid, glacial 
3) Sodium hydroxide  
4) Methanol, HPLC grade 
5) Calcium sulfate CaSO4.2H2O 
6) Calcium chloride CaCl2.2H2O 
7) Magnesium sulfate MgSO4.7H2O 
8) Magnesium chloride MgCl2.6H2O 
9) Calcium acetate Ca(CH3COO)2 
10) Calcium lactate (CH3CHOHCOO)2Ca.5H2O 
11) Isoflavone standards 
Acetic acid and sodium hydroxide pellets were purchased from Merck (Darmstadt, 
Germany), while all the other chemicals except isoflavone standards were purchased 
from Sigma Chemical Co. (St Louis, USA). Authentic standards of daidzin (C21H20O9), 
genistin (C21H20O10), glycitin (C22H22O10), daidzein (C15H10O4), genistein (C15H10O5) and 




Bio-Rad protein assay dye reagent and bovine serum albumin standard were purchased 
from Bio-Rad Laboratories (Hercules, USA) and were used for the protein estimation in 
various soy based samples. HPLC-grade water was obtained from a Milli-Q purification 
system (Millipore Corp., Bedford, USA) and was used for preparing all solutions 
throughout this research. 
 
2.1.2 Food materials 
2.1.2.1 Commercially available brands of soymilk and tofu samples 
Different brands of commercially available samples of soymilk and tofu were purchased 
from supermarkets, cold storages or retail outlets in Singapore, Malaysia, Indonesia and 
Thailand and they were analyzed for their moisture content, protein content and 
isoflavone concentrations. The commercially available soymilks collected from all these 
countries were mostly obtained in tetrapak® forms. Few branded soymilk products were 
found in Indonesia and Thailand, while a wider variety of branded soymilk products was 
found in Malaysia than in Singapore. Two varieties of tofu were obtained: the soft and 
the firm tofu types. Soymilk and tofu samples were stored at a temperature range of 2-
7°C after their purchase and they were analyzed within a day of purchase. 
 
2.1.2.2 Preparation of soymilk – Traditional method 
Soymilk was prepared by traditional processes either to obtain soymilk (9o brix) itself or 
to obtain soymilk (12o brix) suitable for the preparation of tofu.  
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Soymilk was prepared in the pilot plant of a local soymilk processing industry by the 
traditional method.  Identity preserved soybean seeds and particularly the ‘Harovinton’ 
cultivar was obtained from a local supplier and was used as the raw material for this 
study. Soybean seeds were soaked in water at ambient temperature for a period of 5 hr, 
rinsed and ground in water at a bean: water ratio of 1:4. The resultant slurry was cooked 
at 100°C for more than 15min and passed through a centrifugal separator to remove the 
soy residue (okara). The raw soymilk thus obtained had an approximate soluble solids 
content of 9o brix as obtained by a refractometer (Abbe Model 3T, Atago, Japan). The 
okara from the traditional soymilk preparation method was also collected separately and 
was stored at -20°C until analyzed, in order to prevent any deterioration in its quality. 
Care was always taken to analyze every sample within a day or two. 
 
Raw soymilk with approximately 12o brix was prepared and used for the preparation of 
firm tofu. The prepared tofus were evaluated for their isoflavone concentrations to 
understand the effect of different coagulants towards the retention of isoflavones during a 
firm tofu making. 
 
2.1.2.3 Preparation of soymilk – UHT processing system 
The preparation of soymilk by the UHT processing system was carried out in a pilot plant 
provided by a private firm in Singapore (name withheld). Sampling points at different 
stages of the manufacturing process is shown in Figure 2.1. Therefore a comparative 
study on the amounts of isoflavones in the final product obtained from two different 
extraction methods and from two different UHT treatment methods was made easier. The 
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analysis of samples at different stages of the process also helped in evaluating the 
comparative amounts of isoflavone glucosides and aglycones in each sample with respect 
to the treatments it has undergone. 
 
Identity preserved ‘Harovinton’ soybean seeds were obtained from a local seed supplier 
who provided the same cultivar for all the trials. Dehulled soybeans were either hot 
ground or cold ground, using a disc mill (Fryma Grinder, FrymaKoruma AG, 
Switzerland) with water at 95°C or 45°C respectively. Soybeans were added at the rate of 
70 kg/hr and water was added at the rate of 300 L/hr.  The resulting slurry was passed 
through a colloid mill (Fryma Grinder, FrymaKoruma AG, Switzerland) and then through 
a holding tube at 85°C to inactivate the LOX enzyme. Further it was passed through a 
decanting centrifuge for separation of the insoluble residue (okara). The soymilk thus 
obtained (soymilk1) was held at 120°C for 80 sec to inactivate  approximately  80% of 
the Kunitz trypsin-inhibitor (TI) and there-by improving the soy protein digestibility 
(Kwok et al., 1993), flash-cooled to 75°C and further cooled to 25°C. The cooled 
soymilk (soymilk2) was subjected to different ultra high temperature (UHT) treatment 
conditions: one was a direct UHT process and the other was an indirect UHT process. 
This was mainly to understand the influence of the type of UHT process on the level of 
isoflavones in the end product (soymilk3). For the direct UHT system, steam was injected 
into the product and soymilk (soymilk2) came in direct contact with the heating medium. 
The direct UHT process (Tetra Therm VTIS, TetraPak Co’, USA) was carried out at a 
temperature of 143ºC for 10 sec. The indirect system (Tetra Therm FLEX, TetraPak Co’, 
USA) was based on tubular heat exchangers whereby heat was transferred from the 
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heating medium to the product through a heat exchanger. The indirect UHT process was 
carried out at a temperature of 140ºC for 4 sec.  These conditions were chosen from the 
normal industry practices used for UHT treatment of soymilk in the region. 
 
Figure 2.1 shows the processing of soybeans to soymilk. The sampling points at different 
stages of the manufacturing process are also indicated. Soymilk preparations were carried 
out with replicate trials being further carried out to confirm the reproducibility of the 
results obtained. Every trial involved either a direct UHT process (injection of steam into 
the product at 143°C for 10 sec) or an indirect UHT process (using a heat exchanger at 
140oC for 4 sec). Two pilot runs were carried out on each of the trials, one involving hot 
grinding (grinding of dehulled soybeans with water at 95oC) and the other involving cold 





                      De-hulled soybeans   [Sampled beans] 
(70kg/hr Bean) 
        (300L/hr of water) 
              *Hot grind (HG)   First Grinder 
               or Cold grind (CG)    (Disc Mill) 
 
  Second Grinder 
(Colloid Mill) 
 
                           [Sampled ground beans] 
Slurry Pump 
 
Holding tube at 85oC 
(Inactivate Lipoxygenase) 
 
             [Sampled ‘after LOX treated’] 
       [Sampled okara] Okara     Decanter 
 
       Soymilk1                     [Sampled soymilk]  
   
Inactivation of trypsin inhibitor  
(120°C for 80 sec) 
 
                 Flash Cooling to 75°C 
 
Cooling to 25°C 
 
                                  Soymilk2                      [Sampled ‘soymilk after  
               (pH 6.4, Brix 9°)                             TI deactivation’]                     
 
                                                 UHT treatment              
                                             
SOYMILK3       [Sampled ‘soymilk after UHT  
                                                             treatment’] 
 
*Hot grind process (HG) is grinding of beans with water at 95oC, while grinding of beans with water at 
45oC is called Cold grind process (CG). Sampling points are shown in italics. 
 





2.1.2.4 Preparation of tofu 
A single bigger batch of soymilk of 12o brix was prepared according to the traditional soy 
milk making procedure (index no: 2.1.2.2) and it was used for the preparation of every 
coagulant-based tofu. This was done in order to avoid any changes in the soymilk 
composition and or concentration factors. Moreover, this enabled a comparative study of 
the nutritional (isoflavone amounts) and property differences (moisture, texture and 
color) of obtained tofu with respect to the different coagulants used for its preparation. 
 
For the preparation of a tofu, a 500gm portion of soymilk was taken and heated to a 
temperature of 80°C under stirring. The time period of heating, and stirring speed were 
kept constant for every tofu preparation. Tofu was made by coagulating the soymilk 
using any one of the coagulants, calcium chloride, calcium sulfate, magnesium chloride, 
magnesium sulfate, calcium acetate or calcium lactate. Coagulants were used at two 
different concentration levels to better understand the level of coagulant required and 
possible effects if any, on isoflavone concentrations. The coagulant concentrations used 
were 0.4% and 0.5% based on the amount of soymilk used. These coagulant 
concentrations (0.4 % and 0.5%) were chosen based on a preliminary set of experiments 
on coagulant concentrations carried out prior to this study. Coagulant concentration of 
0.10% was too less for coagulation to occur, while 0.60% of coagulant resulted in 
stronger binding and hence too compact network of tofu. Coagulation of soymilk by salts 
such as calcium sulfate and calcium acetate were also studied by Kamel and de Man 
(1982), where they described the minimum concentration required for coagulation with 
calcium sulfate as 0.25% and with calcium acetate as 0.20%. Coagulant concentrations of 
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0.4 – 0.5% based on the amount of soymilk, were found to result in the coagulation of 
soymilk by the different coagulants of this study. Each coagulant was dissolved 
completely in 20ml of cold water and was used immediately. Calcium sulfate was not 
completely soluble in water, and hence saturated solutions of calcium sulfate obtained 
with the above concentrations were used. The hot soymilk and coagulant solution were 
poured simultaneously into a glass container ensuring good mixing without stirring. The 
soymilk-coagulant suspensions were allowed to stand undisturbed for a period of 20min 
to ensure that coagulation occurred. The curds thus formed were broken thoroughly and 
transferred into a specially designed mould (9 x 9 x 8cm) lined with cheesecloth. The 
mould had perforations on the sides and bottom. The whey was drained off naturally for 
10min and the curd was pressed for 1hr using a pressure of 28.0 gm/cm2. After pressing, 
tofu and whey were weighed separately. Tofu was transferred into a plastic bag and 
stored in a refrigerator until analyzed. Tofu was also prepared by coagulating soymilk 
with 20ml of a 5% glacial acetic acid solution in water 
 
2.1.2.5 Soy supplements, health products and infant formulas 
Soy isoflavone supplements, health products and infant formulas were purchased from 
the local stores or nutrition shops in Singapore, Malaysia, Indonesia and Thailand and 
they were analyzed for their isoflavone concentrations. Soy supplements obtained were 
either as tablets or capsules, and were advertised as providing relief for menopausal 
discomforts or as a remedy for women’s problems. The type of product, their health 
implications and dosages are described in Table 2.1. Supplements, which stated that the 
source of phytoestrogens was from kudzu root, or clover, were not analyzed for their 
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isoflavone concentrations since the present study was conducted only on products 
prepared from soy.  The soy based health products obtained were suitable for making 
shake mixes and the directions for their preparations were indicated on the labels. Ready-
to-drink liquid products (RD) of this category were also obtained. All of them were 
advertised as helpful in weight-management in a healthy way. Soy based infant formulas 
(SBIFs) were mainly obtained in the powder form and were prescribed for children who 
are intolerant to lactose. Only five commercially available SBIFs were obtained during 
this study and they were also analyzed for their isoflavone concentrations. 
 
Table 2.1: Identification of the different soy isoflavone supplements involved in the 
study 
 
Product code and specific health effect of the products Dosage/ day 
aProduct 
form 
A Hi-Soy isoflavone supplement for women 1 tablet 
B Women’s soy isoflavones dietary supplement 2 capsule 
C Supplement for women 1 capsule 
D Natural soy isoflavones 2 capsule 
E Phytoestrogen veg capsules 4 capsule 
F To support breast health 2 capsule 
G Calcium with soy isoflavone for menopausal health 1 tablet 
H Calcium and isoflavone 4 tablet 
I Female support formula 2 tablet 
J Help relieves menopausal discomfort 1 tablet 
K For women over 40 2 capsule 
L Phytoestrogens from soy extract 4 capsule 
M Multivitamins together with isoflavones 1 tablet 
aProducts (A – M) type of formulation was soy isoflavone extract / concentrate. 
 
Unless otherwise stated, ‘soy isoflavone supplement’ refers to a product obtained as a 
capsule or tablet and ‘soy based health product’ refers to a soy protein-based product 
obtained in the powder form throughout, in this particular study. 
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2.2 METHODOLOGIES ADOPTED 
The various methods used to carry out the analytical work for the research were either 
used directly or modified from previously established methods. 
 
2.2.1 Sampling procedure 
2.2.1.1 Soybean seeds 
Soybean seeds of 50 - 100gm were finely ground in a coffee grinder (Sumeet Multi 
Grinder, Inno Concepts Inc., GA,USA). The finely ground soybean flour was then mixed 
thoroughly before a representative sample was chosen for analysis.  
 
2.2.1.2 Sampling of soymilk, tofu, whey and related products 
Total contents of the commercially obtained sample of soymilk and tofu were 
homogenized separately, before a representative sample was chosen for analysis. The 
sample packaging was unwrapped only on the specific day of analysis, prior to which the 
products were stored in a refrigerator at 2-7°C. In general, every soymilk and tofu 
prepared was also thoroughly homogenized before an extraction or analysis was carried 
out on a respective sample. Wheys obtained from a single batch of tofu preparation were 
collected together and mixed well before sampling was done. Tofu and wheys obtained 
from a single preparation were always analyzed on the day of preparation.  
 
Samples collected at different stages of a traditional or UHT soymilk preparation 
processes were homogenized thoroughly before an analysis was carried out. The 
preparations were carried out on a plant scale and the samples were brought to the lab and 
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immediately stored in a freezer at -20°C. Samples were thawed individually and 
homogenized well before a representative sample was chosen for extraction purpose. 
 
2.2.1.3 Sampling of soy supplements, health products and infant formulas 
Fifteen randomly selected tablets of a particular soy supplement were ground into fine 
powder to ensure a homogeneous mixture using a coffee grinder. In a similar way the 
contents of 15 capsules of a supplement were mixed together and a representative sample 
was always used for the extraction of isoflavones. This was done to minimize the effect 
of variation between single capsules, while the capsules themselves were discarded.  For 
the soy based health products and SBIFs, the total content of the product was mixed well. 
Further a certain portion (50gm) of the sample was taken from different locations of the 
product container before a representative sample was chosen from this for the extraction 
purpose. The ready-to-drink (RD) products were freeze dried, ground well and used for 
analysis. Freeze drying was carried out using a freeze-dryer (Virtis Model no. BT4K XL, 
Gardiner, USA). 
 
2.2.2 Moisture analysis 
The moisture contents of soybean seed powders were measured as the loss in weight of   
2gm ground sample after drying for 24hr at 105°C in an air oven to a constant weight 
(Memmert Universal Ovens Model U, Wisconsin Oven Corp., USA). Moisture analysis 
was carried out in triplicate and mean value was obtained. 
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Moisture content of samples such as the commercial soymilk and tofu products, prepared 
soymilk and related products of traditional and UHT soymilk making process as well as 
the prepared tofu samples were determined by vacuum oven-drying (AOAC, 2002). 
Accurately weighed 5gm well-mixed test portion in a covered dish, which is previously 
dried at 98-100ºC, cooled in desiccator and weighed soon after reaching room 
temperature. The dish with contents was dried in a 70ºC vacuum oven (model no: 14-OD-
2E, Sheldon Manufacturing Inc., Cornelius, USA) at 25mm Hg until a constant weight 
was reached. At the end of the drying, the loss in weight was obtained and the mean 
value of triplicate analysis was reported as the moisture content of respective soy based 
samples. 
 
Moisture content of tofu wheys was obtained by drying 5gm of samples to a constant 
weight at 105°C in an air oven for 24hr (AOAC, 2002). Mean value was obtained from 
the triplicate moisture analysis of each samples. Tofu whey being very watery with 
especially high water content, an air oven method was chosen for determining its 
moisture content instead of the vacuum oven method. 
 
2.2.3 Protein assay 
The protein content of commercially available and purchased soymilk and tofu products 
was determined during this study. This was carried out to establish a correlation between 
the protein content and isoflavone concentrations of the soymilk and tofu samples. 
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Different analytical methods such as Kjeldahl method and Dumas method are being 
utilized for protein determination. Kjeldahl method is the universally accepted method of 
choice for protein estimation especially with high precision and reproducibility. 
However, the method uses high temperature with hazardous chemicals and is very time 
consuming. Alternative methods are the dye-binding methods and the rapidity of these 
methods is well acceptable with good sensitivity, reproducibility and accuracy (Boyer, 
2000). The BioRad Protein Assay is a dye-binding assay in which a differential color 
change of a dye occurs in response to various concentrations of the protein. It is a very 
popular method used for the quantification of proteins, because it is simple, rapid, 
inexpensive and sensitive (Bradford, 1976). The dye, Coomassie® Brilliant Blue G-250 
(CBBG) exists in three forms: red (λ max = 465nm), blue (λ max = 595nm) and green (λ 
max = 655nm). The absorbance maximum for an acidic solution of CBBG dye shifts 
from 465nm to 595nm when binding to protein occurs. Thus the assay can be monitored 
at 595nm by a spectrophotometer, which measures the CBBG-complex with the protein. 
The assay is useful since the extinction coefficient of a dye-albumin complex solution is 
constant over a 10-fold concentration range. Thus, Beer’s law may be applied for 
accurate quantification of protein by selecting an appropriate ratio of dye volume to 
sample concentration. According to Beer’s law, the relationship between the absorbance 
of a solution and the concentration of the absorbing species is given as A= εbc, where A 
is the absorbance, ε= molar absorptivity, b= path length through solution (cm) and c= 
concentration of absorbing species in molarity. Beer’s law is applicable only to dilute 
solutions, up to approximately 10mM for most analytes. 
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Moreover, the assay is compatible with most agents that interfere with other assays. The 
addition of 1 M NaOH was also suggested by Stoscheck (1990) to allow the 
solubilization of some proteins and reduce the protein-to-protein variation in color yield. 
However, the assay must be read quickly after its completion, because the proteins will 
precipitate in the reagent over time, affecting the linearity of the response. Bovine serum 
albumin (BSA) has long been the standard of choice for this assay. BioRad assay method 
was chosen for the quantification of protein in soy based samples during this study. 
 
2.2.3.1 Measurement of protein in soy based samples 
A calibration curve was prepared by using a series of standard solutions of BSA. 
Standard solutions of 0.25, 0.50, 0.75 and 1mg mL־1 of BSA in water were prepared. An 
aliquot of 0.1ml of each standard was transferred to clean and dry test-tubes and 5ml of 
BioRad dye reagent was added to this. Tubes were covered, shaken well and incubated 
for 30min at room temperature. The absorbance was measured by using a UV-VIS 
spectrophotometer (Shimadzu UV 1601, Kyoto, Japan) at 595nm. A calibration curve 
was plotted for the BSA standard. The absorbance of soy samples were also measured 
after proper dilutions, such as to fit within the standard calibration curve, while the slope 
of the curve was used to calculate the protein content in soymilk and tofu samples. 
 
2.2.4 Yield of tofu 
During the studies on the retention of isoflavones in tofu prepared using different 
coagulants, it was necessary to calculate the yield of tofu. The yield of tofu was 
calculated as the weight of fresh tofu obtained from a specified amount of the soymilk 
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used for its preparation. This was carried out in order to identify the coagulant, which 
gave a better yield of tofu compared with others. 
 
2.2.5 Texture measurement  
2.2.5.1 Principle of texture measurement 
Texture is defined as the mechanical, geometrical and surface attributes of a product 
perceptible by means of mechanical, tactile and where appropriate, visual and auditory 
receptors (Rosenthal, 1999). The test which is more applicable for food industry in this 
respect, is the Texture Profile Analysis (TPA) created at General Foods in the mid- 1960s. 
The TPA test provides textural parameters which correlate well with the sensory 
evaluation parameters. During the TPA test, the food product is brought in contact with a 
plunger which via a pivotal motion (resembling the human jaw) caused the deformation 
of the food. A two-bite cycle is employed. After the 1st bite, the load is removed from the 
sample and allowed to relax somewhat. While the plunger pulled away from the sample 
surface, any tension due to stickiness can be observed. The 2nd bite compressed the 
sample again before allowing it to relax for a second time. The resistance during 
deformation of the food can be monitored throughout the two-bite cycle and a TPA curve 





Figure 2.2:  Texture profile analysis curve from ‘two-bite test’ 
 
 
Different parameters measured from the TPA curve include the hardness, elasticity, 
cohesiveness, brittleness, chewiness, gumminess etc (Bourne, 2002). Hardness is defined 
as the height of the peak force on first bite, which is the force necessary to attain a given 
deformation. Certain products fracture at the Fracturability point (Figure 2.2). Elasticity 
is the extent to which a compressed food returns to its original size when the load is 
removed. Also called springiness, it is the ratio of the distance of the detected height of 
the product on the 2nd compression to the original compression distance (Length 2/ 
Length 1). Cohesiveness is how well the product withstands a second deformation 
relative to how it behaved under the first deformation (Area 2/ Area 1). It is measured as 
the area of work during the second compression divided by the area of work during the 
first compression. Gumminess is the product of hardness and cohesiveness, while 
chewiness is the product of gumminess and springiness. 
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2.2.5.2 Method used for texture analysis of tofu 
The texture of a prepared tofu was determined in order to evaluate the physical quality of 
the tofu obtained while using different coagulants for its preparation. Texture of tofu was 
determined by TPA using a TA.XT2i texture analyzer (Stable Micro Systems, 
Godalming, UK) equipped with a 5-kg load cell.  A sample from the central part of tofu 
was always used for the texture evaluation. A 10mm diameter probe was used at a test 
speed of 2.0mm/sec for this purpose. Cylindrical samples (1.5cm dia x 1cm height) were 
prepared from the central portion of tofu with a stainless steel boring tube and a wire 
cutter. The samples were compressed to 50% deformation. Six replicate tests were carried 
out for every coagulant tofu and the average value was obtained. Hardness, cohesiveness 
and gumminess of individual tofu samples were determined from the TPA curve and a 
comparative study on the texture properties of tofu prepared by using different coagulants 
was made possible. 
 
2.2.6 Color analysis  
2.2.6.1 Principle of color analysis 
Color is an appearance property attributable to the spectral distribution of light. It arises 
from the presence of light in greater intensities at some wavelengths than at others. In 
practice, it is limited to the band of the spectrum from 380 to 770nm, the part of the 
electromagnetic spectrum that is visible to the human eye. In 1931, the Commission 
International de L'Eclairage (CIE), worked in developing a method for systematically 
measuring color in relation to the wavelengths they contain. They adopted one set of 
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color-matching functions to define a standard colorimetric observer, whose color 
matching characteristics are representative of those of the human population having 
normal color vision. This system known as the CIE color model was developed based on 
the tristimulus theory of color perception. The CIE system specifies a color by three 
quantities, X, Y, and Z called tristimulus values. These values represent the amounts of 
three primary colors, red, green and violet, that are required for a standard observer to get 
a match. If each of the tristimulus values is divided by the sum of the three, the resulting 
values x, y, and z, called chromaticity coordinates can be obtained. Color identification 
can be carried out using the tristimulus photoelectric colorimeter, which is relatively 
simple, inexpensive, rugged and well adapted to routine tests.  
 
However, the food industry more often uses Hunter L*, a*, b* so most communication of 
results within this industry is being done using this scale (Figure 2.3). In this coordinate 
system L* is a measure of the lightness of a sample, which is directly comparable to Y in 
the CIE system and ranges from 0 (black) to 100 (white). The Hunter a* value denoted 
redness (positive a*) or greenness (negative a*); the Hunter b* value measures 
yellowness (positive b*) or blueness (negative b*). The a* values are functions of X and 
Y, the b* values of Z and Y. The formulas for Hunter L*, a* and b* are calculated from 
square roots using CIE XYZ and thus Hunter and CIE values are inter-convertible by 





Figure 2.3: CIE L*, a*, b* color space 
 
2.2.6.2 Color analysis of tofu 
The effect of different coagulants towards the color of tofu was evaluated. During this 
study, the color of tofu, expressed in L*, a* and b* values, according to the CIE 
definition were measured using Minolta spectrophotometer model CM-3500d (Osaka, 
Japan). The instrument settings were prescribed for a solid sample of tofu, with the 
calibration mode set to reflectance. The lens position and target mask were set to 
medium, while the zero calibration and white calibration were carried out using a black 
box and white plate, respectively. The color measurements for each sample were 
replicated six times and the mean value was obtained. 
 
2.2.7 pH measurement  
The pH of the wheys was measured using a ThermoOrion model 410A pH meter 
(ThermoOrion, Beverly, MA, USA). Commercially prepared buffer solutions of pH 4.00 




2.2.8 Isoflavone analysis 
The initial objective of the study was to find an extraction procedure for the maximum 
extraction of isoflavones from soy based products with minimum co-extractives. The 
method so chosen shall be simple, rapid and reproducible. HPLC analysis was further 
chosen as an analytical tool for quantification of isoflavones in soy based foods, while 
LC-MS with electron spray ionization was utilized for peak identification studies of 
different soy isoflavone conjugates.  
 
2.2.8.1 Method adopted for extraction of isoflavones from soy samples  
Of the 12 soy isoflavones, there are six isoflavone glucoside esters. They are the acetyl 
and the malonyl isoflavone glucoside esters; which have either an acetyl or a malonyl 
group attached to the isoflavone glucoside at the 6''-O- position. The major isoflavones in 
soybean seeds are mainly the malonyl glucosides of daidzein and genistein (Kudou et 
al., 1991). But processing of soybeans to soy products results in the conversion of 
malonyl glucosides to other forms.  Further to this, the extraction techniques for the 
analysis of isoflavones can cause conversions of the ester glucosides to their respective 
glucosides or aglycone forms, depending on the conditions utilized. 
 
Due to the effects (various temperature applications) of processing and sample 
extractions, the concentration of malonyl and acetyl isoflavones are affected, resulting in 
its conversion to other forms (aglycones and glucosides). Therefore, an understanding on 
the concentration of heat sensitive and unstable isoflavone forms especially during the 
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different stages of a soy food product processing is difficult. However, uniformity during 
quantification studies on isoflavones can be achieved if the ester glucosides can be 
converted to their respective glucosides during the sample extraction process. Moreover, 
much difficulty also exists in procuring the pure standards of isoflavone glucoside ester 
compounds. They are unstable in solution too. With all these technical difficulties, a 
detailed understanding of individual isoflavone conjugate concentrations was not an aim 
of this study. Thus the quantification of all the 12 soy isoflavone conjugates was not 
carried out but instead, a quantification of the total concentration of isoflavones in 
different soy based samples was considered as the major aim of the study. This can be 
achieved by converting the different isoflavone glucoside esters (i.e., malonyl and acetyl 
forms) to their respective glucosides. Further the total concentration of isoflavones can be 
obtained by quantification of the three isoflavone glucosides (daidzin, glycitin, genistin) 
and the three isoflavone parent aglycones (daidzein, glycitein, genistein). Thus a total of 
only six isoflavones need to be quantified for obtaining the total concentration of 
isoflavones in different soy samples. 
 
Choosing a solvent that can result in efficient extraction of isoflavones from the soy 
products was the initial criterion of study. The various extraction solvents used by 
researchers include 70% ethanol, 80% methanol, 80% aqueous acetontirile - 0.1% HCl 
etc (Wang and Murphy, 1996; Eldridge, 1982).  While in accord with most previous 
studies, 80% aqueous methanol was found to be the optimum solvent for the extraction of 
isoflavones (Coward et al., 1993; Setchell et al., 1987; Eldridge, 1982; Murphy, 1981) 
and was chosen for this study. The temperature chosen for extraction was 65°C because 
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an optimized extraction of isoflavones can be obtained at a higher temperature. 
Maximum recovery of isoflavones from soy foods with 80% methanol sufficient for 
reproducible quantitative measurements was also obtained by tumbling the samples for 
2hr (Barnes et al., 1994). Also the extraction procedure if followed by saponification 
process can result in conversion of all the isoflavone glucoside esters to their 
corresponding isoflavone glucosides, leaving the 3 parent isoflavones intact. This 
approach will allow a direct comparison with stable and available, isoflavone aglycone 
and glucoside reference standards. Saponification using a mild alkali solution will neither 
destroy the isoflavone aglycones or the isoflavone glucosides. Hence an extraction 
followed by a mild saponification was chosen as the method for quantification of 
isoflavones during this research. This method was also established by the Association of 
Official Analytical Chemists in the year 2001, after a collaborative study was carried out 
in twelve different laboratories around the world following this particular procedure for 
the quantification of isoflavones in different soy based products (Klump et al., 2001). 
 
Since the samples for isoflavone extraction included a variety of soy based materials 
ranging from soymilks to soy supplements, the test portion used for the extraction 
purpose also differed. For the various product categories, the amount of test portions used 
for isoflavone extraction was optimized for the above established method of extraction 
process. A test portion of 0.50gm of soybean seed powder, 5.0gm soymilk, 5.0gm tofu, 
0.1 – 0.5gm soy supplements, 1.0 – 3.0gm soy based health products and 1.0 – 3.0gm 
SBIFs were commonly used for the extraction purposes. 
 
 67
An accurately weighed amount of test sample was placed in a 250ml Erlenmeyer flask 
with ground-glass stopper (Klump et al., 2001). To this, 40ml of 80% aqueous methanol 
was added. The flask with its contents were shaken in a 65°C water bath for 2hr, cooled 
to room temperature, and 3ml of 2M NaOH was added. They were stirred well at room 
temperature for 10min and the reaction arrested by adding 1ml of glacial acetic acid. The 
contents were swirled and poured into a 50ml volumetric flask, diluted to mark with the 
extraction solution and mixed well. The contents were centrifuged for 10min at 5000rpm 
or 4332 xg (Eppendorf Centrifuge 5804, Hamburg, Germany). An aliquot of the 
supernatant was filtered through a 0.45µm non-pyrogenic filter unit (Schleicher & 
Schuell, Dassel, Germany) and analyzed by HPLC. Storage of isoflavone extracts for 
extended periods might lead to gradual changes in the composition of isoflavone 
conjugates (Barnes et al., 1994). Hence during the quantitation studies, all samples were 
analyzed immediately after their extraction. Samples were extracted and analyzed at least 
in triplicate and otherwise, the extraction and analysis were carried out in six replicates 
(soybean seed powders). 
 
2.2.8.2 Optimization of gradient profile for HPLC analysis of isoflavones. 
Reversed phase HPLC technique (RP-HPLC) is the more commonly used method for 
analysis of phenolic compounds. The separation of soy isoflavones during this study were 
carried out on a YMC-pack ODS-AM 303 column (5µm, 25cm x 4.6mm id), purchased 
from Waters Corp., Milford, USA. Various solvents are being used for RP-HPLC 
analysis, while acetonitrile is the most extensively used solvent. Acetonitrile and water 
were used as the eluting agents for the separation of isoflavones during this study. 
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Aiming for simplicity and better reproducibility, a gradient HPLC method was developed 
to separate the three isoflavone glucosides and the three aglycones simultaneously. 
Though different compositions of acetonitrile and water (binary mobile phase) were 
tested, a satisfactory result was not obtained until a small concentration (0.1%) of acetic 
acid was added to the mobile phases. The gradient profile was further optimized in order 
to obtain a good resolution among the peaks. Glycitin co-eluted with daidzin and the 
optimization of the method required several adjustments including the optimization of 
flow rates to resolve the problem. The addition of polar modifiers such as acetic acid 
caused a decrease in the mobile phase surface tension and also caused an influence on the 
characteristics of the RP adsorbent surface. Some researchers (Setchell et al., 1997; 
Setchell and Cole, 2003) used a certain % of trifluroacetic acid (TFA) in the mobile 
phase for a better separation, while the handling of TFA was not considered easier and 
hence rejected for a long term research work, as in this study. HPLC analysis of 
isoflavones at different pHs by utilization of buffer solutions was another alternative 
choices of mobile phases (Jones et al., 1989). However, utilization of buffer solution was 
also avoided in this study to prevent any clogging of the column and trouble shooting 
during the analysis. Results of analysis showed that a lower concentration of acetic acid 
significantly improved the chromatographic separation of the peaks, by an increased 
resolution and peak sharpness. Thus 0.1% of acetic acid in water and 0.1% acetic acid in 
acetonitrile were used as eluents for the HPLC analysis. The flow rate was another major 
factor of study. Flow rates of eluents were studied between 0.5 – 1.0ml/min until the 
optimization of the chromatographic conditions to enable a better separation of 
isoflavones was obtained at a solvent flow rate of 0.8ml/min. 
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The HPLC apparatus used for isoflavone analysis was a Waters separations module, 
equipped with an inline degasser (Waters In-Line Degasser AF), two liquid 
chromatograph pumps (Waters 515 HPLC pump) and a Waters 2996 photodiode array 
detector. The diode array detector was set from 200-350nm, and the eluting components 
were monitored at 260nm, while processing was carried out using the Waters ‘Empower 
Software System’ (Waters Corp., Milford, USA). A sample of 20 µL was loaded onto the 
column through an auto-sampler. 
 
The details of the HPLC gradient profile developed for the isoflavone analysis are as 
follows. A linear HPLC gradient composed of (A) 0.1% glacial acetic acid in water and 
(B) 0.1% glacial acetic acid in acetonitrile. Following injection of 20µL of sample, 10% 
solvent B was run for 5min period and was increased from 10% to 35% over 50min, and 
finally held at 35% for 10min (Table 2.2). The detector wavelength was set to 260nm, 
while the system was allowed to equilibrate after a complete gradient run of a sample. A 
total time period of 80min was allowed for each analysis, as it was the optimized gradient 
profile developed for isoflavone analysis and it was used during this entire study.  
 
 
Table 2.2: HPLC gradient developed for soy isoflavone analysis and separation 
 
Start time     End time       Flow rate          Mobile phase composition at end time 
     (min)            (min)             ml/min                        %A                 %B  
    0                      5                   0.8                           90                   10 
    5                    50                   0.8                           65                   35 
  50                    60                   0.8                           65                   35 
  60                    65                   0.8                           90                   10 
  65                    85                   0.8                           90                   10 
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The chromatographic conditions were thus optimized to obtain a good separation of 
isoflavone peaks. The identities of separated compounds in the extracts were also 
confirmed by comparison of retention times and co-chromatography with the authentic 
standards. Further to which, as required the purity and identity of peaks in different 
samples were confirmed by LC-MS. 
 
2.2.8.3 Calibration curve for isoflavones standards 
Six isoflavone standards purchased from LC laboratories (Woburn, MA, USA) were used 
for quantifying the amounts of isoflavones in soy based samples. Concentrations levels 
for isoflavones daidzin, glycitin and genistin were within the range of 2 - 50 ppm. While 
the aglycones, daidzein, glycitein and genistein were used within the range of 0.5 – 25 
ppm. Isoflavone standards were prepared after separately dissolving them in methanol. 
Calibration curves were obtained for the six isoflavone standards with high linearity 
(r2>0.995) by plotting the standard concentrations as a function of peak area obtained 
from HPLC analysis of 20µL injections. The concentrations of standard solutions for 
each isoflavone standards required for a calibration curve (Appendix A1 & A2) were 
chosen in such a way, as to cover the possible isoflavone contents in different soy based 
samples. The standard curves were further used to calculate the concentration of 
isoflavones in different soy based products. The standard stock solutions prepared were 
stored at less than 5°C to minimize any solvent evaporation and deterioration of the 




2.2.8.4 Isoflavone structure confirmation by LC-MS 
To confirm the correct identity of the peaks obtained by LC-UV, the standards and 
samples were analyzed by LC-MS. Analyses were performed on a Finnigan Quadrupole 
(MAT LCQ) ion trap mass spectrometer (Thermo Finnigan, San Jose, CA, USA) coupled 
with an electrospray ionization (ESI) source and equipped with a TSP 4000 HPLC 
system, which includes UV600LP PDA detector, P4000 quaternary pump and AS3000 
auto-sampler. The ionization technique used for the structural elucidation of the 
isoflavones was electrospray ionization in the positive and negative mode. The 
isoflavones were separated by RP- HPLC on the YMC pack ODS AM-303 column itself, 
at a flow rate of 1ml/min using the developed gradient run (Table 2.2) as described 
earlier. Chromatogram (Appendix A3) was also obtained by LC-MS analysis, which was 
carried out using the same conditions used for the HPLC analysis. Selected peaks were 
further extracted using the +ve and -ve acquisition mode over an m/z range from 160-800 
with a scan speed of 1 sec per scan. The spray voltage was set at 4.5kV and the capillary 
temperature was set at 250°C. The isoflavone glucosides and aglycones in the extract 
were identified by comparison with that of the retention time and mass spectral data of 
the standards. ESI-MS thus proved the most sensitive and selective method allowing a 
comprehensive identification of all the six isoflavones involved in the study. 
 
2.2.8.5 Procedure for calculation and expression of isoflavone amounts 
At present there is no consistency in the manner in which isoflavone levels in foods are 
expressed or even labeled. There are two different methods of reporting isoflavones, 
though some discrepancy exists in its expression. The detailed isoflavone conjugate 
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profile is obtained by some researchers (Murphy et al., 1999; Walsh et al., 2003) and 
their total concentration is expressed as the sum of the 12 isoflavone conjugates. Such 
explanations are however too complex with thorough descriptions of the entire isoflavone 
compositions including all of the individual conjugate forms. Considering the need to 
simplify this, it would be more preferable to express the isoflavone amounts as simply the 
total isoflavones in aglycone equivalents. Moreover, since the isoflavones are absorbed as 
the aglycone, the total concentration of isoflavones in food products should not be 
expressed as the arithmetic sum of the individual forms. The molecular weights of the 
glucosides are 1.6- 1.9 times greater than the aglycones and hence the total isoflavone 
content should only be expressed after adjusting for their molecular weight differences. 
Ideally molar concentrations could be used. But molar concentrations are the scientific 
units that are not familiar to common people. Hence expressing the isoflavone 
concentrations in µg/gm or mg/100gm of the soy based products might be appropriate.   
 
The knowledge of the potentially maximum bioavailable level of isoflavones is more 
important and the various conjugate forms in which isoflavones exist are of little 
physiological or nutritional significance. Expressing the total concentration of isoflavones 
in ‘aglycone equivalents’ was therefore carried out in this study. This can be 
recommended as the universally acceptable method of choice for expressing the 
concentration of isoflavones. The method of expressing the isoflavone concentrations in 




The concentrations of isoflavone glucosides daidzin, glycitin and genistin were converted 
to aglycone equivalents, using the following equation (Klump et al., 2001). 
Cae =   { MWa  /  MWg }  x   Cg      -----------------------------------------------------------(1) 
 where   Cae = isoflavone aglycone equivalents, µg/gm; MWa =molecular weight of 
aglycone; MWg = molecular weight of glucoside and Cg = concentration of glucosides 
i.e., daidzin, glycitin or genistin, µg/gm. The calculated aglycone conversion factors are 
shown in Table 2.3. 
 
Table 2.3: Aglycone conversion factors 
 














Total isoflavones in µg aglycone equivalents/gm of the sample were calculated by 
summing the concentrations of daidzein, glycitein and genistein and adding this total to 
the sum of aglycone equivalent concentrations of daidzin, glycitin and genistin. 
T1   = Ca (daidzein) + Ca (glycitein) + Ca (genistein)  ---------------------------------------(2) 
T2   = Cae (daidzin) + Cae (glycitin) + Cae (genistin)    ------------------ ------------------ (3) 
where T1 = sum of the concentrations of aglycones and T2 = sum of aglycone equivalent 
concentrations of glucosides. 
Therefore 




2.2.9 Statistical analysis of data 
The mean value obtained from triplicate moisture and protein analyses of soy based 
samples are presented throughout the study. The results of TPA and color analysis data 
were the obtained average value of six replication tests. And the mean values were 
compared for their statistical significance. Analysis of variance was carried out using 
SPSS version 12.0 (SPSS Inc., Chicago, USA). Probability of p≤0.05 was considered 
statistically significant. Isoflavone extraction experiments and analysis were performed in 
triplicate and the isoflavone values are reported as mean ± standard deviation as obtained. 
Analysis of variance was conducted to find the statistical significance between the 












RESULTS AND DISCUSSIONS 
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CHAPTER 3 
METHOD APPLICATION FOR THE QUANTIFICATION OF 
ISOFLAVONES IN SOY BASED FOODS 
 
The initial objective of the study was to develop a method for the efficient separation of 
isoflavones. After optimization of the method for better separation of isoflavones, the 
developed method was applied in determining the concentration of isoflavones in 
different soy based samples. Soymilk and tofu being the most widely consumed soy food 
in the region, they were chosen as the primary material of study. The quantification of 
isoflavones in these soy foods was carried out using the optimized HPLC method. The 
efficient separation of the six isoflavone peaks of a single run together with its 
reproducibility of analysis was evaluated for extending the application of the developed 
HPLC method throughout this research work. The identification and characterization of 
individual peaks was further carried out using LC-MS.  
 
3.1 APPLICATION OF METHOD DEVELOPED FOR ISOFLAVONE ANALYSIS  
Commercially available soymilk samples from Singapore were initially chosen for 
evaluation of the developed HPLC method of isoflavone analysis. Further to this many 
commercially available soymilk samples were collected from other South East Asian 
Countries such as Malaysia, Indonesia and Thailand. A collective database on the content 






Figure 3.1: HPLC chromatogram of the six isoflavones in a sample of soymilk  
 
 
The typical HPLC chromatogram of isoflavones obtained by reversed phase HPLC 
analysis of a soymilk sample is shown in Figure 3.1. The elution order and retention time 
(min) of isoflavones are as follows: daidzin 24.71±0.4; glycitin 25.94±0.5; genistin 
31.61±0.6; daidzein 44.34±0.4; glycitein 45.82±0.3; genistein 55.47±0.44 minutes. The 
developed HPLC method also had additional advantages of not having many interfering 
peaks, which further decreased the complexity of sample analysis. The relative standard 
deviations (RSD) on repeated analysis of the same sample was determined and proved 
acceptable levels of accuracy and precision (<10% RSD). However, the time required for 
an analysis was lengthy (80min). But an effective separation of individual peaks with a 
longer time gap between the neighboring peaks served for an accurate quantification of 
the compounds. This also avoided any co-elution that might have occurred during a 
shorter run time. The developed and optimized HPLC method therefore proved 
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reproducible and repeatable with effective resolution of peaks providing a means for 
accurate quantification of isoflavones in different soy based samples. 
 
The concentration of genistin, daidzin and glycitin followed a decreasing order in many 
of the soy food samples analyzed during this study. This is because, among all the 
isoflavones, genistein derivatives are present in higher proportions followed by daidzein 
and glycitein derivatives respectively. An alkaline hydrolysis caused the removal of the 
acylated groups (malonic acid and acetic acid), causing an increase in the area of the 
existing glucoside peaks. Aglycones were found in lesser amounts than the glucosides in 
many of the soy samples. Glycitein approached zero values in certain cases and was 
always present in least concentrations for every sample analyzed. The peaks obtained 
from isoflavone analysis in soymilk samples by HPLC method was further confirmed by 
LC-MS. It was this optimized and developed HPLC method that was further extrapolated 
for an LC-MS application and the selected peaks were detected in the +ve and –ve 
ionization modes. The results of LC-MS analysis further affirmed the suitability of the 
developed method for the quantification of isoflavones in various soy based samples.  
 
The protein content of the soymilk and tofu samples was also determined in parallel for 
an understanding of its relationship to the isoflavone contents of the individual products. 
Further the protein content of the product was related to their isoflavones concentrations. 
This is the first set of studies which determined the level of isoflavones and protein 
content in the soymilk / tofu samples for an evaluation of its direct relationship. 
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3.2 RESULTS OF LC-MS ANALYSIS OF ISOFLAVONES 
Electrospray ionization mass spectrometry (ESI-MS) provides mass spectrum with little 
or no fragmentation and this technique is suitable for the characterization of phenolic 
compounds in food products. The isoflavone aglycones, daidzein, glycitein and genistein 
and the isoflavone glucosides, daidzin, glycitin and genistin, were identified by 
comparison of the retention time and mass spectral data with those of their standards. 
Details of ions observed in positive and negative ion spectra of the isoflavones generated 
by ESI-MS are shown in Table 3.1. 
 
Table 3.1:  Ions observed in positive and negative ion spectra of isoflavone glucosides 
and aglycones, generated by ESI – MS 
 
Isoflavone +ve  ions -ve ions 
Daidzein 255.4 [M+H]+ 253.5 [M-H]− 
Glycitein 285.3 [M+H]+ 283.5 [M-H]− 
Genistein 271.4 [M+H]+ 269.5 [M-H]− 
255.3 [M+H-Glc]+ 253.4 [M-H-Glc]− 
417.0 [M+H]+ 415.4 [M-H]− Daidzin 
 475 [M-H+CH3COOH]− 
285.0 [M+H-Glc]+ 283.1 [M-H-Glc]− 
447.2 [M+H]+ 445.2 [M-H]− Glycitin 
 505 [M-H+CH3COOH]− 
271.1 [M+H-Glc]+ 269.1 [M-H-Glc]− 
433.1 [M+H]+ 431.3 [M-H]− Genistin 
 491 [M-H+CH3COOH]− 
    *Isoflavones were separated by 0.1% acetic acid in water and acetonitrile gradient profile on a  
      YMC   pack ODS column. 
 
 
Using the ESI mode, the molecular ions [M+H]+ and  [M-H]− appeared as the most 
abundant ions in the positive and negative ion spectra respectively. Ion peaks at m/z 
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255.4, 285.2 and 271.2 are the positive molecular ions obtained for the three isoflavone 
aglycones of daidzein, glycitein and genistein respectively. Each isoflavone β-glucoside 
conjugate produced an [M+H]+ ion and the corresponding aglycone fragment ion in the 
+ve acquisition mode.  Figure 3.2 illustrates the MS spectra of soy isoflavone aglycones 
daidzein, glycitein, genistein and β-glucoside conjugates daidzin, glycitin, genistin 
respectively. Molecular ions [M+H]+ of m/z 417.0, 447.2 and 433.0 and the specific 
fragments of [M+H – glucosyl]+ at  m/z  255, 285 and 271 for daidzin, glycitin and 
genistin are obtained respectively. For the isoflavone glucosides, they readily formed 
adducts with the acetate ions and these ions were the most abundant in negative ion mass 
spectra. Thus additionally, the acetate adduct [M-H+CH3COOH]− ions were observed 
(Table 3.1). The molecular ions and the adduct ions generated by the ionspray interface 
provided an ideal method for detection of soy isoflavones. This confirms the application 



























Figure 3.2:  MS spectra of soy isoflavone aglycones (a) Daidzein (b) Glycitein (c) 





3.3 QUANTIFICATION OF ISOFLAVONES IN SOYMILK 
Results of isoflavone analysis of soymilk samples from Singapore are presented 
collectively, while the results of isoflavone analysis in soymilk samples from other South 
East Asian countries are separately presented. A similar arrangement was also done while 
describing the isoflavone analysis results of tofu samples. 
 
3.3.1 Isoflavone concentrations in soymilk samples from Singapore  
Table 3.2 shows the results of isoflavone analysis of commercially available soymilk 
samples collected from Singapore market. The samples analyzed from Singapore had 
protein contents ranging from 2.0 – 4.2gm/100gm and the protein is derived almost 
exclusively from soy in all of them. Globally, there are two different starting materials 
used for the production of soymilk: whole soybeans and soy isolates. But in South East 
Asian countries, whole soybeans are used traditionally to prepare soymilk and, the 
protein content in the beans might also affect the final amount of protein in the soymilk 










Table 3.2: Total isoflavone data (on wet weight basis) reported as µg aglycone 
equivalents per gram of the sample for commercially available soymilks from Singapore. 
 
Milk type M% P% Din Glyin Gin Dein Glyein Gein TotalA (µg/gm)
Brand A 96.0 2.04 44.23 8.41 49.92 6.85 1.11 4.86 76.41±0.28 
Brand B 90.6 2.85 69.77 11.58 76.88 3.63 0.11 1.71 103.52±0.83 
Brand C 85.2 3.67 102.56 11.56 143.18 4.09 0.36 3.74 167.71±1.60 
Brand D 82.6 3.70 115.07 24.81 142.37 1.32 0.09 0.95 177.46±0.97 
Brand E 86.2 4.20 136.72 11.95 140.12 12.35 0.77 7.40 199.25±0.99 
M% =% moisture, P% =% protein, where the protein content is calculated from the BioRad protein assay. 
Din =daidzin, Glyin =glycitin, Gin =genistin, Dein =daidzein, Glyein =glycitein, Gein =genistein.  TotalA = 
total isoflavone ±SD where SD is the standard deviation of four replicated samples and the mean values for 
total isoflavones are stated here.  
 
 
The moisture content of the samples varied among one another and ranged from 82.60 -
96.00%, while the total isoflavone concentrations in soymilks ranged from 76.41 
to199.25 µg/gm on a wet weight basis. Among the different brands of soymilk analyzed, 
‘Brand E’ contained the highest amounts of daidzein and genistein. When soy foods are 
processed with water for a long residence time, the native soy β–glucosidase will become 
active generating more of aglycones as in soaking of soybeans prior to processing into 
soymilk. The soybeans used for preparing ‘Brand E’ soymilk might have had a longer 
soaking period than the other soymilk brands. Within the soymilk group, the items with 
higher protein content showed significantly higher isoflavone levels than the items with 
lower protein content (Figure 3.3). From the results of analysis of isoflavones in this soy 
food group, it appears that isoflavones are found at higher concentrations in high protein 
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containing soy foods. However commercial products being analyzed, the source of 
soybean used by different producers might be different and hence a comparison of 
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Figure 3.3: Correlation of protein and isoflavone levels for soymilk samples 
 
3.3.2 Isoflavone concentrations in soymilks from other South East Asian countries 
Table 3.3 shows the level of isoflavones in commercially available soymilk samples 
obtained from Malaysia, Indonesia and Thailand. Soymilks sold in Malaysia had protein 
contents much lower than those sold in Singapore. Soymilks with >2.5% protein content 






Table 3.3: Total isoflavone data (on wet weight basis) reported as µg aglycone 
equivalents per gram of sample for the commercially available soymilks from Malaysia*, 
IndonesiaĬ and ThailandŤ. 
 
Milk type M% P% Din Glyin Gin Dein Glyein Gein TotalA (µg/gm)
Brand M1* 86.0 2.50 54.63 9.36 82.94 3.33 2.26 2.81 99.60±0.28 
Brand M2* 87.2 2.30 20.13 4.25 27.56 20.53 3.04 14.34 70.15±0.41 
Brand M3* 88.0 2.20 33.71 6.59 49.61 2.06 2.19 1.09 61.16±0.10 
Brand M4* 87.6 2.12 28.17 4.08 36.54 7.68 2.28 5.22 58.02±1.40 
Brand M5* 88.2 2.00 47.76 4.52 ND 3.18 2.06 1.80 39.12±0.03 
Brand M6* 88.2 2.00 22.68 4.19 28.79 1.20 ND 0.39 36.12±1.40 
Brand M7Ĭ 89.0 3.80 45.67 6.74 62.71 6.61 2.31 5.92 86.24±0.22 
Brand M8Ĭ 88.5 1.50 31.38 5.82 43.04 3.07 ND 2.08 54.94±0.20 
Brand M9Ť 87.4 3.79 35.54 6.40 55.82 9.29 2.50 7.60 80.08±0.67 
Brand M10Ť 86.4 3.83 59.98 9.44 100.98 ND ND ND 105.77±1.41 
M% =% moisture, P% =% protein. Din =daidzin, Glyin =glycitin, Gin =genistin, Dein =daidzein, Glyein 
=glycitein, Gein =genistein.  ND= not detected. TotalA = total isoflavone ±SD, where SD is the standard 
deviation of four replicated samples and the mean values for total isoflavones are stated here.  
 
If the soymilks had relatively similar moisture content with different protein contents, the 
trend of higher isoflavone levels with increase in protein content can be easily 
established. Though generally high concentrations of isoflavones were found in soymilks 
with higher protein contents, inconsistency of results were also found in some cases. 
Brand M7, a product of Indonesia, was found to contain a comparatively low 
concentration of isoflavones in spite of having higher protein content (3.80%). This might 
be an exception, where the soymilk is probably not prepared from whole soybean itself, 
but might be prepared from chemically treated (i.e., alcohol washed) soy protein 
concentrate or SPC. Aqueous alcohol extraction is commercially used for removing the 
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soluble carbohydrates from defatted soy flakes. Since aqueous alcohols are excellent 
sources for isoflavones, the process would lead to considerable loss of isoflavones. 
Therefore if an alcohol washed SPC is used for the preparation of soymilk, a product with 
less isoflavones are obtained. 
 
The total concentration of isoflavones in the soymilks collected from different South East 
Asian countries ranged from 36.12 - 199.25 µg/gm, on a wet weight basis. Generally, 
soymilks were found to contain a higher concentration of glucosides, primarily genistin, 
followed by daidzin and glycitin respectively. Aglycones can be formed during the 
traditional method of preparation of soymilk, whereby the soaking of soybeans in water 
for a longer period of time might have been followed in some cases. ‘Brand M2’ a 
soymilk brand from Malaysia was the only exception (Table 3.3), where a higher 
amounts of aglycones were found with respect to its glucoside amounts, possibly due to 
drastic differences in processing conditions used for its preparation. Soaking of soybeans 
for a period of 16-24hr or a fermentation process are possible explanations for the higher 
amounts of aglycones in ‘Brand M2’ than the others. The variety of soybeans and the 
processing techniques applied to produce soymilk could be the other factors contributing 
to the variation of isoflavone conjugates in different brands of soymilk. However, it was 
apparent that higher concentrations of isoflavones are found in soymilks with higher 





3.4 QUANTIFICATION OF ISOFLAVONES IN TOFU 
3.4.1 Isoflavone contents in commercially available tofu samples from Singapore 
Many different varieties of tofu suitable for different cooking purposes were found in 
Singapore market. Various processing methods might be utilized in making different 
types of tofu. There are the aseptic style tofus, where commercial soymilks are 
coagulated in the package with glucono-δ-lactone and no whey is removed or tofu can be 
even momen or traditional style, where whey is discarded after the curd production 
(Dwyer et al., 1994).  While if the coagulation  was carried out using calcium salt, the 
metallic cation from the coagulant Ca2+, reacts with proteins in soymilk and precipitate to 
form curds (Shurtleff and Aoyagi, 1979b). Some protein associated isoflavones might 
be released into the whey as well, during a firm tofu preparation. Therefore in 
establishing a database on isoflavone concentrations in tofu, it is critical to understand the 
type of processing each type of tofu has undergone to properly interpret the results of 
isoflavone concentration and its distribution. The concentrations of isoflavones in 
different types of commercially available tofus collected from the Singapore market are 








Table 3.4: Total isoflavone data (on wet weight basis) reported as µg aglycone 
equivalents per gram of the sample for the commercially available tofus from Singapore 
market. 
 
Tofu type M % P % Din Glyin Gin Dein Glyein Gein TotalA(µg/gm) 
Silken tofu 85.9 5.28 131.73 15.40 109.28 2.44 ND 2.82 163.85±2.45a 
Chinese tofu 89.6 6.76 129.92 16.95 109.53 1.94 0.05 2.28 162.91±2.29a 
Organic tofu 88.6 6.53 139.77 16.14 120.67 4.26 0.04 2.50 177.90±1.81a 
Braised tofu 67.4 9.69 109.36 19.75 123.82 6.04 0.25 4.82 167.91±6.59a 
Deep-fried 74.4 11.70 217.32 26.42 205.96 10.88 0.49 7.84 297.55±4.54b 
Taw kwa 74.4 9.67 236.66 23.98 229.06 5.50 0.21 3.68 312.42±2.33bc 
M% =% moisture, P% =% protein, where protein content is calculated from the BioRad protein assay. Din 
=daidzin, Glyin =glycitin, Gin =genistin, Dein =daidzein, Glyein =glycitein, Gein =genistein.  ND = not 
detected. TotalA = total isoflavone ±SD, where SD is the standard deviation of four replicated samples and 
the mean values for total isoflavones are stated here. Like superscripts in the same column do not differ 




‘Silken’, ‘Chinese’ and ‘Organic’ tofu were the soft tofu varieties obtained from 
Singapore market. These tofus differed in their moisture and protein contents. Also the 
types of coagulants used for their preparation were different (as observed from labeling). 
However, the concentrations of isoflavones in these commercially available soft tofu 
varieties were nearly the same (p≤0.05). The minor differences in the isoflavone 
concentrations could be partly due to the variety of beans used for its preparation or the 
manner in which the tofu was prepared using different coagulants. Some coagulants 
might be even better and more efficient than the other in terms of retaining isoflavones in 
tofu from soymilk (Jackson et al., 2002). 
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‘Taw kwa’ is a type of firm tofu while, deep-fried and braised tofu is prepared from ‘taw 
kwa’. ‘Deep-fried’ tofu is usually made by frying the firm tofu in oil at a high 
temperature of 180-185ºC.  For braised tofu making, the firm tofu is marinated with a 
sauce (sweet or spicy), whereby the pH will be reduced and it further undergoes a 
pasteurization procedure. These procedures caused the isoflavone levels in braised tofu to 
be much lower than that of ‘taw kwa’ and ‘deep-fried’ tofu. The presence of other non-
soy components such like spice powder, sweet and sour sauce etc in the braised tofu 
greatly influenced the isoflavone content of the total food consumed. A linear trend in 
isoflavone levels with the protein content of tofus couldn’t be established in this study 
(Figure 3.4). But it was apparent that higher concentrations of isoflavones were present in 
tofus which had higher protein content.  Thus taw kwa and deep-fried tofu contained a 
much higher protein content than the soft tofu samples and they also contained higher 
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Figure 3.4: Protein-isoflavone relationship in tofu samples 
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Currently, it is not mandatory to label the concentration of isoflavones in soymilks or 
tofus. But protein contents are sometimes labeled on soy foods, which can serve as an 
indication of the comparative amounts of isoflavones in the available products found on 
the shelf. Every products purchased from Singapore indicated the approximate amount of 
protein levels on their labels. This can be very helpful for the consumers and nutritionists 
in identifying a product with more functional benefits. 
 
3.4.2 Isoflavone concentrations in tofu samples from other South East Asian countries 
A soft tofu from Malaysia was labeled as ‘Tofu lembut’ while a firm one was labeled as 
‘bean curd’. The tofu samples collected from Malaysia and Indonesia were either a soft 
tofu or a firm tofu, made from pure soymilk and were not added with other non soy 
components. Tofus are commonly sold in open streets of Indonesia without any packing, 
but commercially available tofu samples from local stores in Indonesia were purchased 
during this study. Table 3.5 details the level of isoflavones in tofu samples collected from 
















Table 3.5: Total isoflavone data (on wet weight basis) reported as µg aglycone 
equivalents per gram of sample for the commercially available tofu samples from 
Malaysia*, IndonesiaĬ and ThailandŤ. 
 
 
Tofu type M% P% Din Glyin Gin Dein Glyein Gein Total
A 
(µg/gm) 
Soft tofu Ť 90.8 6.07 24.66 8.74 62.90 2.08 4.42 8.50 74.95±0.13 
White tofu Ĭ 87.00 6.10 16.54 ND 9.85 32.92 6.35 40.33 95.87±0.19 
Silk tofu Ť 91.00 6.70 31.31 9.99 50.92 22.49 5.70 21.39 106.91±0.09 
Silk tofu Ĭ 91.20 6.70 39.21 8.35 58.32 21.41 5.19 26.54 118.87±0.63 
Silk tofu* 90.20 7.10 76.70 13.43 98.43 7.61 4.48 4.92 133.95±1.19 
Taufu lembut* 89.00 6.30 112.62 18.76 178.47 2.96 6.45 2.42 204.14±0.14 
Sakura tofuŤ 83.73 8.14 13.63 6.88 34.71 51.19 ND 56.92 142.52±0.13 
Organic tofuŤ 77.60 14.30 22.93 5.68 63.20 57.29 4.07 60.35 178.85±1.62 
Tahu Ĭ 76.50 9.36 96.14 21.23 156.71 17.97 4.66 15.70 208.55±0.32 
Firm tofu* 81.40 13.10 94.08 15.15 181.48 19.18 4.82 19.33 223.90±2.63 
Selan Jaya Ĭ 81.50 13.80 92.90 18.03 139.85 45.65 7.00 21.59 229.91±2.75 
Yellow tofu Ĭ 72.80 11.61 105.68 21.02 186.20 29.50 6.09 26.25 256.18±3.43 
Bean curd* 75.00 12.90 247.19 21.4 309.05 10.62 ND 6.42 374.86±0.05 
M% =% moisture, P% =% protein where protein content is calculated from the BioRad protein assay.  
Din =daidzin, Glyin =glycitin, Gin =genistin, Dein =daidzein, Glyein =glycitein, Gein =genistein.  ND = 
not detected. TotalA = total isoflavone ± SD, where SD is the standard deviation of four replicated samples 
and the mean values for total isoflavones are stated here. Soft tofu Ť, White tofu Ĭ, Silk tofu Ť, Silk tofu Ĭ, Silk 
tofu*, Taufu lembut* are all soft tofu samples while Sakura tofu Ť, Organic tofu Ť, Tahu Ĭ, Firm tofu*, Selan 
Jaya tofu Ĭ, Yellow tofu Ĭ , Bean curd* are all firm tofu samples 
 
 
Generally a soft tofu contained less protein and less isoflavones amounts than the firm 
tofu. Firm tofu making, uses a soymilk of higher solid content than that required for soft 
tofu making. Moreover, wheys are pressed out during a firm tofu preparation and that 
makes the protein molecules to bind together and form a firm network, which is not in the 
case of a soft tofu. Hence the firm tofus if not added with non soy components are higher 
in protein and isoflavone contents than the soft tofu types. While most of the Singapore 
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tofu products are not mixed with any non-soy components, the Thai products are 
sometimes incorporated with seaweeds and other food substances, which ultimately 
reduced the total concentration of isoflavones in the product. For example, organic tofu 
from Thailand was a firm tofu, but was composed of other non soy components and 
hence the isoflavone concentration was comparatively low. 
 
3.5 DISCUSSION ON THE RESULTS OF ISOFLAVONE ANALYSIS  
 The extraction procedure followed in this study used a mild saponification step that 
converted the isoflavone glucoside ester forms to corresponding isoflavone glucoside 
forms, leaving the three parent isoflavones intact. This approach allowed a direct 
comparison with the stable, readily available, isoflavone parent and glucoside reference 
standards. The optimum conditions for the extraction of isoflavones from food products 
were thoroughly investigated   before a method of extraction was chosen. Solvent loss if 
any by evaporation, during the extraction procedure was also corrected in this extraction 
procedure by the final volume make up done towards the end of the extraction procedure 
(index no: 2.2.8.1). This further helped in obtaining a high reproducibility of the sample 
analysis. However, one cannot exclude the possibility that an alternative solvent mixture 
may be optimal for different soy food matrices.  
 
The isoflavones were well separated by the developed and optimized reversed-phase 
HPLC analysis method, permitting the analysis of both the glucosides and the aglycones 
in a single chromatographic run and a legitimate quantification was easily made possible. 
The procedure followed in this study for the analysis of isoflavones in soy foods was 
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simple, rapid, reproducible and less detrimental to column life. It also had a particular 
advantage over methods in which the isoflavone glucosides were calculated by the 
differences in concentration of isoflavone aglycones, determined using isocratic HPLC 
methods or between acid-hydrolyzed and unhydrolyzed samples (Wang et al., 1990). 
However, the method used in this study didn’t give a detailed analysis pattern of every 
conjugates of soy isoflavones. Thus the malonyl and acetyl conjugate concentrations 
were not estimated individually, but the total concentration of isoflavones in the soy 
product was only determined during the complete study.  
 
The present study therefore resulted in a comprehensive analysis of several brands of 
soymilk and tofu samples from South East Asian countries. No published reports are 
available on the collective data of isoflavone contents in soymilk and tofu samples from 
South East Asian Countries. Franke and others (1999) did a comparative study on the 
isoflavone levels in raw and cooked forms of ‘taw kwa’, raw tofu, ‘fried-taw kwa’ and 
dried soybean curd sticks. Cooking was carried out for 5min for all these soy foods by 
these researchers. In general, cooked products showed lesser isoflavone levels than the 
raw products probably because of the leaching of isoflavones into the water. Since there 
are many different types of tofu and their methods of preparation are different, the results 
reported by these authors were a little confusing. For example, raw ‘taw kwa’ and raw 
tofu showed nearly an equal amount of isoflavones (297µg/gm) in their study. However, 
it was not understood, how raw ‘taw kwa’ differed from raw tofu and why both showed 
equal amounts of isoflavones. In this study, we differentiated between the soft and firm 
tofu types available in the market for a better and general understanding on the protein 
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content and concentration of isoflavones. A guideline towards identifying the product of 
high nutritional value was hence made possible in a more convenient way.  
 
The protein content of soymilk and tofu samples were always labeled for Singapore and 
Thailand products, while it was sometimes labeled for Malaysian products too. 
Indonesian products were usually not labeled with their protein contents, especially for 
tofu samples. Protein labeling can be used as a good indication of isoflavone contents in 
soymilk and tofu samples, if they are prepared from soybean itself and provided the 
protein content is entirely derived from it. When other food components are added to the 
soybean products, the overall isoflavone concentrations were lower. In a similar way, if 
soy protein isolate is used as a raw material instead of soybean for the preparation of 
soymilk or tofu, then the isoflavone contents in the soy food will be much lower. 
 
A mass balance of isoflavones for the soy products or a direct comparison of isoflavones 
between the above listed foods cannot be made in this study, since the soybean variety 
used to produce each food is unknown and the total isoflavone content can vary 
depending on many factors including the variety, geographical location and growth year 
of the soybeans. Results of the isoflavone analysis of these commercially available 
products were similar to those reported by other researchers (Wang and Murphy, 1994). 
However, it was apparent that higher concentrations of isoflavones are present in those 
soymilk or tofu samples containing high protein content. There aren’t any published 
reports which quantified the isoflavones and protein simultaneously to understand the co-
relation between the protein content and isoflavone amounts in soy foods. This is the first 
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set of studies which analyzed wide brands of soymilk and tofu samples from the South 
East Asian Countries to obtain a generalized conclusion of their isoflavone and protein 
contents. Moreover, the concentration of isoflavones in these commercially available soy 
foods if labeled can serve as an indication of its functional value for the consumers. 
Levels expressed as total aglycone equivalents would also provide an indication of the 
potentially maximum bioavailable level of isoflavones in the food, because it is only the 
aglycones that are absorbed from the human intestine. It is even more logical to label the 
amount of isoflavones in mg aglycone equivalents per 100 gram of the soy food, for 
which the public will have a better grasp of understanding. 
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CHAPTER 4 
EFFECT OF EXTRACTION METHODS AND UHT TREATMENT 
CONDITIONS ON THE LEVEL OF ISOFLAVONES DURING 
SOYMILK MANUFACTURE 
 
With the advancement in process development and equipment design, different 
processing systems are being made available for the soymilk manufacturing industry. 
These production modules can result in continuous extraction of soymilk from soybeans. 
However, the fundamental consideration of what happens to the nutritional quality and 
functional ingredients of soymilk is lacking. Determining the fate of isoflavones, the 
principal phyto-nutrients in soymilk, during various stages of processing was therefore 
considered essential. The processing conditions used for its preparation are the most 
important parameters that ultimately determine the quality of soymilk obtained. A 
particular processing system might have its own advantages and disadvantages in terms 
of the nutritional quality of the soymilk obtained. One such soymilk processing system is 
studied here by evaluating the effect of different extraction methods and heat treatments 
on the level of isoflavones in the final soymilks obtained. The HPLC method developed 
for isoflavone analysis during this study was further utilized for the quantification of 
isoflavones in the raw material, intermediates, byproducts and final soy preparations of 





4.1 ISOFLAVONE LEVELS IN SOYMILK PREPARED BY HOT-GRIND 
     VERSUS COLD-GRIND METHOD 
The processing system used in this study for the preparation of soymilk had a particular 
advantage of grinding the soybeans directly with hot or cold water rather than a ‘soak and 
grind process’ used conventionally. The traditional soymilk making process, termed as 
the ‘soak and grind process’ involves the soaking of soybeans in water for a prescribed 
period of time (4-12hrs) followed by grinding them in fresh water. Wang and Murphy 
(1996) did a mass balance study during the preparation of soymilk, where soaked beans 
were found to contain a lesser concentration of isoflavones than the raw soybeans. The 
differences in their content of isoflavones were explained as due to the leaching of 
isoflavones into the soaking water. Such losses of isoflavones into the soaking water were 
avoided by using the direct grinding process utilized in this study.  
 
There is an extensive literature available on the processing effects of isoflavones during 
the preparation of soymilk and tofu by the traditional process (Coward et al., 1993; 
Jackson et al., 2002), but little information is available on the effect of extraction 
methods and ultra high temperature (UHT) treatment conditions on the level of 
isoflavones during soymilk manufacture. Moreover, the recent trend in utilization of 
these automated extraction and UHT processing modules for the preparation of soymilk 
makes it essential in understanding the nutritive contents of the end product obtained 
from such processing systems. The most common new extraction methods utilized for the 
preparation of soymilk are either a hot grinding or a cold grinding process, while the 
UHT treatment commonly applied to soymilks are either a direct or an indirect UHT 
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process. The processing module used in this study resulted in the direct grinding of 
soybeans with hot or cold water, while the sterilization of soymilk was achieved by either 
a direct or an indirect UHT treatment so as to obtain an aseptic style soymilk. Thus a 
comparison in the isoflavone concentrations between the hot grinding and cold grinding 
of soybeans, as well as between the direct and indirect UHT treatment processes was 
carried out in order to understand its effect on the concentration of isoflavones in the 
soymilk obtained. 
 
The total concentration of isoflavones in soy samples were expressed in microgram 
aglycone equivalents per gram of the sample on a dry matter basis (µg/gm DM). Table 
4.1 & 4.2 shows the results of isoflavone analysis in samples of the hot grind and cold 
grind process respectively, while the results of the duplicate trials are shown in Table 4.3 
and 4.4. 
 
The malonyl isoflavone forms are highly unstable to heat. The high-temperature heat 
processing of soymilk may cause changes in the concentrations of malonyl isoflavone 
conjugates, due to the conversion of the malonyl forms to their respective glucoside 
forms. However, a detailed investigation on the individual isoflavone conjugates profile 
was not carried out but it was only the total amount of isoflavones that was determined in 
this study to understand the effects of processing. Moreover, there is a difficulty in 
comparing the isoflavone levels in the soybeans with that of the soymilks obtained on a 
dry weight basis, because the composition of dry matter in the whole beans and that 
obtained for soymilk differ as a result of the removal of okara and injection or removal of 
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steam/water at different steps involved in the soymilk manufacturing system. Hence, a 
comparison of isoflavone levels in soymilks obtained from two different grinding 
procedures (Hot versus Cold) and after two different UHT treatment methods (Direct 
versus Indirect) were carried out to better understand the effects of processing on the 
isoflavone levels in the soymilks obtained. Isoflavone concentrations are reported as the 
means of three determinations with their standard deviations (SD). Test for analysis of 
variance were carried out to determine the significant differences between the isoflavone 
values in soymilk obtained by hot and cold grinding methods as well as between the two 
different UHT treatment processes. P≤ 0.05 was considered significant (SPSS version 
12.0, SPSS Inc., Chicago, USA). 
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Table 4.1: Total isoflavone concentrations in µg aglycone equivalents per gram of the sample reported on a dry matter basis, in various 
samples of a hot grind process trial. 
 
Sample names (HG process) M% Din Gln Gin Dein Glen Gein TotalA (µg/gm)
Soybeans for indirect process 10.0 805.66 184.55 948.33 19.11 51.77 ND 1273.40±1.13a 
Ground beans 86.4 1023.67 223.08 1006.76 ND ND ND 1396.79±3.52b 
LOX treated 85.8 1016.17 210.49 990.77 8.69 0.70 10.84 1394.61±1.79b 
Okara 73.0 625.66 143.70 638.22 19.51 1.66 15.18 909.05±0.54c 
Soymilk1 90.0 1397.40 271.00 1288.40 19.50 0.75 14.60 1866.66±1.22d 
Soymilk after TI deactivation 90.8 1374.23 286.84 1352.93 5.00 0.65 9.45 1883.05±0.35d 
Soymilk after indirect UHT 90.4 1270.52 276.87 1322.08 6.66 ND 10.20 1795.81±1.10d 
Soybeans for direct process 10.0 798.91 188.00 945.00 21.80 52.94 ND 1273.25±3.94a 
Ground beans 84.5 1094.58 196.06 1037.87 9.48 ND 7.93 1459.75±6.18b 
LOX treated 84.6 1114.93 198.63 1056.75 9.61 ND 8.37 1486.19±1.65b 
Okara 73.8 746.06 3.88 762.40 13.12 4.92 9.61 962.46±1.00c 
Soymilk1 90.0 1490.00 273.50 1493.60 11.50 0.20 9.30 2039.11±3.28e 
Soymilk after TI deactivation 91.0 1624.88 275.88 1482.33 13.22 0.33 10.77 2119.31±0.67e 
Soymilk after direct UHT 90.6 1313.83 251.06 1322.34 11.11 0.32 8.72 1809.28±0.38d 
M  % = moisture %.   Din= daidzin; Gln= glycitin, Gin=genistin; Dein= daidzein; Glen= glycitein; Gein=genistein. ND = not detected. 
Soymilk after TI deactivation = soymilk2. 
Soymilk after direct UHT = soymilk3. 
TotalA = total isoflavones expressed in µg aglycone equivalents ± standard deviation. 
Means with different letters in the same column are significantly different at p<0.05. 
 103 
 
Table 4.2: Total isoflavone concentrations in µg aglycone equivalents per gram of the sample reported on a dry matter basis, in various 
samples of a cold grind process trial. 
 
Sample names (CG process) M% Din Gln Gin Dein Glen Gein TotalA (µg/gm) 
Soybeans for indirect process 10.0 805.66 184.55 948.33 19.11 51.77 ND 1273.40±1.13a 
Ground beans 86.2 350.00 100.72 424.63 390.57 72.24 269.13 1275.34±1.35a 
LOX treated 85.0 418.80 95.13 464.60 269.73 57.33 201.86 1135.78±5.55ab 
Okara 74.0 361.96 94.46 419.73 171.92 29.65 105.19 850.41±1.01c 
Soymilk1 89.4 1158.86 216.50 1164.71 73.30 8.11 50.56 1705.88±2.68d 
Soymilk after TI deactivation 90.4 1162.18 218.43 1150.72 ND 5.65 32.81 1606.89±0.57d 
Soymilk after indirect UHT 90.8 1189.00 207.90 1188.30 72.28 7.71 54.78 1736.36±0.61d 
Soybeans for direct process 10.0 798.91 188.00 945.00 21.80 52.94 ND 1273.25±3.94a 
Ground beans 84.2 577.21 103.16 587.65 287.02 55.06 199.17 1326.92±2.76a 
LOX treated 85.2 538.91 92.22 548.98 286.62 54.79 209.45 1281.99±2.30a 
Okara 74.6 315.43 71.33 351.45 224.68 51.53 162.36 896.39±2.94c 
Soymilk1 90.2 1455.81 256.12 1387.95 68.26 8.06 47.19 2043.63±0.08e 
Soymilk after TI deactivation 91.2 1371.02 243.97 1334.43 73.18 7.38 48.75 1956.43±1.94e 
Soymilk after direct UHT 91.0 1198.88 210.33 1211.66 68.11 7.22 46.77 1745.88±1.86d 
 
M  % = moisture %.   Din= daidzin; Gln= glycitin, Gin=genistin; Dein= daidzein; Glen= glycitein; Gein=genistein. ND = not detected. 
Soymilk after TI deactivation = soymilk2. 
Soymilk after direct UHT = soymilk3. 
TotalA = total isoflavones expressed in µg aglycone equivalents ± standard deviation. 
Means with different letters in the same column are significantly different at p<0.05. 
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Table 4.3: Total isoflavone concentrations in µg aglycone equivalents per gram of the sample reported on a dry matter basis, in various 
samples of the DUPLICATE hot grind process trial. 
 
Sample names (HG process) M% Din Gln Gin Dein Glen Gein TotalA (µg/gm) 
Soybeans for indirect process 10.0 749.00 147.05 864.33 ND ND ND 1091.52±2.02a 
Ground beans 87.6 766.45 152.90 835.40 22.58 ND ND 1110.40±1.12a 
LOX treated 87.0 774.84 157.07 879.00 ND ND ND 1122.86±0.02a 
Okara 74.0 426.69 100.65 524.03 18.34 15.84 1.73 688.25±1.62b 
Soymilk1 90.0 941.00 194.75 1071.00 85.00 25.00 41.00 1519.38±2.10c 
Soymilk after TI deactivation 88.6 736.99 149.35 848.77 ND ND ND 1075.92±0.99a 
Soymilk after indirect UHT 90.2 927.14 195.91 1041.53 ND 21.32 0.51 1364.06±0.21d 
Soybeans for direct process 11.0 695.73 126.51 847.41 18.87 50.00 ND 1104.17±1.01a 
Ground beans 82.6 631.32 132.7 722.75 16.49 29.25 ND 967.72±0.42ab 
LOX treated 82.4 686.87 135.28 810.17 19.65 ND ND 1031.86±0.07a 
Okara 74.0 488.34 107.15 578.23 16.80 16.23 1.96 763.01±0.28b 
Soymilk1 88.0 991.58 197.66 1161.41 30.33 ND ND 1487.97±0.92c 
Soymilk after TI deactivation 88.5 869.56 169.3 987.39 20.43 ND ND 1276.69±5.23d 
Soymilk after direct UHT 89.7 923.68 188.83 1008.64 21.94 ND 0.388 1337.38±2.28d 
M  % = moisture %.   Din= daidzin; Gln= glycitin, Gin=genistin; Dein= daidzein; Glen= glycitein; Gein=genistein. ND = not detected. 
Soymilk after TI deactivation = soymilk2. 
Soymilk after direct UHT = soymilk3. 
TotalA = total isoflavones expressed in µg aglycone equivalents ± standard deviation. 
Means with different letters in the same column are significantly different at p<0.05. 
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Table 4.4: Total isoflavone concentrations in µg aglycone equivalents per gram of the sample reported on a dry matter basis, in various 
samples of the DUPLICATE cold grind process trial. 
 
Sample names (CG process) M% Din Gln Gin Dein Glen Gein TotalA (µg/gm) 
Soybeans for indirect process 10.0 749.00 147.05 864.33 ND ND ND 1091.52±2.02a 
Ground beans 84.4 239.61 46.28 345.25 291.15 50.64 184.87 918.32±0.60b 
LOX treated 84.4 236.53 47.50 344.48 301.53 51.28 192.30 935.18±1.41b 
Okara 73.6 213.14 47.12 290.79 166.21 30.71 105.18 644.09±1.87b 
Soymilk1 89.2 846.29 173.79 973.61 71.01 22.87 32.03 1362.20±2.47c 
Soymilk after TI deactivation 90.4 778.33 169.47 927.5 61.35 26.04 24.47 1275.06±3.26c 
Soymilk after indirect UHT 90.2 784.38 168.57 938.06 64.38 24.89 26.83 1289.03±1.71c 
Soybeans for direct process 11.0 695.73 126.51 847.41 18.87 50.00 ND 1104.17±1.01a 
Ground beans 82.6 190.40 39.13 286.89 312.87 49.02 197.93 880.38±1.19b 
LOX treated 82.2 309.21 58.59 393.25 252.58 44.10 159.43 928.14±0.38b 
Okara 72.2 150.17 32.26 237.23 202.41 33.23 128.20 624.42±1.53b 
Soymilk1 87.7 796.99 167.15 900.56 69.186 19.83 31.78 1277.09±0.70c 
Soymilk after TI deactivation 90.5 827.47 177.15 892.21 64.94 24.00 24.94 1289.94±0.38c 
Soymilk after direct UHT 90.0 805.00 164.50 901.20 65.30 23.15 29.70 1278.04±3.08c 
M  % = moisture %.   Din= daidzin; Gln= glycitin, Gin=genistin; Dein= daidzein; Glen= glycitein; Gein=genistein. ND = not detected. 
Soymilk after TI deactivation = soymilk2. 
Soymilk after direct UHT = soymilk3. 
TotalA = total isoflavones expressed in µg aglycone equivalents ± standard deviation. 





The type of grinding process most probably caused a difference in the activity of glucan 
endo-1, 6- β–glucosidase, popularly known as the β-glucosidase. This enzyme present in 
soybean hydrolyzes the isoflavone glucosides, thereby producing the respective 
aglycones (Xie et al., 2003). Grinding of soybeans at a lower temperature resulted in an 
increase in the action of β–glucosidase, as shown by the increase in the concentration of 
aglycones. HPLC data showed that the samples of ‘ground beans’ along with the ‘LOX 
treated beans’ and the ‘okara’ obtained from the cold grind process had a higher 
concentration of aglycones namely the daidzein, genistein and glycitein (Table 4.1). The 
respective samples from a hot grind procedure had little amount of aglycones in them. A 
similar trend was observed in every trial carried out (Table 4.2, 4.3, 4.4). The cold 
grinding of soybeans at a temperature of 45°C favors an enhanced activity of the β–
glucosidase, whereby the isoflavone aglycones, daidzein, genistein and glycitein are 
formed. This resulted in higher aglycone concentrations in samples of the cold grind 
process. Studies by Matsuura and others (1989) observed an activated β–glucosidase 
action under special conditions of processing, such as the soaking of soybeans in water. 
The optimum condition for β–glucosidase activity was also observed at a temperature of 
45°C by these researchers (Matsuura et al., 1995).  It was clear from this study that the 
soaking of soybeans in water for a time period was not necessarily required, but the 
grinding of soybeans with water at 45°C was enough for an enhanced action of β–
glucosidase. The length of time for which the soybeans resided within the lower 
temperature (45°C) was lesser than that would have happened during a soaking 
procedure. However, this short period of time was found enough for the β–glucosidase 
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enzyme to cause its action, thereby leading to the conversion of isoflavone glucosides to 
their respective aglycones. This may be due to size reduction during grinding, which 
facilitates the enzyme/substrate interaction. This also proves that the temperature (45°C) 
of contact of soybeans had a major influence towards the enhanced action of the enzyme 
causing the formation of aglycones. 
 
Isoflavone levels in the final soymilks obtained by hot-grind and cold-grind processes are 
shown in Table 4.1 and 4.2 respectively. It was found that soymilk prepared by hot-grind 
process contained significantly higher (p<0.05) isoflavone concentrations than that 
prepared by a cold-grind process. For example, the total amount of isoflavones in 
soymilk prepared by a hot grind process was 1795.81µg/gm DM and that from a cold 
grind process was 1736.36µg/gm DM. Such a trend of increased isoflavone 
concentrations in hot ground samples compared with that of cold ground samples was 
observed for every trial independent of whether it was direct UHT treated or indirect 
UHT treated (Table 4.2, 4.3, 4.4). Hot grinding caused an increase in the extraction of 
isoflavones into the soymilk compared with cold grinding. Such an improvement in the 
extraction of isoflavones into the soymilk could be due to the higher solubility of 
isoflavones in hot water than in cold water extract (Gugger and Grabiel, 2000). This 
highlights the need for soymilk manufacturers to give a greater preference for hot 
grinding over cold grinding from the point of view of an improvement in the extraction of 
isoflavones into the soymilk. The nutritional quality of soymilk in terms of its 
phytochemical concentration can therefore be improved to a certain extent by using a hot 
grinding procedure for the extraction of soymilk instead of a cold grinding process. 
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4.2 ISOFLAVONE LEVELS IN SOYMILK SUBJECTED TO DIRECT VERSUS 
INDIRECT UHT TREATMENT 
Soymilk prepared by hot grind or cold grind processes were subjected to direct or indirect 
UHT treatment processes so as to extend the shelf life for the product. The soymilk 
samples after a direct/indirect UHT treatment (soymilk3) were also analyzed for their 
isoflavone concentrations.  The total isoflavone amounts in soymilk obtained by the hot 
extraction proceeded by a direct UHT treatment was 1809.28 µg/gm, (Table 4.1) while 
the same by corresponding indirect UHT treatment was 1795.81µg/gm, expressed on a 
dry matter basis (Table 4.1). In a similar way the total isoflavone amounts in soymilk 
prepared by a cold extraction proceeded by a direct UHT treatment was 1745.88 µg/gm 
(Table 4.2), while the same by corresponding indirect UHT treatment was 1736.36 µg/gm 
(Table 4.2). Results of isoflavone analysis showed no significant differences in 
isoflavone levels (p<0.05) in the soymilk subjected to direct versus indirect UHT 
treatment. Considering the phytochemical concentration of the soymilk obtained, 
preference to any one of the two UHT methods is not really recommended, since both the 
processes results in a nearly equal impact on the isoflavone concentrations of the end 
product. Therefore, either a direct or an indirect UHT treatment can be chosen for the 
soymilk processing. 
 
The direct and indirect UHT treatments given to the soymilk were at a temperature of 
143ºC for 10 sec or 140ºC for 4 sec respectively. The differences in temperature and time 
period of application of heat for the direct and indirect UHT processes might have been 
too little to cause a huge impact on the comparative concentrations of isoflavones in the 
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end product. Thus the isoflavone levels in the soymilk obtained after a hot extraction 
followed by a direct or indirect UHT process, remained nearly the same. A similar trend 
was also observed for the soymilk obtained after a cold extraction followed by a direct or 
indirect UHT treatment. However, a UHT process either direct or indirect may have 
resulted in an increase in the concentrations of isoflavones in comparison to the soybeans 
used for extraction. A detailed mass balance study can only help with evaluating the 
same. Less access and confidentiality of certain processing systems utilized for this study 
were certain limitations in carrying out a detailed study. Therefore, only a comparative 
study was carried out instead of a mass balance study to evaluate the isoflavone levels in 
the soymilk prepared by the different UHT heat treatment processes. Results of the 
comparative study on the level of isoflavones in soymilk after a direct or indirect UHT 
treatment showed non-competitive values.  Thus the soymilk manufacturers can choose 
either a direct or an indirect UHT treatment for the processing of soymilk. The kind of 
UHT treatment given to soymilk has little influence towards the level of isoflavones in 
soymilk and it also allows the possibility of having more choices of heat treatment 
options between a direct and an indirect process for the soymilk manufacturers. 
 
4.3 OKARA AND ISOFLAVONE LOSSES 
A large proportion of isoflavones were found to be lost in the soy residue (okara) after a 
hot grind or cold grind followed by decanting.  The comparison of isoflavone levels in 
soybean seeds and okara after calculating them on the same basis of moisture are shown 


















































































Total isoflavones in soybean seeds and okara are expressed in µg aglycone equivalents per gram of sample 
on a dry matter basis.  Soybean seeds are denoted as ‘bn’ and okara as ‘ok’. hg = Hot grind; cg = Cold 
grind. ‘id’ represent an indirect UHT process, while ‘d’ represent a direct UHT process.  hg* and cg* 
represent  hotgrind and coldgrind UHT duplicate trials, respectively. TRP = Traditional soak and grind 
process.  
 
Figure 4.1: Comparison of isoflavone levels in soybean seed and okara during the hot 
and cold grinding trials and from a traditional soymilk process 
 
 
Traditionally, soymilk is made by soaking soybeans in excess water followed by 
grinding, filtering, and cooking (Liu, 1997). The preparation of soymilk was also carried 
out by a soak and grind process during this study. The traditional soymilk preparation 
was carried out in a local soymilk manufacturing factory under industrial conditions as 
described earlier in chapter two (index no: 2.1.2.2). The soymilk residue or okara is 
removed during the filtration process. A certain amount of fat, carbohydrate, protein and 
isoflavones are also removed along with the okara during such type of filtration 
processes. The amount of isoflavones lost into the okara during the traditional soymilk 
making process was therefore determined in this study. The soybeans used for the 
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traditional soymilk making process contained 1530.67 µg/gm of isoflavones, while the 
okara contained 519.27 µg/gm of isoflavones, expressed on a dry matter basis (Figure 
4.1). Results of HPLC analysis showed that the amount of isoflavones fractionated into 
the okara during the traditional soymilk manufacturing process was comparatively lower 
than the amount of isoflavones being lost into the okara during a ‘no soak procedure’ 
used for soymilk making. Studies conducted by Wang and Murphy (1996), reported as 
recovering high levels of isoflavones in the soymilk by pressing the okara. The results of 
isoflavone analysis in okara obtained from the soak and grind process showed similar 
results by retaining lesser amounts of isoflavones in them. Lesser amounts of isoflavones 
were fractionated into the okara of a traditional soymilk making process, when compared 
with that of the amounts present in the soybean seeds used for its preparation.  
 
This highlights the need to evaluate the advantages and disadvantages of automated and 
advanced processing systems used for soymilk preparations on an industrial scale. 
Retaining the isoflavones in the prepared soymilk is also an equally important parameter 
of nutritional significance while considering such type of processing modules. A high % 
of solid matter is being removed as okara and it is considered as an industrial waste with 
much of it being used as a landfill.  Therefore, it is very essential to at least identify the 
processing conditions such that the losses of nutrients into these waste products can be 
minimized either by optimizing the desired processing steps or by choosing alternative 
processing methods. Okara is not utilized fully as food or feed sources, until recently; 
okara powder has been used to partially replace wheat flour for bread making.  It is 
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therefore imperative to conduct further studies on the ways to minimize the loss of 
isoflavones into the okara and to maximize the extraction of isoflavones into the soymilk.  
 
4.4 GENERAL DISCUSSION 
Among the different processing conditions, the type of heat treatments given to soymilk 
during the extraction and sterilization processes are the major parameters that determine 
the yield and nutritive value of the final product obtained. Much of the research to date 
has been done on the understanding of the availability of lysine, thiamine and riboflavin 
of soymilk during heat treatment (Kwok and Niranjan, 1995; Kwok et al., 1998). The 
available lysine content in heat-processed soymilk has a nutritional implication, where it 
has been correlated with the biological value (PER) and pepsin digestibility (Van Buren 
et al., 1964). High temperature heat treatments given under optimum conditions are 
found to improve the protein quality (Kwok et al., 1998). The superiority of application 
of UHT heat treatment in maximizing vitamin retention was also discussed by Kwok et 
al (1998). Though isoflavones are not classified as nutrients, they reportedly affect 
human health as much as vitamins and minerals. But the effect of isoflavones during 
UHT processing has never been studied in detail. 
 
Ideally, an optimal thermal process for soymilk is the one which results in maximum 
destruction of bacterial spores with minimum degradation of sensory and nutritional 
quality. This study reveals the fate of isoflavones during the extraction and UHT 
processing of soymilk. Such data are very useful for process optimization during a 
soymilk preparation. Nowadays, in large-scale production of soymilks, automated 
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extraction and UHT systems are being used. Though such systems offer time and energy 
savings, the question still remains whether there is a conflict between an ideal system and 
optimal retention of important functional and nutritional components into the soymilk 
during its manufacture.  Since the health claim places soybean products into a selected 
category of foods that possess unique medicinal and nutritional values, its quality need to 
be maintained or not at least lowered by utilization of high technology and advanced 
processing systems. Under the many constraints of using such type of soymilk processing 
systems, some advantages and disadvantages are inevitable consequences of thermal 
processing. However, a comparative study on the level of isoflavones followed here, 
helped in identifying the process module which can be best chosen to retain the 
maximum amount of isoflavones in the end product. This is the first study on a 
continuous pilot plant unit using different extraction systems and UHT treatments to 
process soymilk. Moreover, the results on the fate of isoflavones are also useful while 
defining mathematical and kinetic models to understand the maximum retention of 
nutrients in the soymilk prepared by the UHT process. 
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CHAPTER 5 
EFFECT OF DIFFERENT COAGULANTS ON THE ISOFLAVONE 
LEVELS AND PHYSICAL PROPERTIES OF FIRM TOFU  
 
Tofu is a more widely accepted food among the soy food product categories. It is made 
by the coagulation of soymilk with salt or acid to produce a soy protein gel which traps 
water, soy lipids and other constituents in the matrix. Different types of coagulants are 
used for the coagulation of soymilk to obtain tofu. However, limited information is 
available about the selection of suitable coagulants for the production of tofu.  
 
Tofus made from different coagulants cannot be easily differentiated between each other 
since they all appear similar but, their structural and other properties may be different. 
The knowledge of the effect of different coagulants in retaining isoflavones in tofu 
remains almost unknown. Considering the phytochemical concentrations of tofu, it was 
deemed essential to understand the type of coagulants that can best retain the maximum 
amount of isoflavones in the prepared tofu. The quantification of isoflavones in tofu 
samples and the separated wheys were therefore carried out using the HPLC method 
developed for isoflavone analysis during this study. Each coagulant may produce tofu 
with different textural properties and equally important are the physical properties of 
tofu, which characterize its acceptance. The physical properties of tofu prepared from 
different coagulants were also determined in this study and a comparative evaluation in 
physical properties between them was further carried out. Thus an understanding of the 
total effect of different coagulants towards the physical properties and isoflavone 
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contents in tofu was made possible. These studies helped in identifying the most suitable 
coagulant that not only resulted in a firm tofu with better physical properties but also one 
in which the highest amount of isoflavones were retained. 
 
5.1 EFFECT OF DIFFERENT COAGULANTS ON THE ISOFLAVONE LEVELS 
IN TOFU 
Identity preserved ‘Harovinton’ beans were used for the preparation of soymilk. The 
amounts of daidzin, glycitin, genistin, daidzein and genistein in soybeans used for this 
study were determined, and the contents were found to be 1022.19 ± 13.2, 111.52 ± 7.8, 
1049.32 ± 15.4, 37.14 ± 0.77 and 16.90 ± 0.53µg/gm respectively, on a dry weight basis.  
Extraction followed by a mild saponification utilized in this study and as described earlier 
in Chapter two (index no: 2.2.8.1) converted all the isoflavone glucoside ester forms into 
their corresponding glucosides. Further to which, the total amount of isoflavones in 
soybeans were expressed in aglycone equivalents and this corresponded to a total of 
1405.50 ± 17.3µg/gm, on a dry weight basis. Soymilk was prepared in bulk from a single 
batch of the above soybeans and the prepared soymilk was also analyzed for its 
isoflavone concentrations. The prepared soymilk had a total of 182.19 ± 0.36 µg/gm of 
isoflavones on a wet weight basis, which was equivalent to 1570.64 µg/gm on a dry 
weight basis. This particular batch of soymilk was henceforth used for the preparation of 
tofu. 
 
The different coagulants used in this study for the preparation of tofu were calcium 
sulfate, magnesium sulfate, calcium chloride, magnesium chloride, calcium acetate, 
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calcium lactate and acetic acid solution. All the calcium salts, magnesium salts and the 
acidic coagulant (acetic acid) used in this study precipitated the soymilk proteins. Tofus 
were prepared using every coagulant at two different concentration levels, except for the 
acidic coagulant. The coagulant concentrations used for tofu preparation were 0.4 and 
0.5% based on the amount of soymilk used.  The lowest concentration of coagulant 
applied by Lu et al (1980) to obtain coagulation was 0.1% for calcium chloride, 0.2% for 
calcium lactate and 0.3% for calcium sulfate.  Moreover, coagulants such as calcium 
sulfate, calcium lactate and calcium acetate used at 0.1 – 0.2% were found not to result in 
soybean curd formation by some researchers (Lu et al., 1980; Kamel and de Man, 
1982), while precipitating the soy proteins with 0.6% of coagulants like calcium sulfate 
was found to form too hard a tofu by other researchers (Schaefer and Love, 1992; Kao 
et al., 2003). Tofu is a perishable food product and its preparation over a wider range of 
coagulants (0.1 - 0.6%) for many different coagulants was not possible in this study, 
since the physico-chemical properties along with its isoflavone evaluation need to be 
carried out immediately after its preparation. Hence during this study which involved 
many different types of coagulants, the concentration of coagulants utilized for the 
preparation of tofu was 0.4 - 0.5%, which is neither the least nor the highest levels of 
coagulant usage. Moreover, the concentration level of the coagulants so chosen was also 
the typical amounts used for tofu formations. Tofu was also prepared using 5% of acetic 





Table 5.1: Comparison of isoflavone contents in soybean curds prepared using different 
coagulants 
 
Coagulant type Usage level  (% w/w) 
Tofu obtained 
    (gm) 
Isoflavones in tofu (µg/gm)  
on a dry wt basis  
Calcium sulfate 0.5 225.36a 1317.88 ±6.77e 
Calcium sulfate 0.4 232.49a 1424.00 ±0.67f 
Calcium chloride 0.5 210.18b 1301.06 ±2.43ei 
Calcium chloride 0.4 209.99b 1295.85 ±2.41eh 
Magnesium sulfate 0.5 246.26ac 1333.77 ±0.19e 
Magnesium sulfate 0.4 234.49a 1282.16 ±1.21g 
Magnesium chloride 0.5 203.46b 1279.54 ±4.69g 
Magnesium chloride 0.4 219.27a 1279.54 ±1.11g 
Calcium acetate 0.5 195.14d 1280.18 ±4.24g 
Calcium acetate 0.4 192.75d 1285.30 ±3.98g 
Calcium lactate 0.5 220.55a 1301.81 ±6.01ei 
Calcium lactate 0.4 232.20a 1292.36 ±4.20 eh 
*Acetic acid 5%  20ml 212.50b 1280.18 ±7.03g 
 Isoflavones reported as µg aglycone equivalents per gram of tofu, expressed as the mean ± standard 
deviation. Like superscripts in the same column do not differ significantly at p≤ 0.05.   
*Acetic acid 5% solution of 20ml was used for the preparation of a tofu. 
 
 
Table 5.1 shows the effect of different soy protein coagulants on the level of isoflavones 
in the prepared tofu. Coagulation of soy proteins by calcium salts is caused by the cross-
linking between protein molecules by the calcium ions (Wang and Hesseltine, 1982). 
When calcium sulfate was used as a coagulating agent, it was observed that the tofu 
prepared from lower concentration of calcium sulfate (0.4%) gave a higher product yield 
than when higher concentration (0.5%) was used. The same tofu coagulated with 0.4% 
calcium sulfate was also found to contain a higher concentration of isoflavones than the 
other. The decrease in the yield of tofu with increasing calcium sulfate concentration 
could be due to increasing syneresis and loss of whey from the curd as more bonding 
occurred thus making the protein matrix denser and compact (Sun and Breene, 1991). 
Moreover, calcium sulfate was also found to be a better coagulant than calcium chloride 
in terms of the yield of tofu and in the retention of isoflavones in the tofu. The differences 
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in the speed of the different coagulants in precipitating the soy protein might be an 
explanation for such an effect.  
 
The chloride salts, calcium chloride and magnesium chloride were found to be rapid in 
their action of coagulating the soy proteins. After the addition of these coagulants into the 
soymilk, a quick formation of curd was observed whereby the wheys separated fast. In 
comparison and visualized by naked eye as the separation of whey occurred, the 
coagulating speeds of the respective sulfate salts were found to be very slow. A time 
period of more than 8min was required for the curd formation to occur when using the 
calcium and magnesium sulfate salts. However, the quick coagulating power of calcium 
chloride resulted in more exclusion of isoflavones into the whey during the coagulation 
process. The calcium chloride coagulated tofus had a lesser concentration of isoflavones 
compared with the calcium sulfate coagulated tofus. Using calcium chloride at 0.4% or 
0.5% level did not cause a significant difference in the yield of tofu (p<0.05), though 
there was a minor difference in the concentration of isoflavones in them (Table 5.1). Thus 
the rapid action of certain coagulants like calcium chloride in forming the coagulum than 
the slow acting salts like calcium sulfate might cause a significant reduction in the 
amount of isoflavones in the tofu prepared from it.  
 
Magnesium ions can also be used instead of calcium ions for soy protein coagulation, 
since this divalent cation can form crosslinking between the protein molecules. But the 
sites of crosslinking in the protein molecules may be different for both calcium and 
magnesium ions causing the latter to form a loose network. The exact mechanism of gel 
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formation together with its stabilization effect caused by magnesium ion is not clearly 
understood, where by its effect may be different from that caused by calcium ions. 
However, similar to the results of calcium salts, the magnesium sulfate coagulated tofu 
was also found to contain higher isoflavone concentrations than the magnesium chloride 
coagulated tofu.  
 
Calcium lactate and calcium acetate are rarely used as coagulants for tofu manufacture. 
The possibility of using these calcium salts as suitable coagulants was explored during 
this study and their impact on the level of isoflavones in the prepared tofu was further 
evaluated. These calcium salts have a major advantage of being more soluble in water 
than calcium sulfate and hence its ease of handling. Results of analyses showed that 
calcium lactate is a better coagulant than calcium acetate, in terms of the yield and 
retention of isoflavones in the tofu. However, the isoflavone concentrations in calcium 
acetate tofu were found to be equivalent to that present in magnesium chloride and acetic 
acid coagulated tofu (Table 5.1), which means it could form a protein network with more 
isoflavone entrapment, though the yield of tofu was lower. There are no reports available 
on the isoflavone contents in calcium acetate or calcium lactate coagulated tofu.   
 
A mild acetic acid solution is commonly used as a tofu coagulant, especially in Indonesia 
(Shurtleff and Aoyagi, 1979b). The application of acetic acid is mainly to increase the 
shelf life of tofu and for imparting a mild acidic taste.  In this study, a 5% acetic acid 
solution was used for the preparation of tofu. The mechanism of action of an acidic 
coagulant in causing the soy protein to coagulate is probably different from that of 
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calcium or magnesium salts, but the retention of isoflavones in acetic acid coagulated 
tofu was found to be similar to some calcium or magnesium salt coagulated tofu. Reports 
were not available on the preparation of acetic acid coagulated tofu or the analysis of 
isoflavone amounts in acetic acid coagulated tofu and wheys. Results of HPLC analysis 
showed that the concentration of isoflavones in acetic acid coagulated tofu was much 
similar (p≤0.05) to that of the isoflavone concentrations in magnesium chloride and 
calcium acetate coagulated tofu (Table 5.1).  
 
5.2 EFFECT OF DIFFERENT COAGULANTS ON THE PHYSICAL 
PROPERTIES OF TOFU 
Tofu being bland in taste, properties such as the texture, color and moisture are the 
different parameters that ultimately determine the quality of a tofu obtained. Even though 
the concentration of coagulants used in this study was within a narrow range of 0.4 - 
0.5%, the tofu obtained differed in their physical properties, especially in their texture 
characteristics. The network formation of tofu generally involves the denaturing of soy 
protein followed by their aggregation with a coagulant and formation of a network. 
However, different coagulants might have resulted in the formation of tofus with 
different moisture, texture and yield. While the phytochemical concentrations of tofu are 
critical in terms of its functional food value, the physical properties of tofu are equally 





5.2.1 Evaluation of the yield, moisture and color of tofu 
Table 5.2 shows the results of the yield, moisture and color of tofu obtained after using 
different coagulants.  
 
Table 5.2: Yield, moisture and color of tofus prepared using different coagulants 
 
Color determination Coagulant type 
Usage level  
Usage 






(gm) L a* b* 
Calcium sulfate 0.5 79.2 225.36a 85.65 0.535 24.39 
Calcium sulfate 0.4 79.5 232.49a 85.82 0.281 24.95 
Calcium chloride 0.5 76.6 210.18b 86.66 0.421 23.01 
Calcium chloride 0.4 76.1 209.99b 86.57 0.388 22.79 
Magnesium sulfate 0.5 79.6 246.26a,c 86.41 0.003 23.00 
Magnesium sulfate 0.4 78.7 234.49a 85.78 0.359 23.74 
Magnesium chloride 0.5 78.3 203.46b 86.56 0.435 23.12 
Magnesium chloride 0.4 78.7 219.27a 86.98 0.280 23.30 
Calcium acetate 0.5 77.3 195.14d 85.96 0.549 23.56 
Calcium acetate 0.4 77.4 192.75d 85.91 0.614 24.19 
Calcium lactate 0.5 79.0 220.55a 86.53 0.320 23.30 
Calcium lactate 0.4 79.7 232.20a 85.97 0.287 23.72 
*Acetic acid 5%  20ml 76.8 212.50b 86.73 0.657 22.36 
        Tofu M% = percentage moisture in tofu.  
       *Acetic acid 5% solution of 20ml was used for the preparation of a tofu. 
        Like superscripts in the same column do not differ significantly at p≤ 0.05.   
 
 
Comparison of the tofus coagulated with sulfate and chloride salts, the slow acting 
coagulants gave a better yield of tofu than the rapid acting ones. The rapid curd formation 
observed for coagulants like calcium chloride and magnesium chloride might have 
caused the formation of aggregates that are too large in size to form a good gel and a 
uniform distribution of coagulant might be difficult to be achieved during such a rapid 
reaction between the soy protein and the coagulant. The yield of tofu is very critical 
especially for the tofu manufacturers. To slow down the reaction with soy proteins, 
mixing of rapid acting coagulants with the slow acting coagulants is done by many tofu 
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manufacturers on an industrial scale. Used at the same concentration levels, sulfates gave 
a better yield of tofu than their respective chlorides. Isoflavone analysis also showed the 
sulfate salt coagulated tofus as retaining a higher concentration of isoflavones in them 
than the chloride salt coagulated tofus. Among all the different coagulants of this study, 
calcium sulfate at 0.4% level was found to give the highest yield of tofu. While the yield 
of calcium acetate tofu was the least, the yield of acetic acid coagulated tofu was found to 
be nearly the same (p≤0.05) as when using calcium chloride or magnesium chloride as 
coagulants (Table 5.2). 
 
With regard to the color, either white or creamy white color is the desirable tofu 
characteristic. Every tofu produced had a creamy white color. The L values for the tofus 
ranged from 85.93 to 86.41 while a* and b* values ranged from 0.003 – 0.657 and 22.36 
– 24.95, respectively. The different coagulating agents were found to have a little effect 
(p≤0.05) on the color of tofu, especially when using the same lot of bulk soymilk, as in 
this case. The acetic acid coagulated tofu showed the highest a* value (0.657), indicating 
an increase in the redness and a low b* value (22.36), indicating a decrease in the 
yellowness for this particular tofu.  
 
The moisture content of tofu samples varied with the use of different coagulants and 
ranged from 76.1 – 79.7%. The variation in the moisture content of tofu obtained after 
using different coagulants is probably due to the differences in gel network influenced by 
different anions and its ionic strengths towards the water holding capacity of the soy 
protein gels. Thus the coagulant concentration and the type of anion will further affect the 
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hardness of an obtained tofu. The high moisture content accounted for a higher tofu yield 
since excess water became incorporated into the tofu (Wang and Hesseltine, 1982; Sun 
and Breene, 1991). Such a positive correlation between tofu yield and moisture contents 
has also been observed by Cai et al (1997). Tofu with high moisture contents appeared 
smooth while those with low moisture contents had a coarse texture by visual 
examination.  
 
5.2.2 Evaluation of the textural properties of tofu 
 
 
Figure 5.1: Typical texture profile analysis curve obtained for a firm tofu 
 
The use of different coagulants appeared to primarily influence the textural parameters of 
a tofu obtained. The ‘texture profile analysis’ performed on each of the prepared tofus 
helped in evaluating the effects of different coagulants on the firmness of individual tofu 
matrix. The typical texture profile analysis (TPA) curve obtained for a tofu sample is 
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shown in Figure 5.1. TPA analysis helped in obtaining the hardness, cohesiveness, 
chewiness and gumminess of the tofus prepared. Comparing the hardness of the different 
tofus obtained a firm tofu with greater hardness than another would mean it is harder and 
firmer with greater cohesiveness. Such a tofu will possess high elasticity and greater 
chewiness making it more difficult to eat.   
 

















Calcium sulfate 0.5 416.82a 9.66f 0.649g 247.51h 2.39m 
Calcium sulfate 0.4 458.53a 9.69f 0.635g 262.47h 2.54m 
Calcium chloride 0.5 515.29b 9.88f 0.645g 301.46i 2.97m 
Calcium chloride 0.4 484.16b 9.68f 0.648g 286.75h 2.77m 
Magnesium sulfate 0.5 292.49c 9.86f 0.644g 171.89j 1.69n 
Magnesium sulfate 0.4 293.36c 9.89f 0.639g 168.34j 1.66n 
Magnesium chloride 0.5 414.56a 10.00f 0.663g 255.32h 2.55m 
Magnesium chloride 0.4 395.49d 9.88f 0.661g 238.94h 2.36m 
Calcium acetate 0.5 607.77e 10.00f 0.657g 368.84k 3.68o 
Calcium acetate 0.4 617.68e 9.81f 0.652g 368.69k 3.61o 
Calcium lactate 0.5 370.54d 9.82f 0.660g 226.41h 2.22m 
Calcium lactate 0.4 339.42d 9.84f 0.657g 205.39l 2.02m 
Acetic acid 5% 20ml 436.01a 9.37f 0.656g 263.83h 2.47m 
Like superscripts in the same column do not differ significantly at p≤ 0.05. 
Spring* = springiness;   Cohesive# = cohesiveness. 
 
 
The hardness of a tofu made on a production scale may be greater than that obtained by a 
lab scale process, because of the possibility of application of higher pressures for 
expulsion of wheys. However, an equal amount of pressure for a definite time period was 
applied during this study which helped in a comparative evaluation of the textural 
properties of the tofu prepared. The textural properties of tofu prepared using different 
coagulants are shown in Table 5.3.  
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Calcium sulfate coagulated tofu had a hardness value lesser than the calcium chloride 
coagulated tofu. A firm, but not too hard tofu was obtained after using calcium sulfate as 
a coagulant. However, when magnesium sulfate was used as a coagulant the 
corresponding tofu had textural properties which were much different from others. The 
hardness and chewiness of magnesium sulfate coagulated tofu was less than the hardness 
and chewiness of every other tofu prepared in this series. While the moisture content of 
this tofu was higher, that of its whey was the least among all the others. Probably an 
incomplete precipitation of soy proteins occurred and instead of having a compact protein 
network, it had a loose network encompassing many air gaps within it. This might be one 
of the reasons why magnesium sulfate is rarely used alone as a coagulant for firm tofu 
preparation. It is commonly used after mixing with other nigari type coagulants such as 
magnesium chloride and calcium chloride (Hou et al., 1997). However, comparatively 
higher levels of isoflavones were found in magnesium sulfate-coagulated tofu. Moreover 
the magnesium sulfate-coagulated tofu retained a higher concentration of isoflavones 
than its chloride salt-coagulated tofu. 
 
Compared with the other coagulants of study, calcium acetate resulted in a tofu with 
greater hardness, accompanied by a maximum release of wheys and lesser amounts of 
tofu. TPA data revealed this tofu as the hardest tofu among all the tofus obtained during 
this study (Table 5.3). A tofu with lower yield contained less water and would be harder 
and such a condition was well observed in the case of calcium acetate coagulated tofu. 
The high hardness of calcium acetate tofu is probably one of the reasons that make it less 
acceptable for human consumption. While the lower yield of this tofu might be of 
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concern for the tofu manufacturing industry too. The acetic acid coagulated tofu showed 
comparable textural properties to the calcium sulfate coagulated tofu, though the yield of 
this tofu was less than the latter.  
 
5.3 EVALUATION OF THE EXPELLED TOFU WHEYS 
Tofu whey is the residual liquid separated during the production of firm tofu.  Removal 
of whey by pressing is requisite, to obtain a compact and close network of firm tofu. The 
amount of whey released varied with the type of coagulant used for the preparation of the 
tofu. This variation in the amount of whey was due to the different water holding 
capacities of the tofu. Recent studies by Jackson et al (2002), illustrated the probability 
of leaching of isoflavones into the whey, however, a clear understanding on the effect of 
different coagulants towards the ability to retain isoflavones in the tofu and its leaching 
into the wheys were described as unknown. Moreover, whey is considered as a waste 
stream and hence its nutritive value is always neglected. This is the first set of studies, 
which analyzed wheys in a very sequential manner to identify the loss of isoflavones. The 
pH of the expelled wheys was also determined during this study for an understanding of 
the coagulation effect caused by individual coagulants towards the curd formation and its 
influence towards the tofu properties.  
 
5.3.1 Tofu wheys and pH effect 
Table 5.4 shows the details of the amounts of wheys expelled during the different tofu 
preparations, together with its pH and isoflavone concentrations.  
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Table 5.4: Amount, pH and isoflavone contents in the wheys collected during tofu 
preparation 
 








Isoflavones in whey 
(µg/gm) 
wet wt basis 
Calcium sulfate 0.5 96.2 257.08 5.76 101.30±0.47 
Calcium sulfate 0.4 96.2 249.27 5.77 102.12±0.18 
Calcium chloride 0.5 95.9 275.02 5.62 99.23±0.45 
Calcium chloride 0.4 96.1 271.10 5.70 103.35±0.72 
Magnesium sulfate 0.5 95.8 238.36 5.91 106.47±0.13 
Magnesium sulfate 0.4 95.8 246.89 5.91 111.11±1.34 
Magnesium chloride 0.5 95.8 279.11 5.74 103.88±0.58 
Magnesium chloride 0.4 96.2 265.60 5.84 103.73±0.38 
Calcium acetate 0.5 95.8 292.79 5.90 98.98±0.58 
Calcium acetate 0.4 96.0 293.15 5.91 104.72±0.83 
Calcium lactate 0.5 96.2 262.02 5.92 105.19±0.15 
Calcium lactate 0.4 96.2 247.45 5.95 109.51±0.54 
Acetic acid 5% 20ml 96.7 263.43 5.29 102.79±1.04 




Comparing the sulfate and chloride salts, the pH of the chloride salt tofu wheys were 
found to be lower than that of the equivalent sulfate salt tofu wheys. The pH of the 
magnesium sulfate tofu whey was 5.91 when the concentration of coagulant used was 
either at 0.4 or at 0.5% level. A decrease in pH was always described as essential for the 
coagulation of soy proteins by many researchers (Lu et al., 1980; Kamel and de Man, 
1982). However, when compared to calcium sulfate and calcium chloride, the decrease in 
pH caused by magnesium sulfate and magnesium chloride respectively, was far less. 
These results suggest that calcium ions are stronger and more sensitive in combining with 
soy proteins than the magnesium ions.  
 
The amount of whey released was higher for calcium acetate tofu than for calcium lactate 
tofu (Table 5.4). The pH of calcium acetate and calcium lactate tofu wheys were found in 
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a very narrow range of 5.90 – 5.95. A decrease in pH to less than 6.0 is required for soy 
protein coagulation to occur (Lu et al., 1980), but even at the same pH, different 
coagulants behaved differently. For example, the hardness, gumminess and chewiness of 
the calcium acetate tofu were the highest while these values were the least for magnesium 
sulfate coagulated tofu (Table 5.3), though both the tofu wheys had a similar pH. This 
further proves that calcium ions derived from calcium salts like calcium acetate or 
calcium lactate (though not necessarily from calcium chloride or calcium sulfate), might 
bind more strongly to soy proteins than the magnesium ions.  
 
The pH of the whey separated from acetic acid coagulated tofu was found to be the least 
(pH = 5.29) among all the others and it appeared more translucent than any of the other 
wheys collected. This was also confirmed by the least solids present in its wheys since its 
moisture content (96.7%) was the highest among all. The pH decrease caused by acidic 
coagulants like acetic acid might aggregate proteins by weakening the electric repulsion 
and liberates the hydrated water of protein, while the binding of calcium to carboxyl 
groups of proteins might have brought about the association of proteins by calcium salt 
coagulants (Ono et al., 1976). But the results of this study showed the option of using a 
mild acetic acid solution as an alternative for calcium or magnesium salts for the 
preparation of tofu. However, an acetic acid coagulated tofu might not be an extra source 





5.3.2 Isoflavones in tofu wheys 
Tofu wheys consist of complex sugars and are flatulence-causing factors. They are also a 
major disposal material of concern for tofu manufacturers (Uzzan and Labuza, 2004). 
There are no reports about the utilization of tofu whey either as a nutritional liquid or as a 
modified product suitable for human consumption. Recently, it has been used as a 
medium for the production of lactic starters (Thi et al., 2003). However, wheys are also a 
source of minor proteins (Kao et al., 2003). Isoflavones might form complexes with 
protein in soymilk, which can be released together with wheys during the coagulation 
process. Depending on the type of coagulant and its concentration, it is also possible that 
more isoflavones may become excluded from the tofu and pass into the wheys during the 
coagulation process resulting in a lower quantity of isoflavones left in the resultant tofu. 
This can be partially explained as an incomplete coagulation process. Wheys were 
analyzed for their isoflavone concentrations in this study and the concentrations of 
isoflavones in released wheys are shown in Table 5.4.  
 
A significant amount of isoflavone was found to be lost into the expelled wheys 
depending on the type of coagulant used for the preparation of the tofu. On an average 
104.02 µg/gm of isoflavones were lost into the tofu wheys, expressed on a wet weight 
basis. The losses of isoflavones in whey may be due to protein-associated isoflavones 
being released into the whey (Jackson et al., 2002). Wheys appeared very dilute and 
translucent with a moisture content ranging from 95.8 - 96.7%. Release of wheys might 
be essential during a firm tofu preparation, however, steps to minimize the drainage of 
proteins and associated isoflavones into the whey is crucial in order to enhance the 
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functional value of the tofu. The need for proper utilization of this low cost by-product as 
a source of isoflavones or as a functional liquid product is essential. Results of isoflavone 
analysis showed that, tofu wheys can serve as a potential alternative source of 
isoflavones. 
 
An evaluation of the level of isoflavones in the prepared tofus and wheys helped in a total 
understanding of the influence of different coagulants towards the ability to retain 
isoflavones in the product (tofu) and the byproduct (whey) of the process. Obtaining a 
tofu with the desired texture, color and moisture together with its maximized functional 
food value might be critical, but certainly achievable. This research thus identified 
calcium sulfate as the best coagulant in obtaining a high-quality tofu with soft and 
smooth structure. The highest concentration of isoflavones was obtained in tofu with 
0.4% calcium sulfate when compared to the higher percentage of the same coagulant. 
Yield of this tofu was also the highest among all the other different coagulants studied. 
Some studies have also supported the use of calcium sulfate as a highly available source 
of calcium for pre-menopausal women (Martin et al., 2002). Though calcium sulfate is 
the oldest and the most widely used coagulant, it shall still be considered as the most 
superior coagulant with its ability to form a tofu with good texture and with high 
nutritional properties.  
 
A certain amount of isoflavones form complexes with proteins and are released into the 
wheys. But the excess outflow of isoflavones into the whey can be restricted if an 
appropriate coagulant is used. This can help in obtaining a tofu with higher isoflavone 
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content and thereby causing a minimum leaching of isoflavones into the wheys. 
Optionally soybean cultivars containing high isoflavone content can be utilized for the 
preparation of soymilk or tofu. However, limitation exists in their availability. Therefore 
the type of coagulant can be a viable and major option available to every tofu 
manufacturers in obtaining a product with improved isoflavone amounts. The study thus 
substantiated the relationship between the coagulant type and isoflavone amounts in the 
tofu prepared from it. The results of this study can further serve as a guide for process 
optimization of tofu making with respect to the type of coagulant, where it becomes 
essential to retain the maximum nutrients in the tofu prepared, especially when the 
choices of coagulants are plenty. 
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CHAPTER 6 
CONCENTRATION AND PROFILE OF ISOFLAVONES IN SOY 
BASED SUPPLEMENTS, HEALTH PRODUCTS AND INFANT 
FORMULAS: EVALUATION OF ITS LEVEL OF INTAKE  
 
Recent approaches of incorporating soy isoflavones into the diet involve the preparation 
of products containing different concentrated forms of soy extracts. A plethora of soy 
isoflavone supplements and health products are available in the market place. They are 
mainly targeted for the health of women, where they are commercialized as an alternative 
therapy for alleviating menopausal discomfort, for the prevention of osteoporosis or even 
for an improvement in breast health. With the increased consumption of these products, it 
is important to determine their isoflavone content and compositions.  
 
Soy based infant formulas (SBIFs) are another group of foods consumed to a large extent 
by infants with allergies to cow’s milk.  Isoflavones being bioactive phytoestrogens with 
hormonal and non-hormonal activities, an understanding on the concentrations of 
isoflavones in SBIFs are also very important.  Therefore, the objective of the present 
study was to determine the concentration and profile of isoflavones in randomly selected 
samples of commercially available soy isoflavone supplements, soy based health 
products and SBIFs obtained from South East Asia. The HPLC method developed earlier 
served as a convenient method for isoflavone quantification, while ESI-MS was used to 
establish their specific peak identities. 
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6.1 ISOFLAVONES IN SOY SUPPLEMENTS 
The profile and concentration of isoflavones in different commercially available soy 
isoflavone supplements are shown in Table 6.1. The concentration of isoflavones in these 
supplements ranged from 405 - 57570 µg/gm of the product, expressed as aglycone 
equivalents. 
 
Table 6.1: Isoflavone concentrations in commercially available soy supplements, 
expressed as µg aglycone equivalents per gram of the product. 
 
Din Glyin Gin Dein Glyein Gein Product 
Code x103 (µg/gm) x103 (µg/gm) 
Total  isoflavones 
x103 (µg/gm) 
Product A 30.74 4.56 41.95 5.09 2.53 2.03 57.57±0.99a 
Product B 21.38 3.67 62.49 1.05 1.12 0.39 57.03±1.16a 
Product C 17.80 3.15 25.23 0.33 0.60 0.11 29.71± 0.35b 
Product D 11.29 1.97 15.22 0.17 0.25 0.07 18.18±0.09c 
Product E 13.34 5.03 3.66 0.14 0.28 ND 14.08±0.87c 
Product F 5.92 0.89 8.26 0.23 0.20 0.33 10.13±0.21cd 
Product G 6.06 0.85 8.01 0.10 0.12 ND 9.53±0.20d 
Product H 7.36 3.94 2.08 0.31 0.15 ND 8.81±0.13d 
Product I 3.69 0.33 9.35 0.15 0.22 0.09 8.79±0.12d 
Product J 4.67 1.94 1.67 0.13 0.26 1.74 7.28±0.18d 
Product K 3.75 0.99 2.76 0.18 0.11 0.07 5.02±0.05d 
Product L 0.35 0.18 0.13 ND ND ND 0.466±0.02e 
Product M 0.10 0.03 0.17 0.17 ND ND 0.405±0.01e 
Din =Daidzin, Glyin =Glycitin, Gin =Genistin, Dein = Daidzein, Glyein = Glycitein, Gein = Genistein. 
ND = not detected. Total isoflavones reported as mean ± standard deviation. 
Means with common letters are not significantly different at p ≤ 0.05. 
 
 
The highest concentration of isoflavones was found in product ‘A’ labeled as a ‘Hi-Soy 
isoflavone supplement’ and manufacturers of this product were the only ones who labeled 
the profile of individual isoflavones with concentrations and summed up the values to 
obtain the total isoflavones, which equaled 100mg per tablet. But, it is mainly the 
aglycones that are absorbed by the gut and exert their protective effects (Izumi et al., 
2000). Hence the total concentration of isoflavones if expressed as the arithmetic sum of 
12 soy isoflavones, as done by this manufacturer, will only over-estimate the true 
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isoflavone concentration (Erdman et al., 2004). The extraction of isoflavones followed 
by a saponification procedure used in this study and as described earlier in Chapter two 
(index no: 2.2.8.1), converted the different forms of isoflavone glucoside esters into their 
corresponding glucosides, leaving the three parent isoflavones intact. Further, the total 
quantified amounts of isoflavones in soy based products were expressed as µg aglycone 
equivalents per gram of the sample.  The values provided by the manufacturers on the 
labels of the products mostly referred to the total of the 12 soy isoflavones. However, 
after expressing in aglycone equivalent concentrations, the total amount of isoflavones in 
product ‘A’ was only 58.54 mg/tablet instead of 100mg/tablet (as labeled).  
 
The prescribed serving size for each isoflavone supplement differed from manufacturer to 
manufacturer, and the total amount of isoflavones, expressed as aglycone equivalents, per 
serving was therefore calculated from that obtained by HPLC analyses multiplied by the 
weight of the product contents and their serving sizes. The details of the resultant daily 
intake of isoflavones from the soy isoflavone supplements based on their serving sizes 
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Isoflavones in aglycone equivalents/ p iece*
Daily intake of isoflavones in aglycone equivalents
 
Piece* refers to the product form, which is either a tablet or a capsule. 
‘Daily intake of isoflavones’ is calculated from the quantified amounts of isoflavones of a product and 
based on the dosage recommendations given by the manufacturer. 
 
Figure 6.1: Comparison of the amount of isoflavones per tablet or capsule and the 
possible daily intake of isoflavones, expressed in aglycone equivalents for the different 
soy isoflavone supplements. 
 
 
Product B was found to contain 57030 µg of isoflavones  per gram of capsule, and a 
serving of two capsules (each weighing 1.635g)  per day would give a total of 186.48mg 
of isoflavones compared to 58.54mg of product A, served one tablet per day (Figure 6.1). 
This also highlights the importance of the actual weight of a tablet or capsule and the 
serving sizes of the individual soy isoflavone supplements. Consumers may not be aware 
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of this fact and may only be looking for a highly concentrated pill of isoflavones. 
Moreover, the manufacturers compete in showing higher figures on their product labels, 
especially since there is no established and standardized method of expressing the 
concentration of isoflavones. Much confusion also exists for the consumers, when 
comparing the labels of soy isoflavone supplements available over-the-counter and 
produced by different manufacturers. As would be obtained from product ‘B’, a high 
daily intake of isoflavones from some of these products may be of concern, since they 
might result in deleterious effects to humans, which have been shown in animal studies 
(Leopold et al., 1976; Setchell et al., 1987). 
 
Product ‘M’ of ‘multivitamins together with isoflavones’ contained the least amount of 
isoflavones, 405µg/gm, while another product ‘L’ labeled as ‘phytoestrogens from soy 
extract’ had only 466µg of isoflavones per gram of the product. Every soy supplement 
marketed, was found to have some data on isoflavone concentrations, though most of 
their labeling appeared ambiguous. A generalized statement termed “soy isoflavone 
extract of 40%” was labeled on three of the soy isoflavone supplements (A, B & F). This 
labeling will be understood as the product would contain 40% of isoflavones per tablet / 
capsule. The amount of isoflavones per gram of supplement ‘A’ and ‘B’ was statistically 
not different (p≤0.05), while that in supplement ‘F’ of 10.13 mg/gm of sample was found 
to be five times lower than that of A or B (Table 6.1). This shows the huge differences in 
the isoflavone content of identically labeled products of soy isoflavone supplements. The 
wide variations in the amount of isoflavones in these products are of particular interest, 
since it relates to how much isoflavones are consumed with every tablet or capsule taken 
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in orally. Ingestion of  supplements ‘C’ to ‘M’ would provide a daily intake of less than 
30mg isoflavones (Figure 6.1), which is less than or equivalent to the isoflavone amounts 
that can be obtained from a serving of  200ml of soymilk or 100g of tofu (Murphy et al., 
1999). Thus according to the results of this study, the real daily doses of isoflavones in 
aglycone equivalents obtained by 80% of the products studied are only moderate or 
lower, in comparison with the amounts available from natural soy foods. 
 
The profile of isoflavones found in different soy isoflavone supplements also varied 
among one another (Table 6.1). Eight out of the 13 products contained genistin as the 
major isoflavone while the remaining products had daidzin in higher amounts than 
genistin. Depending on the clinical effect being sought, the type of supplement or the 
profile of isoflavones may strongly influence the end point (Setchell et al., 2001).  
 
6.2 ISOFLAVONES IN SOY BASED HEALTH PRODUCTS 
Several soy based health products designed for weight management are considered to be 
suitable for health. These products were mostly prepared from soy protein isolates and 
were either flavored or unflavored. Obtained in powder form (P1 to P11), they need to be 
reconstituted with water or even milk to obtain a diet shake. Few products are labeled as 
having isoflavones in them, while the concentration of isoflavones was not specified in 
any of these products. They being soy protein products, their primary purpose is not as 
isoflavone supplements, but as sources of soy protein.  
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HPLC analysis showed that the level of isoflavones per gram of these products was much 
lower than those in soy isoflavone supplements. Table 6.2 shows the composition and 
concentration of isoflavones per gram of the different commercially available soy based 
health products obtained after HPLC analysis. The level of isoflavones in these products 
ranged from 46.32 - 1333.80 µg per gram of the product. No two products appeared the 
same in their profile and content of isoflavones. 
 
Table 6.2: Isoflavone concentrations per gram of the product and the amounts obtained 
from a serving of the commercially available soy based health products, expressed in 
aglycone equivalents  
 
Product 
code Din Glyin Gin Dein Glyen Gein 
aTotal amount 






P1 822.76 109.44 1148.44 nd 43.60 nd 1333.80±21.64b 33.34 (25g) 
P2 529.57 36.17 1154.62 62.78 19.78 85.16 1235.98±0.36c 43.87 (35.5g)
P3 334.36 53.07 661.79 28.59 31.07 24.65 720.00±19.83d 25.92 (36g) 
P4 181.65 215.99 455.47 7.03 23.46 4.66 568.77±5.18e 14.22 (25g) 
P5 233.66 38.11 532.05 11.08 27.68 10.98 549.32±5.75e 15.38 (28g) 
P6 139.28 17.06 346.28 4.02 5.52 8.65 330.59±12.10f 10.58 (32g) 
P7 38.50 150.78 94.67 1.69 4.38 5.01 189.83±13.68g 14.98 (78.9g)
P8 37.89 2.54 106.65 3.71 4.85 4.95 104.95±1.13h 5.25 (50g) 
P9 33.88 1.99 74.41 3.92 4.33 4.17 80.90±1.21h 2.75 (34g) 
P10 6.95 47.69 22.36 1.06 4.43 nd 54.10±1.06i 3.02 (55.8g) 
P11 5.58 41.03 26.84 nd nd nd 46.32±0.77i 2.74 (59.2g) 
Din =Daidzin, Glyin =Glycitin, Gin =Genistin, Dein = Daidzein, Glyen = Glycitein, Gein = Genistein. 
nd = not detected.  
aTotal amount of isoflavones is the quantified amount of isoflavones obtained by HPLC analysis and 
reported as mean ± standard deviation. 
b – iMeans in the same column with different superscripts are significantly different at p ≤ 0.05. 
*Isoflavone amounts per serving (mg) is calculated from the quantified amounts of isoflavones per gram of 
a product and based on the serving amounts stated by the manufacturer. 
 
‘Product P1’ was found to contain the highest concentration of isoflavones of 1333.80 µg 
followed by ‘Product P2’ with 1235.98 µg per gram of the product. Higher amounts of 
genistin followed by daidzin were present in every soy based health product except for 
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P4, P7, P10 and P11. Product P4 showed a different profile of isoflavones with the 
amounts of genistin>glycitin>daidzin. Products P10 and P11 were produced by the same 
manufacturer, but differed in their amounts of protein, as indicated on their labels. As low 
as 46.32 µg of isoflavones per gram of the product was present in P11, a chocolate 
flavored product, while the same flavored with vanilla, P10 had 54.10µg. Product P10 
had slightly higher protein content than P11 and the same trend was found for their 
isoflavone concentrations as well. The concentration of glycitin was found to be greater 
than the sum of the concentrations of daidzin and genistin for these two products. 
However, genistein was reported to be the most biologically active phytoestrogen 
(Mazur et al., 1998). 
 
From the obtained total isoflavone content of soy based health products and according to 
their serving amounts, the possible intake of isoflavones were calculated and shown in 
Table 6.2. It can be seen that the different soy based health products when prepared 
according to the manufacturer’s directions resulted in different amounts of isoflavones in 
their finished products. This is the first study where several soy isoflavone supplements 
and soy based health products were analyzed in parallel to obtain comparative data of 
their isoflavone profiles and concentrations.   
 
Liquid products of the same category were also obtained during this study. The 
concentration of isoflavones in these ‘ready-to-drink’ products obtained by HPLC 
analysis is shown in Table 6.3.  These products were always found in open shelves in 
nutrition/ health shops and were stored at ambient temperatures.  
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Table 6.3: Isoflavone amounts in different ready-to-drink products, expressed as µg 
aglycone equivalents per gram of the product.  
  RD# is the ready to drink product code. 
  Din =Daidzin, Glyin =Glycitin, Gin =Genistin, Dein = Daidzein, Glyein = Glycitein, Gein = Genistein. 
  ND = not detected. 
  Total isoflavones reported as mean ± standard deviation. 
  Means with common letters are not significantly different at p ≤ 0.05. 
 
 
Product ‘RD2’ and ‘RD3’ are ready-to-drink products (RD) flavored with vanilla and 
chocolate respectively, and are products from the same manufacturer. A complete serving 
size of 250ml of RD2 and RD3 provided a total of 21.70mg and 2.80mg of isoflavones 
respectively (Figure 6.2). Though both RD2 and RD3 showed a protein content of 
9.3g/serving, the level of isoflavones in them were drastically different from one another. 
Moreover, the Product RD2 appeared to be the ready-to-drink form prepared from 
Product P10, which is the powdered form of the product intended for the same 
application. But the profile of isoflavone in this product was much different, with the 
glycitin concentrations nearly 14 times greater than the sum of daidzin and genistin 
concentrations. This product might be manufactured from soy germ extract, as glycitin is 
the major isoflavone of the soybean hypocotyls (Gugger, 2002). Every RD product 
appeared to be made from soy germ, since they showed very high concentrations of 
glycitin. Little information is available about the biological activity of glycitin and 
glycitein, though its estrogenicity is considered lesser than that of daidzein and genistein.  
 
RD# Din Glyin Gin Dein Glyein Gein Total isoflavones  (µg/gm) 
RD1 7.03 45.03 14.86 0.53 0.83 0.43 44.06±1.80a 
RD2 2.29 115.43 5.87 4.22 0.45 ND 83.28±1.39b 
RD3 1.46 9.13 5.03 0.55 ND ND 10.40±0.01c 
RD4 2.28 73.59 6.77 1.76 0.91 ND 55.18±0.58ab 
















































The serving size (ml) for each ready-to-drink product is indicated.  
Protein content in 100gm of individual product samples is represented as p%.  
 
Figure 6.2: Total isoflavone amounts obtained from a serving of the different ready-to-
drink products  
 
The intake of isoflavones after the consumption of these RD products ranged from 2.80 -
21.70mg, per serving (Figure 6.2). Though soy protein isolate was the major protein 
source in these RD products, they also contained milk proteins and sodium caseinate in 
them. When other food components such as casein and flavouring materials are added to 
the soybean product, the overall isoflavone concentrations would be lowered. Moreover, 
in such a case, the protein content in the product cannot be directly correlated with their 
isoflavone concentrations. 
 
On an average, the amount of isoflavone intake obtained from a serving size of the RD 
product (Figure 6.2) was lower than that obtained from a serving of the soy based health 
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product in the powder form (Table 6.2). However, the profile of isoflavones in these 
products depends on the raw materials used for their preparations, which might be soy 
germ or even soy protein isolate. Analyses showed that the soy based health products do 
not possess the same isoflavone profile or content, as that obtained from soy foods, which 
are produced from whole or de-hulled soybeans. These differences may however lead to 
markedly different plasma isoflavone profiles when ingested (Setchell et al., 2001).  
 
Soymilk and tofu are the most popularly consumed soy foods in the region and are 
gaining popularity through out the world. Analyses of several commercially available 
brands of soymilk from the region (as described earlier in Chapter three) showed an 
average isoflavone concentrations ranging from 76 -199 µg/gm, which can provide 15.20 
– 39.80 mg of isoflavones, from 200ml serving of soymilk, on a wet weight basis. Soft 
and firm tofu samples contained an average of 168.22 and 302.00 µg/gm of isoflavones, 
respectively, on a wet weight basis.  Thus an intake of 100g portion of soft and firm tofu 
types can result in a possible ingestion of less than 16.82 and 30.20 mg of isoflavones, 
respectively (assuming cooking water was not thrown away). Considering the population 
in South East Asia as soy food eaters and good amounts of isoflavones are already 
available to them through these soy foods, an additional intake of soy isoflavone 
supplements or health products may however result in higher ingestion of these 





6.3 ISOFLAVONES IN SOY BASED INFANT FORMULAS 
 
Soy- based foods are used primarily to replace milk or milk-based formulae in the diets 
of children who are allergic and intolerant to milk or having galactosemia. These 
products are largely available in the form of powders that need to be reconstituted with 
water before consumption. Soy protein isolates are the most refined soy protein 
ingredients used primarily for the preparations of SBIFs worldwide (Merritt and Jenks, 
2004). Only a few brands of infant formulas were obtained for this particular study and 
their protein content ranged from 13 - 16%. Though the major ingredient in all these 
infant foods was soy protein; the presence of isoflavones or their amounts was not labeled 
in any of them.  
 
Table 6.4 shows the profile and concentration of isoflavones in different commercially 
available SBIFs. The isoflavone content in these products ranged from 59.50 - 226.84 µg 
per gram of the formula.  These values are in general agreement with those published for 
different other SBIFs from USA and other parts of the world (USDA & Iowa State 
University, 2002). The observed differences in isoflavone concentrations among the 
different SBIFs can be due to the differences in the percentages of soy protein isolates 
used for their preparation. Considering the seasonal variation in the isoflavone content of 
soybeans themselves as a factor of two to five (Tsukamoto et al., 1995), its influence can 
be considerable for soy isolate preparations. Murphy et al (1997) observed a lower 
variation (210- 290 µg/gm of the formula) in the amount of isoflavones in SBIFs 
commercialized in the United States. Results of this study showed the existence of a 
wider variation in the concentration and profile of different soy isoflavones in SBIFs. 
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Table 6.4: Isoflavone concentrations in commercially available soy based infant 
formulae expressed in µg aglycone equivalents per gm of the product in powder form. 
 
Product 
Code Din Glyin Gin Dein Glyein Gein 
Total  isoflavones 
(µg/gm) 
IF1 94.61 14.18 217.79 9.77 4.48 9.62 226.84±1.39a 
 IF2 59.78 10.51 162.47 23.02 12.75 16.00 196.55±16.60b 
IF3 54.60 12.86 140.20 2.82 ND 1.48 133.48±1.45c 
IF4 25.34 4.88 75.60 26.33 5.22 29.04 126.45±6.32c 
IF5 14.40 33.00 33.78 2.19 5.54 0.87 59.54±1.26d 
   Din =Daidzin, Glyin =Glycitin, Gin =Genistin, Dein = Daidzein, Glyein = Glycitein, Gein = Genistein. 
   ND = not detected. 
   Total isoflavones reported as mean ± standard deviation. 
   Means with common letters are not significantly different at p ≤ 0.05. 
 
 
The predominant isoflavone identified in majority of the SBIFs was genistin followed by 
daidzin and glycitin, respectively. Studies by Setchell et al (1997) also found isoflavone 
glucosides as the major isoflavones in five SBIFs collected from the U.S. However, the 
product IF5 of this study was found to contain an equal proportion of genistin and 
glycitin, while daidzin was present in very low amounts. IF5 also contained casein 
besides having soy protein isolate. As a result, the isoflavone concentrations cannot be 
directly correlated to the protein content of the product. 
 
Product IF1, had the highest concentration (226.84µg/gm of formula) of isoflavones 
among the five infant formulas analyzed. The feeding instructions for infants of different 
age group were different for individual formulas. When prepared according to the 
manufacturer’s directions, the calculated concentrations of isoflavones that might be 
ingested by the infants of different age groups are shown in Table 6.5. 
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Table 6.5: Daily intake of isoflavones by infants (categorized based on their age) after 
consuming different soy based infant formulas, expressed in mg aglycone equivalents 
 
 
Serving (g/day)a is the amount of infant formula consumed per day as per the manufacturer’s direction. 
Isoflav (mg/day)b is the calculated intake of isoflavones based on serving sizes and expressed in aglycone 
equivalents. 
c –  fValues of isoflavones bearing common letters are not significantly different at p ≤ 0.05. 
 
 
The daily intake of isoflavones for the infants consuming these SBIFs was found to range 
between 6.71 and 31.21mg depending on the product and age of the infant. Setchell et al 
(1997) found two SBIFs, which can result in an isoflavone intake of 47mg per day for an 
infant of 4-month old. However, the maximum intake of isoflavones from the SBIFs of 
this study for a 3 - 6 month old infant was found to be approximately 31.21 mg/ day. The 
product IF1 contained the highest concentration of isoflavones per gram of the product 
and it also would result in the ingestion of the highest levels of isoflavones through every 
age group. Moreover the serving sizes recommended for this formula was higher 
compared with those of other SBIFs. Product IF4 would provide much lower levels of 




































































































Setchell et al (1997) found in their studies that infants fed SBIFs had 13000-22000 times 
higher circulating concentrations of isoflavones than their plasma oestradiol 
concentrations, which may be sufficient to exert biological effects, whereas the 
contribution of isoflavones from breast-milk and cow-milk was negligible. It might also 
be advisable to reconsider their utilization for infants, especially in the presence of 
hormonal disruption (Fort et al., 1990). 
 
6.4 EVALUATION OF PRODUCT LABELS, CONTENTS, INTAKE AND NEED 
FOR STANDARDISATION OF ISOFLAVONE LEVELS 
Epidemiological studies have shown isoflavones as having various health protective 
effects including the lowering of cholesterol (Anderson et al., 1999), decreasing the 
incidence of different types of cancers (Lee et al., 1991), menopausal symptoms (Dixon 
and Ferreira, 2002) and even osteoporosis (Setchell and Cassidy, 1999). But, soy 
isoflavone supplements sold over-the-counter were found to be targeted mainly for 
women, to help postmenopausal syndromes, to support breast health, and to aid in weight 
control, while the other positive effects of isoflavones were never labeled. This is because 
women being more health conscious and especially being aware of the possible side- 
effects and long term health consequences from using hormone therapy for amelioration 
of the discomforts associated with the menopausal transition (Kurzer, 2003), are more 
inclined towards consuming dietary phytoestrogens as an alternative. However, a wide 
variation was found to exist in the amount of isoflavones in soy isoflavone supplements 
and hence their concentrations need to be standardized. Many studies have also shown 
that isoflavone aglycones are absorbed better than the glucosides (Izumi et al., 2000; 
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Ruiz-Larrea et al., 1997). However, among the different soy isoflavone supplements 
studied, aglycones were found at much lower levels compared with their total isoflavone 
amounts. When expressed in aglycone equivalents, the isoflavone content in these 
products was much lower compared with their labeled amounts. 
 
SBIFs have been generally shown to be nutritionally safe and adequate for normal growth 
of infants. However, it might also be advisable to reconsider their use for infants, 
especially in the presence of possible hormonal disruptions (Fort et al., 1990). Humans 
do not normally have high concentrations of estrogens until after puberty and therefore 
feeding the infants with SBIFs may result in higher concentrations of isoflavones in 
blood and tissue (Badger et al., 2002), which might be of concern. The possible chronic 
effects that might occur after high levels of intake of isoflavones need to be further 
studied to confirm their safety. 
 
The display of isoflavone concentrations on the labels of every soy isoflavone 
supplement, soy based health product and SBIF, if made mandatory, could be more 
advantageous to consumers, researchers and health practitioners, since it can provide 
additional nutritional information. Expressing the isoflavone concentrations in aglycone 
equivalents is recommended as this will enable the consumers to make a better 
comparison of the active ingredients in the products available on the shelves. This study 
further highlights the need for standardization of these products. Urgent research is also 
needed to find the optimal doses of the different isoflavone forms, long term effects and 
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CHAPTER 7 
CONCLUSIONS AND FUTURE RESEARCH 
7.1 CONCLUSIONS 
The major conclusions that can be drawn from this study are the following: 
 
A rapid, simple and reproducible method for the extraction and quantification of 
isoflavones in soy based products was developed using HPLC. The optimized method 
developed for the study separated the six soy isoflavones in a single chromatographic run 
and confirmation of the identified peaks was done by LC-MS. This proved the efficacy of 
the developed method in using it as a routine method for isoflavone analysis. The 
analytical method itself is also a useful tool for further study of isoflavones. 
 
A comprehensive analysis of isoflavone and protein contents in soymilks and tofus 
collected from different South East Asian countries was carried out as part of this study. 
Higher amounts of isoflavones were found in products with high levels of protein. This is 
the first set of studies which give guidelines to choose soymilk and tofus based on their 
protein contents. However, this may not be true, if alcohol-washed soy protein was used 
for the preparation of soymilk. The data on isoflavone amounts in soy products, extend 
the results reported by other researchers like Murphy (1981), Eldridge (1982), Wang et 
al (1990) etc. The database is also useful for clinical researchers, who might wish to 
choose a soymilk with higher isoflavone content, so as to permit smaller volumes of 
soymilk to be consumed for their clinical studies and thereby facilitating compliance in 
dietary intervention studies. 
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Studying the effect of novel, automated and advanced soymilk processing systems used 
lately by soymilk manufacturers, it was found that hot grinding caused an improvement 
in the extraction of isoflavones into the soymilk compared to cold grinding, while there 
was no apparent differences in the loss of isoflavones due to direct UHT heating 
compared to indirect UHT heating.  
 
The studies on the effect of different coagulants used for the preparation of tofu showed 
that the isoflavone content varied significantly with the use of different coagulants. Tofu 
produced using calcium sulfate as a coagulant gave the highest yield of tofu and it also 
retained the highest amount of isoflavones. This was the first set of studies which showed 
the effect of coagulants on the content of isoflavones during the preparation of tofu. 
Okara and wheys, the waste stream of the processes were found to carry certain amounts 
of isoflavones along with them. This study further highlights the need for urgent research 
in converting them to isoflavone ingredient products suitable for human or animal feed. 
 
Considering the recent trend in market flooding with soy isoflavone supplements and 
related products, a comprehensive analysis of isoflavone concentrations in soy based 
supplements, health products and infant formulas from South East Asian countries was 
carried out. Different brands of SBIFs would result in the ingestion of different amounts 
of isoflavones by the infants. The amounts of isoflavones were expressed on the basis of 
aglycone equivalents units and a better comparison of the isoflavone amounts in the 
different products was made possible. Among the products analyzed, soy isoflavone 
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supplements had the highest isoflavone concentrations, followed by soy based health 
product. However, taken in moderate amounts they will most likely provide certain health 
benefits and it is good to educate people in this respect. This study highlights the need for 
standardization in expressing the concentration of isoflavones and the urgent necessity of 
defining specific dietary recommendation for soy isoflavones with regard to individual 
disease prevention. 
 
7.2 SUGGESTIONS FOR FUTURE RESEARCH 
On the basis of the results obtained from the present studies, the following studies are 
recommended: 
♦  Analytical results showed the loss of isoflavones into the by-products of soymilk and 
tofu preparations. Considering okara and whey as rich sources of isoflavones (although 
diluted), these materials need to be utilized and processed further to prevent loosing 
these functionally significant compounds and using them as raw materials for 
isoflavone ingredient product development. The isoflavone ingredient of choice has to 
fit into the organoleptic and physical nature of the developed product (solid or liquid, 
colloidal or clear, powder/bar), the desired ratio of isoflavone to soy protein (especially 
if intending to use the FDA claim for soy proteins), stability and shelf life and finally 
the price. 
 
♦ Information regarding the bioavailability of isoflavones from soy supplements as 
compared with that of soy foods are limited (Setchell et al., 2001). Differences might 
exist in the bioavailability and metabolism of isoflavones dependent on the nature of 
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their chemical form and an evaluation studies will help in understanding the fate of 
isoflavones, its pharmacokinetic properties, bio-potencies as well as the differences 
based on consumption of a supplement instead of soy food.  
 
♦ Toxicological studies related to isoflavones or the amount that may result in deleterious 
effects in human are also unknown. For the same reason, superiority of certain 
isoflavone components in terms of activity and bioavailability, as well as recommended 
dosage, cannot be clearly determined. Studies pertaining to its allowable amounts, 
relating them to specific disease preventions can serve as guidelines for the consumers 
while choosing a soy product for consumption. Determining the Effective Dose 50 
(ED50), Lethal Dose 50 (LD50), or equivalent values of isoflavones with dose-effect 
relationships in animal and human studies are also recommended. 
 
♦ With the recent advances in non-thermal preservation methods of pulsed electric field, 
irradiation, UV light, or chemical preservation, there is absolutely no data concerning 
its influence on the isoflavone profile in soy or isoflavone-enriched products. The 
recent advances in these technologies and the progressive increase in developed soy 
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Two examples of the HPLC calibration reports are shown. 
Appendix A1: LC Calibration Report of genistin 
Appendix A2: LC Calibration Report of glycitin 
 
 
 
 
 
 
 
 
 
 
 
 A
 re
pr
es
en
ta
tiv
e 
ch
ro
m
at
og
ra
m
 o
bt
ai
ne
d 
fo
r a
 sa
m
pl
e 
of
 so
ym
ilk
 b
y 
LC
-M
S 
A3 
APPENDIX: A3 
